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The oxidative behavior of Auranofin, 2,3,4,6-tetra-O-acetyl- 1 -thio-P-D- 
glucopyranosato-S(triethylphosphine)gold(I), was investigated by using cyclic 
voltammetry (CV) in 0.1 M B U & G ~ F & H ~ C ~ ~  and 0.1 M Bu4NPFdCH2C12 solutions 
using Pt working and auxiliary electrodes and a Ag/AgCl reference. CV studies at scan 
rates from 50-2,000 mVs" and Auranofin concentrations between 1 and 4 mM, show two 
irreversible oxidation processes occurring at + 1.1 V and +1.6 V vs. Ag/AgCl. 
Treatment of Auranofrn with the one electron oxidizing agent [Cp2Fe]PF6 gave a 
p-thiolato digold cluster, [(Et3PAu)2( p-SR)]? and the disulfide, 
bis(tetraacetlythiog1ucose). A mechanism for Auranofin oxidation is proposed on the 
basis of chemical and electrochemical studies. The p-thiolato species is also obtained by 
treatment of Auranofin with Et3PAuN03 in CH3CN or addition of methanolic silver 
nitrate to an equimolar mixture of Auranofin and Et3PAuC1 followed by product 
isolation. The X-ray structure is reported for the Auranofin analogue, 
[A1~(PMe~)~(thioglucose)2](NO3)2. The structure of the cluster confirms the coordination 
of two Me3PAu' to a bridging thiolato moiety and the two-thiolates are on opposite sides 
and trans to each other. The gold-gold distances are Aul-Au2= 3.106(7), Aul-AuA= 
3.17 1 ( 1 l), and Au2-Au2A= 3.144( 12)8,. 
The cyclic voltammetry of Solganol, aurothioglucose, was investigated in 0.5 M 
NaC104/H20 solutions using a three-electrode system consisting of a platinum working 
electrode, a platinum-wire auxiliary electrode, and a silver-silver chloride reference 
electrode. A broad peak obtained at +1.2 V, which affected by scan rate and pH changes. 
Multiple CV scans of Solganol showed an enhancement in current due to a possible 
filming on the electrode surface. Bulk electrolysis of Solganol showed n = 2. Chemical 
oxidation using [CpzFeIPFs showed no change in the NIvR peaks and there was no 
change in the color of the mixture. Based on bulk electrolysis, resistance to chemical 
oxidation, and pH studies, the peak at +1.2 V vs Ag/AgCl was assigned as AuVnl. 
A series of binuclear Au(1) halide and thiolate complexes (AuX)2dppbz (X = C1, 
Br, I, p-SC&CH3) were synthesized. All of the newly synthesized complexes gave 
satisfactory elemental analysis and characterized by 'H and 31P NMR. The complex 
(AuCl)2dppbz crystallized in the orthorhombic space group Pbca with a = 16.955(3), 
b = 18.160(2), c = 22.225(1) A, a = p = y =90°, Z = 8 (at 293 K). The Au ... Au bond 
length of 2.99 8, is in the range of gold-gold interaction distance. 
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CHAPTER 1 
Introduction 
Oxidation States of Gold 
Gold can be found in several oxidation states; 0, I, and I11 are the most common 
but complexes containing gold in the -I, 11, IV, V states are known.’,2 Gold coordination 
chemistry is dominated by the oxidation states I and 111. Gold(I), with the electron 
configuration of [Xe]4f45d”, usually forms linear compounds with sp hybridization at 
gold; however trigonal planar (sp2 hybridization) and tetrahedral (sp3 hybridization) 
coordination geometries are known. The first example of a tetrahedral gold(1) center 
characterized by X-ray crystallography, is the bis chelated diphosphine complex 
[Au(dppe)2I2’, where dppe is 1 ,Zbis(diphentlphosphno)ethane.’ 
Gold(1) is a soft metal ion and therefore has a preference for soft donor atoms, 
such as sulfur, over hard ligands such as nitrogen and oxygen. Compounds of gold(III), 
with electron configuration of [Xe]4f4$, i.e. isoelectronic with platinum(II), are square 
planar with four donor atoms. Gold(1II) is a hard metal ion and favors hard donor atoms 
such as nitrogen and oxygen more than gold(I).’” 
In the absence of stabilizing ligands gold(1) disproportionates to gold(0) and 
gold(III), a powerful oxidizing agent. It is this property which precludes the use of 
gold(II1) as a useful pharmaceutical in the reducing mammalian environment. Ligands 
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that stabilize gold(1) include cyanide, phosphines, arsines and a range of sulfur- 
containing ligands (sulfides and thiols for example).’” 
History of Gold in Medicine 
Gold is an ancient metal with a long medical history. The biological benefits 
attributed to gold in history may surpass its monetary attraction. Gold has been used in a 
variety of forms as a medicine by ancient civili~ations.~’~ In medieval Europe alchemists 
had a variety of prescriptions known as aurum potabile, which contained small amounts 
of gold. In the 17‘h century, a gold cordial was used for the treatment of ailments, such as 
fever which was believed to be caused by a decrease in the vital spirit. A mixture of gold 
chloride and sodium chloride, Na[AuC14] was used in the 19* century to treat syphilis. 
Gold cyanide, K[Au(CN)z], discovered by the German bacteriologist Robert Koch in the 
twentieth century, was used as a bacteriostatic toward the tubercle bacillus. Gold therapy 
for tuberculosis was subsequently introduced in the 1920s. The suggestion that the 
tubercle bacillus was the causative agent for rheumatoid arthritis led to the use of gold 
therapy for this disease, which led the Empire Rheumatism Council in 1960 to confirm 
the effectiveness of gold compounds against rheumatoid a r th r i t i~ .~ ,~  
Gold@) Drugs in the Treatment of Rheumatoid Arthritis, Cancer, and AIDS 
Rheumatoid arthritis is a chronic inflammatory disease characterized by erosion 
of peripheral joints. It is a systemic autoimmune disorder of unknown e t i~ logy .~  The 
early gold dmgs used for treatment of rheumatoid arthritis, for almost six decades, were 
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water-soluble gold(1) thiolate complexes such as Myochrysine and Solganol. These drugs 
are administered by deep intramuscular injection at weekly intervals. They provide 
considerable pain relief, decrease joint inflammation, and more importantly, restore joint 
function. Improvement in the disease is not expected for at least four months after 
beginning a course of  injection^.^ During treatment with Myochrysine, gold was found in 
much higher concentrations in the red blood cells of smokers than in the same cells in 
non-~rnokers.~ The reason is that hydrogen cyanide is inhaled by smokers and forms the 
very stable complex, gold cyanide which allows the gold to be taken up and bound to red 
cells. Serious side effects were noticed such as nephrotoxicity, mouth ulcers, skin 
reactions, and blood disorders. The high toxicity and serious side effects led to the search 
for a drug with reduced toxicity and higher pharmacological activity. 
In 1985, Auranofin (Figure 1.1) was reported to be orally effective in human 
rheumatoid arthritis  condition^.^ The advantages of oral Auranofin over injectable drugs 
include lower gold levels in blood and kidney and less t~x i c i t y .~  That the anti-arthritic 
action of Auranofin is due to gold is proven by the fact that the non-gold-containing 
substructures of Auranofin administered to rats have no effect.3k The orally active 
Auranofin drug is slightly less effective than the injectable drugs but causes fewer serious 
side effects. 
There is no unique mechanism of action for antiarthritic gold drugs due to the 
lack of understanding of rheumatoid arthritis. From a practical point of view, the main 
advantage of understanding the mechanism of action would be to improve the therapeutic 
to toxic ratio of gold  drug^.',^,^ 
4 
/OAC 
/OH 
I OAc 
Auranofin 
Solganol 
n 
Myoc hrysine 
Figure 1.1. Structure of gold(1) drugs used as anti-rheumatoid arthritis. 
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Gold compounds such as the tetrahedral complex [Au(dppe)2]Cl have also shown 
promising medical activity as antitumor drugs. The proposed mechanism of action was 
the formation of DNA-protein cross-links.’ Although this compound had remarkable 
activity against cancer cells; it was not entered for clinical trials due to problems with 
cardiotoxicity during toxicology ~ tud ies .~  
The demonstration of antitumor activity of [Au(dppe)2]C1 encouraged wider 
studies on other gold complexes (Figure 1.2). [AuClz(damp)], damp = 
dimethylaminomethylphenyl (Figure 1.2) has been evaluated for human tumor cells.Ib 
Initial studies indicated that this new drug demonstrated modest antitumor activity, seen 
as a reduction in tumor growth, against breast cancer. An evaluation of the antitumor 
activity of Auranofin showed that it was active against some tumor models in vivo but 
ineffective against solid tumors.lb 
The design and testing of gold complexes for antitumor activity over the past 
several decades has been based on three  rationale^^-^: (1) analogies between square planar 
complexes of Pt(I1) and Au(III), both of which are d8 ions; (2) analogy to the 
immunomodulatory effects of gold(1) antiarthritic agents; (3) complexation of gold(1) and 
gold(II1) with known antitumor agents to form new compounds with enhanced activity. 
The discovery that Auranofin had activity against HeLa cells in vitro and P388 leukemia 
cells in vivo led to the screening of many Auranofin  analogue^.^ 
The retrovirus, which causes AIDS, is human immunodeficiency virus (“€I”’). 
HIV is part of a group of slow viruses, which cause diseases that develop extremely 
slowly. A powerful means to attack the AIDS virus would be to find a specific inhibitor 
6 
Au(damp)Xp (X = CI-, OAc-, etc.) 
damp = dimethylaminomethylphenyl 
PPhp 
A 
I I 
I I 
PhpP 
Au 
CI 
Au 
CI 
A 
Ph2P\ Au. /pph2 + 
/ .. 
/ 
Ph2pWpPh2 
d p p e = b is (d i p h e n y I p h 0s p h in o)e t h a n e 
Figure 1.2. Structure of gold(I) complexes used as anticancer. 
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for the replication process of the HIV virus. Gold cyanide, [Au(CN)z]', is found at 
varying levels in patients treated with common antiarthritic drugs. The observation that 
infected cells incubated with gold cyanide showed rapid uptake of gold suggested the 
possibility that gold cyanide might be useful in the treatment of AIDS." Gold cyanide 
can readily enter cells and attack the replication process of the retrovirus in an infected 
host. Interestingly, only 20 ppb of gold cyanide were required to inhibit the replication of 
HIV in vitro." 
The chemistry of gold is intriguing in its history, which is one of the most 
interesting and colorful stories in chemistry. There is little wonder that gold easily 
occupied an honored place when it was considered for therapeutic purposes. 
Many questions remain to be answered in gold chemistry: How are gold drugs 
distributed in the body's organs? How does gold produce its toxic effects? What effects 
do gold drugs have on the immune system? The search for the answer for these questions 
is challenging in studying gold drugs. 
X-ray Structure of Gold@) Drugs 
The X-ray crystallography of Auranofin shows a monomer with a near linear S- 
Au-P linkage (173.6') and virtually identical S-Au (2.29 A) and Au-P (2.26 A) bond 
lengths (Table 1.1 and Figure 1.3)." The glucopyranose ring is not planar but exists in 
the chair conformation. The gold side chain is oriented markedly toward the ring oxygen 
suggesting some type of attraction (Figure 1.3), perhaps Van der Waals nature, between 
gold and oxygen atom. 
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After many decades of effort, the Myochrysine analogue [CsNa2HAu2(STm)2In , 
Figure 1.4, has been crystallized and its structure determined by X-ray crystallography.” 
Using vapor phase deposition, Bau was able to isolate tiny colorless crystals in the form 
of thin square tiles or, more commonly, stubby needles in about two weeks.I2 The 
crystals were allowed to grow slowly over a 2 months period to a size adequate for X-ray 
collection. The structure is polymeric with two interpenetrating spirals. Helices of 
opposite 
handiness occur in equal numbers: the right-handed helices contain exclusively S- 
thiomalate. The bridging Au-S bond distances are 2.28 and 2.26 A. Table 1.1 shows the 
bond lengths (A) and angles (O) of Auranofin, Myochrysine, and related structures. l 2 - I 5  
Table 1.1. Bond lengths (A) and Angles (O) of Auranofin, Myochrysine, and 
related structures. 
R = C~H~PI-‘~, Tm = Thiomalate. 
9 
I 
07 
? 
7 
“7 
H18 
05 
Au 
Figure 1.3. X-ray structure of A~ranofin.’~ 
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Figure 1.4. X-ray structure of Myochrysine analogue.12 
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Bioinorganic Pharmacology of Gold Drugs 
A considerable body of evidence suggests that in vivo gold exists primarily as 
go~d (~ ) .  3 ~ 1 4 ~ 1 5  Gold drugs exposed to body fluids and proteins react predominantly by 
ligand exchange reactions that preserve the gold(1) oxidation Aurosomes 
(lysosomes that accumulate large amounts of gold and undergo morphological changes) 
from gold-treated rats contain predominantly gold(I), even when gold(II1) has been 
administered. Thiols and thioethers, including cysteine and methionine residues in 
proteins and peptides, are capable of reducing gold(II1) to gold(1) (Figure 1.5).16,'7 Even 
disulfide bonds react rapidly to reduce gold(I1I).I6 Thus, it appears that the bulk of gold 
present in vivo is likely to be gold(1). Nonetheless, the potential for oxidizing gold@) to 
gold(II1) in vivo has long been recognized." 
myleoperoxidase/ oxidative burst 
Golddrugs - + Au(1) Metabolites Gold (I11 
thiols, thioethers, disulfides 
Figure 1.5. Biological Redox Cycling of gold(1) and ~ o I ~ ( I I I ) . ~ , * ~  
The high affinity of gold(1) for sulfur and selenium ligands suggests that proteins, 
including enzymes and transport proteins, will be critical in vivo targets. In addition, it is 
12 
clear that extracellular gold in the blood is primarily protein bound, suggesting protein- 
mediated transport of gold during 
Serum albumin, the principal extracellular protein of blood, binds between 80% 
and 95% of the gold in serum and functions as a defacto transport agent. Thirty-four of its 
35 cysteine residues are present as 17 disulfide bonds. Auranofin reacts with the a cys-34 
in albumin via a ligand exchange reaction that displaces the sulfhydryl groups (Figure 
1.6) to form AlbSAuPEt3. The same product is obtained if Et3PAuC1 reacts with 
a l b ~ m i n . ' ~ * ' ~ * ~ ~  The product showed 31P NMR peak at 38.8 ppm (Table 1.2). 
HS-CH,, 
Albumin + Et3P0 
y - CH2\ 
HS- CH2' 
Et3P + , ,A lbumin  
s- CH, 
Figure 1.6. Reactions of serum albumin with Auranofin in buffered aqueous solutions at 
pH values near physiological pH.19 
The free acetylthioglucose liberated from Auranofin reacts further with the 
cysteine-34 disulfide bonds to liberate cysteine and also displaces the Et3P ligand, leading 
to its oxidation (Figure 1.6).20 Under conditions approximating those in vivo, complex 
formation is first-order in Auranofin and has a rate constant of 2.9 k 0.2 s-', which 
13 
Complex 
indicates that Auranofin will have a short lifetime after entering the bloodstream where 
albumin is present in large excess. 
Sadler and colleagues reported a conformational change in albumin that 
accompanies gold binding to cy~-34 .~~ ,"  The rate of gold binding may correspond either 
to the rate of opening of the cys-34 crevice to solvent molecules or to the rate of the 
conformational change that accommodates gold binding. 
Hemoglobin reacts with Et3PAu+ taken up by red cells exposed in vitro to 
Et3PAuCI although it may not be a significant red cell binding site at the lower 
concentrations that prevail during clinical use of Auranofin." 31P NMR evidence is 
consistent with the formation of S-Au-P coordination by displacement of chloride at the 
hemoglobin cysteine p93 residues, which are on the surface of the p subunits." 
31P NMR 
Table 1.2. 31P NMR of Gold -Protein Complexes. 
Alb-S-(AuPEb);! 36.5 
Hb-(SAuPEt3), 7 34.0 
Ref 
23,24 
24 
24 
25 
Previous studies have demonstrated that Auranofin can undergo facile thiol- 
exchange reactions with biological ligands. In acidic medium, like the stomach, the 
reactivity of the thiolate ligand of Auranofin can be enhanced.21 Auranofin reacts with 
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HC1 in aqueous solution and in 50% methanovwater to form 
chloro(triethylphosphine)gold(I) and the product reacts with Auranofin to form a thiolate- 
bridged dinuclear gold complex with two gold triethylphosphine moieties bound to a 
single thioglucose ligand (Figure 1.7). The thermodynamics and kinetics of these 
reactions have been studied in water and in 50% methanollwater. The equilibrium 
constants for the formation of Et3PAuC1 are 4.6 x M-' in 
50% methanol/water.26 The equilibrium constant for the formation of the thiolate-bridged 
digold complex is 1.2 x 1 O3 (water), 1.3 x 1 O2 (50% methanol/water), and 0.7 x 1 O2 (95% 
methanol). The kinetics for the formation of the thiolate-bridged digold complex is too 
rapid to be observed by ordinary mixing techniques. 
M-' in water and 2.0 x 
r l +  
L J 
Thiolate bridged digold complex 
Figure 1.7. Reaction of Auranofin with HCl in water or 50% methanol/water.26 
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Previous Redox Studies of Gold@) Drugs 
Hypochlorus acid (HOCI), which is generated by the enzyme myeloperoxidase 
during the oxidative burst at inflammed sites, can oxidize the gold in Myochrysine to 
gold(II1) in ~i t ro .~’ ,~’  This finding has been extended to additional gold compounds. For 
example, gold(1) thiolates including Auranofin are oxidized to Au(I1I) with preliminary 
or concomitant oxidation of the ligand~.~’ 
Et3PAuSAtg + 5 OC1- + 2H+  AuCli + AtgS03- +Et3PO + H20 +C1- 
AuC1i + RS03- + H20 
1.1 
1.2 l/n[AuSR], + 4 OC1- + 2H’ + 
The dc and differential pulse polarography studies of Auranofin by Perez and 
coworkers at a dropping mercury electrode, establishes that Auranofin undergoes a 
diffusion controlled and reversible reductive redox process at -0.5 V vs. SCE at pH 
greater than 9.5.29 Bulk electrolysis at -0.8 V yields an n value of 1 indicative that 
reduction involves the AuVo couple. Below a pH of about 8.5, a proton dependent 
pathway occurs. Protonation of triethylphosphine @Ka = 8.69) is believed to be 
responsible for the shift in potential as a function of pH. A linear relationship between the 
limiting current and Auranofin concentration was also noted in the concentration range 
3.63 x lo-’ to 5.1 x lom4 M.29 
The reducing properties of antiarthritic drugs such as Auranofin, Solganol, and 
Myochrysine were investigated by Huck and  coworker^.^' The standard redox potentials 
of drugs which instantly react with the oxidant, 5,5’-dithiobis-(2-nitrobenzoic acid), were 
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determined by titration with potassium hexacyanoferrate(II1) in a 0.1 M phosphate buffer 
@H 7.0, 25OC), at a dropping mercury electrode using a SCE reference. Unfortunately, 
none of the gold-containing compounds reacted very quickly with the oxidant and the 
standard potentials could not be measured directly even after long incubation periods in 
phosphate buffer at 37 C. 0 30 
Photophysical Studies of Gold@) Drugs 
The study of the excited state of gold drugs could also lead to significant advances 
in the understanding of the mechanism of Au(1) drugs in the body which are used for the 
treatment of rheumatoid arthriti~.~' According to Corey and Khan, several gold drugs 
have been shown to quench singlet oxygen, ' 0 2  (Table 1.3). They propose that it is by 
this action that gold compounds are capable of aiding in the treatment of the disease 
which appears to be oxygen related.31 
Emission from singlet oxygen occurs at 7752 cm-' .32 The molecule is converted to 
its lower lying triplet state. The quenching of singlet oxygen is thought to occur by 
energy transfer to species with electronic or vibrational states that are energetically 
compatible or by the interaction of singlet oxygen with heavy atoms that have large spin 
orbit coupling. The proposals for the action of gold drugs in the quenching mechanism of 
0 2  have led our group and others to study the photophysical properties of gold(1) 1 
c ~ r n p l e x e s . ~ ~ ' ~ ~  
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Auranofin 
Auranofin is luminescent in the solid state and in EtOH glasses at 77K (Arna = 
0.75 lo7 0 . 2 ~  lo7 
618 Auranofin is also photoreactive (Amaw = 254 nm) in acetonitrile, undergoing 
Et3PAuSCH3 4.5 lo7 3.7 lo7 
p-Carotene 1.1 x 10'O 1.5 x 10'" 
photodecomposition that appears not to include production of elemental gold. 
Table 1.3. Rate constants for the quenching of ' 0 2  by various  agent^:^' 
Quencher I I MethodB I 
dimethylnaphthalene- 1,4-endoperoxide at 3OoC. Method B: solvent, benzene; ' 0 2  
generated by self-sensitized photooxidation of rubrene at 30' C. 
Electrochemistry Overview 
Over the past couple of decades potential sweep techniques, such as cyclic 
voltammetry, have been applied to an ever-interesting range of systems, and at the same 
time the mathematical description of these techniques have been developed sufficiently to 
enable kinetic parameters to be determined for a wide variety of  mechanism^.^^ 
Reversible Systems. A simple reversible reaction can be described by Equation 1.6 and 
0 is the only species present in solution. As soon as a potential where 0 is reduced is 
reached the surface concentration of 0 decreases Gom its bulk value in order to satisfy 
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the Nernst equation and a concentration gradient is set up (Figure 1.8). The surface 
concentration of 0 is further decreased until it effectively reaches zero. Reversible cyclic 
voltammogram can only be observed if both 0 and R are stable and the kinetics of the 
electron transfer process are fast.35 
0 + ne-  = R 1.6 
Diagnostic tests for cyclic voltammograms of reversible processes are as follows:35 
I .  AE, = E,* -E,C = 59/11 mV 
2. Ep-Ep,2 = 59/n mV 
1 A C =  3. I, /I, 
4. I, cc vlR ( v is scan rate) 
5. E, is independent of v 
Irreversible Systems. The most marked feature of a cyclic voltammogram of a totally 
irreversible system is the total absence of a reverse peak. Whereas for the reversible case 
the value of E," is independent of the sweep rate, v, for the irreversible case E: is found 
to vary with the sweep rate (Figure 1.9). It can be seen in Figure 1.9 that increasing the 
scan rate increases the peak separation and the peak height is slightly reduced from that 
for a reversible 
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Diagnostic tests for cyclic voltammograms of an irreversible processes are as follows:35 
1. No reverse peak 
2. I," oc v " ~  ( v is scan rate) 
3. Ep-E,/2 = 48/acna mV 
4. E: shifts -30/acna mV for each decade increase in v 
Quasi-reversible Systems. It is quite common for a process that is reversible at low 
sweep rates to become irreversible at higher ones after having passed through a region 
known as quasi-reversible at intermediate values (Figure 1.10). This transition from 
reversibility occurs when the relative rate of the electron transfer with respect to that of 
mass transport is insufficient to maintain Nernestian equilibrium at the electrode surface. 
Diagnostic tests for cyclic voltammograms of quasi-reversible processes are as follows:35 
1. AEp is greater than 59/11 mV and increase with increasing v 
2. I, /I, 1 provided ccc = a~ = 0.5 
3 .  I, increases with v' '~  but not proportional to it 
4. E: shifts negatively with increasing v 
A C =  
As a general conclusion, the extent of irreversibility increases with increase in 
sweep rate, while at the same time there is a decrease in the peak current relative to the 
reversible case and an increasing separation between anodic and cathodic peaks. 
20 
Figure 1.8. Cyclic voltammogram for a reversible process, 0 + e- = R. (a) v, (b) 1 Ov, 
(c) 50v, and (d) ~ O O V . ~ ~  
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E - E:/V 
Ia 
c I - E-E:/V 
0.0 -0.1 -0.2 0.2 0.1 
Figure 1.9. Cyclic voltammogram for an irreversible process, 0 + e- = R. 
potential sweep rates (a) 0.13 Vs-', (b) 1.3 Vs-I, (c) 4 Vs-', (d) 13 VS-' .~'  
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/ Reversible 
IIAt 
Figure 1.10. Transition fiom a reversible to an irreversible system on increasing scan 
35 rate. 
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Goals of This Work 
Little is known concerning the redox behavior of the anti-rheumatoid arthritis 
gold thiolate drugs. Hoping to contribute to understanding the possible sources of toxic 
and therapeutic causes of gold drugs, we conducted chemical and electrochemical redox 
studies on Auranofin and Solganol. An understanding of the oxidative properties of gold 
drugs is important in light of the proposed toxic side effects of Au(II1) in vivo. In a broad 
sense, the goals of this thesis stem fiom the poor understanding of the fate of gold 
thiolate drugs in the oxidizing biological environment. 
Our group has been studying the electronic structure and thermal, electronic, and 
photochemical reactivity of d'' gold(1) complexes, especially those containing phosphine 
and thiolate l i g a n d ~ . ~ ~ . ~ ~  Recently our group studied the chemical oxidation of gold 
thiolates using [Cp#e]PF6 in methylene chloride.36 Chemical titration experiments on 
Ph3PAu(SC&CH3) using the mild oxidant, [CpzFe]PF6 confirms the formation of 
significant quantities of disulfide, (SC&CH3)2. Chemical oxidation afforded the 
opportunity to isolate the products of the first oxidation process. Reaction of 0.5 mmol of 
Ph3PAu(SC6&CH3) and 0.25 mmol of [Cp#e]PF6 in CH2C12 resulted in formation of 
[(Ph3P)4Au4(~-SC~CH3)2][PF6], (SC6&CH3)2, and C P ~ F ~ . ~ ~  Similar oxidation studies 
have been carried out on dinuclear gold thiolates. Disulfide and tetranuclear gold clusters 
were i ~ o l a t e d . ~ ~ . ~ ~  
My first project involved the electrochemical oxidation and bulk electrolysis 
studies of Auranofin in 0.1 M Bu&F"F'&H2C12 and 0.1 M BQNBF~/CH~CI~ solutions 
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using Pt working and auxiliary electrodes and a Ag/AgCl reference. Results are discussed 
in chapter 2. 
My next project involved treatment of Auranofin with the one electron oxidizing 
agent, [Cp2Fe]PF6. The oxidation resulted in a p-thiolato digold cluster [Et3PAu)~(p- 
SR)]22' and the disulfide, bis(tetraacetylthiog1ucose). The p-thiolato species was obtained 
several by independent procedures involving the treatment of Auranofin with Et3PAuN03 
in CH3CN or CH2C12 or addition of methanolic silver nitrate to an equimolar mixture of 
Auranofin and Et3PAuCl. The cluster was characterized using 'H NMR, 31P NMR, mass 
spectroscopy, and elemental analysis. Disulfide exchange reactions of the tetragold 
cluster with bis(tetraacetylthioglucose), (SC&C1)2, (SC6&CH3)2, and glutathione 
disulfide were studied. I tried growing x-ray quality crystals of the cluster by varying the 
counter anion from PF; to NO3-, BFi, CF3S03-, Sn(Ph)z(N03)3-. The results of these 
trials are presented in chapter 3. Successful trial to grow X-ray quality crystals was 
acheived by changing the triethylphosphine group to trimethylphosphine. X-ray structure 
of the tetragold(1) cluster is discussed in chapter 3. 
The electrochemical and chemical oxidation of the polymeric gold(1) thiolate drug 
Solganol will provide the literature with a broad understanding of the oxidative behavior 
or the source of toxicity of monomeric (Auranofin) versus polymeric (Solganol) gold 
drugs. 
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The last project involves the synthesis, characterization, and investigation of the 
photophysical behavior of a new class of halo and thiolato gold(1) complexes of the 
formula (AuX)zdppbz, X = C1, Br, I, p-SC6KCH3. 
Hopefully my thesis will stimulate further studies in the biochemistry of gold 
drugs. 
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CHAPTER 2 
Electrochemical Oxidation of Auranofin: An Anti-arthritic 
Gold @)-Sulfur Drug' 
Introduction 
The medicinal effects of gold drugs have been extensively investigated during the 
last two decades.* However, a recent review of the electrochemical literature shows that 
the redox data for biologically important gold and silver complexes is generally still 
l a~k ing .~  This is especially significant for gold drugs, where the redox reactivity, 
especially oxidation, has been invoked in partial explanation of both therapeutic and toxic 
side effects. 
Aura nof in 
Auranofin, (2,3,4,6-tetra-O-acetyl- 1 -thio- p-D-glucopyranosato- 
S)(triethylphosphine)gold(I), is a water insoluble phosphine gold thiolate complex that is 
31 
used as an orally active anti-arthritic drug in both experimental animals and man. 
Reductive polarography of Auranofin has been previously r ep~ r t ed .~  Auranofin has been 
investigated by a variety of  technique^.^^^,^ X-ray crystallography shows that Auranofin is 
monomeric with a nearly linear S-Au-P linkage (173.6') and virtually identical Au-S 
(2.29 A') and Au-P (2.26 A') bond  length^.^ The triethylphosphine group appears to 
stabilize the gold-thiol m ~ i e t y . ~  The 1 9 7 A ~  Mossbauer for Auranofin shows relatively 
high parameters (IS = 3.55 mndsec, QS = 8.64 mmhec, relative to gold) compared to 
Myocrisin and Solganol, intrinsic to the Au-P bond.' Auranofin is luminescent in the 
solid state and in EtOH glasses at 77K (Amax = 61 8 Auranofin is also photoreactive 
(Amm = 254 nm) in acetonitrile, undergoing photodecomposition that appears not to 
include production of elemental gold.8 The dc and differential pulse polarography studies 
of Auranofin by Perez and coworkers at a dropping mercury electrode, establishes that 
Auranofin undergoes a diffusion controlled and reversible redox process at -0.5 V (vs. 
SCE) at pH greater than 9.5.4 Bulk electrolysis at -0.8 V leads to an n value of 0.9 
electrons per molecule and suggests that the reduction involves the AuI/O ~ o u p l e . ~  
Oxidation of Auranofin with hypochlorite, a strong oxidant released by 
phagocytic cells, has also been studied by Shaw and coworkers.' Sulfonate and Et,PO 
formed first followed by oxidation of Au(1) to Au(II1). 
The electrochemistry of a series of neutral phosphine gold(1) thiolate complexes 
has been investigated in our laboratory.6 The series includes cyclic dinuclear gold(1) 
complexes formed from 1,2-propanedithiolate (pdt) and bis-chelating phosphines, 
Au,(LL)(pdt) (LL= dppe and dpppn), open dinuclear gold(1) complexes formed from 
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para-thiocresolate (p-tc) and bis-chelating phosphines, Au~(LL)@-tc)2 (LL= ddpe, dppp, 
dppb, dpppn), and a mononuclear complex, Au(PPh3)@-tc). Oxidative cyclic 
voltammetry experiments were performed at Pt and glassy carbon electrodes in 0.1 M 
B Q N P F ~ C H ~ C N  and CH2C12 solutions. Adsorption effects occurred in all 
electrode/solvent combinations investigated and were minimized by wiping the electrode 
between each CV experiment. The position and wave shape of the oxidation processes 
were somewhat dependent on the electrode/solvent combination. 
Our goal is to report oxidative cyclic voltammetry and bulk electrolysis studies of 
Auranofin. 
Experimental Section 
Reagents. Methylene chloride and the supporting electrolytes, tetra-N-butylammonium 
hexafluorophosphate (BqNPF6) and tetra-N-butylammonium tetrafluoroborate 
(BmNBF4) were used as received (Aldrich). Auranofin was purchased from Pfanstiehl 
Laboratories, Inc., IL. PPh3Au-p-tc was prepared according to previously published 
methods5 
Abbreviations. The following abbreviations are used: p-tc = p-thiocresol, pdt = propane 
dithiolate, dppe = bis(dipheny1phosphine) ethane, rev = reversible, irr = irreversible. 
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Ft Button Worlung Electrode 
Ag/AgCl Reference Electrode Ft Paddle Coimter Electrode 
Figure 2.1. Cell for cyclic voltammetry experiments. 
Cyclic Voltammetry (CV) Experiments. CV experiments were conducted using an 
EG&G Princeton Applied Research 273 potentiostat/galvanostat under computer control. 
CV measurements were performed in methylene chloride with 0.1 M BQNPF, or 0.1 
BQNBF~ as supporting electrolyte. Fresh solutions containing electrolyte (1 0 ml) were 
prepared prior to each CV experiment. Each solution was deoxygentaed by purging with 
nitrogen for 2-5 minutes. Background CV’s were acquired before the addition of gold 
complex. A three-electrode system was used, comprised of a platinum (1.6 mm diameter) 
working electrode, a platinum wire or paddle auxiliary electrode, and a silvedsilver 
chloride (Ag/AgCl) reference electrode (Figure 2.1). The working electrode was wiped 
prior to each experiment. The auxiliary electrode was lightly sanded before each set of 
experiments with fine sand paper. Potentials are reported vs. Ag/AgCl at room 
34 
temperature and are not corrected for junction potentials. Each CV experiment was 
repeated a number of times. 
Bulk Electrolysis Experiments. Bulk electrolysis experiments were performed using an 
EG&G Princeton Applied Research 273 potentiostaUgalvanostat in CH2C12/0.1 M 
Bu&lBF4 solutions. The electrolytic cell divided into three compartments with a fine 
porosity glass frit between the compartments (Figure 2.2). The main compartment 
contained a cylindrical platinum mesh working electrode and Teflon stir bar centered 
within the platinum mesh. The other two compartments contain the platinum counter 
electrode and the silver-silver chloride reference electrode. 
The electrolytic cell was assembled after oven drying at 110' C. A CH2C12/0.1 M 
BQNBF~ solution was introduced into the cell, stirred, and degassed with nitrogen for 10 
minutes. Auranofin was added (10 to 20 mg) and the solution was stirred and degassed 
for 10 minutes. 
The total number of electron equivalencies (n) passed was calculated by assuming 
that the background current constant during the electrolysis experiment. The total number 
of coulombs (Q = I x time) was subtracted from the total number of coulombs passed 
during the experiment (Qtotal): 
N = (Qtotai-Qbackground)/(F)(MOl) 
F = Faraday constant. 
Mol = number of added Auranofin moles. 
35 
Counter 
Electrode \ 
Auxiliary Electrode 
/ 
\Reference 
Electrode I 
I 
Fine Porosity Glass Frit Stir Bar 
Figure 2.2. Cell for bulk electrolysis experiments 
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Results 
Cyclic Voltammetry Experiments. The results of cyclic voltammetry experiments on 
Auranofin are shown in Figure 2.3. Figure 2.3 a-b are the current-voltage responses for 1 
mM Auranofin in 0.1 M BqNBF4/CH2C12 solutions at scan rates of (a) 50 mV/s and (b) 
500 mV/s, respectively. In each CV, there are two anodic processes. In Figure 2.3a they 
occur at about + 1.1 V (vs. Ag/AgCl) and +1.6 V, while in Figure 2.3b, they occur at 
somewhat higher potentials. The two redox processes were found to be irreversible at all 
scan rates, concentrations, and switching potentials (e.g. +1.2 V) investigated. Both 
processes appear characteristic of an EC mechanism, with the following reaction being 
quite fast. CV experiments with ferrocene, a reversible one-electron redox couple, at 50 
mV/s and 500 mV/s show a potential shift of similar magnitude as seen for Auranofin 
(Figure 2.3a-b). This result suggests that the shift originates from the electrochemical cell 
used, such as from cell resistance (iR drop), and not from kinetic effects of a following 
reaction. 
Figure 2.4a-c shows the effect of change of concentration as well as of 
electrolyte. The current-voltage response for 1 mM Auranofin in 0.1 M Bu&Jl"PdCH2C12 
solution at scan rates of 50 mV/s is shown in Figure 2.4a. This CV is the result of the 
same experimental procedure used to generate the CV for Figure 2.3a, except for a 
change of electrolyte (BqNPF6 vs. BqNBF4). At first glance, the CV wave-shapes of 
Figure 2.4a vs. 2.3a appear significantly different. However, close inspection of Figure 
2.3a shows similar anodic processes to 2.3a, i.e. one starting at about +1 .O V as well as 
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Figure 2.3b. Cyclic voltammogram of 1 mM Auranofin using Pt working and auxiliary 
electrodes and Ag/AgCl reference in 0.1 M Bu4N13F,/CH2C1, at 500 mV/s. 
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one at +1.65 V. What is also apparent is the great diminution of the current response of 
Figure 2.4a compared to Figure 2.3a. It has been previously demonstrated that the CV 
wave-shapes for phosphine gold thiolate complexes are sensitive to the type of electrode 
as well as to solvent owing to the effects of adsorption at the electrode.6 Repeated CV 
cycling of Auranofin also leads to filming of the electrode, indicative of adsorption at the 
electrode. Presumably, the filming process is affected during oxidation by the rate at 
which oxidized (positively charged) complexes are removed from the surface of the 
electrode. It is therefore not unexpected that changing the anion (PFL vs. BF4-) would 
also effect the wave-shape. The data suggests that the PF; anion is not as efficient as BF4- 
in keeping the electrode clear of oxidation products, leading to an increase in filming rate 
and thus leading to a great reduction in the current response. The effect of increasing 
concentration of Auranofin from 1 mM, 2 mM, and 4 mM is seen in Figures 2.4a, 2.4b, 
and 2.4c, respectively. The increase in the current response of both oxidation processes 
demonstrates that the observed electrochemistry originates from the analyte and not the 
solvent or electrolyte. Cyclic voltammetry experiments were also performed on 
Ph3PAu@-thiocresolate) under similar conditions used for Auranofin (0.1 M 
B Q N B F ~ / C H ~ C ~ ~  solutions at scan rates of 50 mV/s) (Figure 2.5). The results allow 
comparison to other electrochemical investigations reported for phosphine gold thiolate 
complexes.6 The electrochemistry of gold(1) complexes with pyridine-2-thiolate was 
investigated by Laguna and coworkers.6C The gold@) cationic complexes [Au2(dppm)(Z- 
pyS)]' and [Au~(dppe)(2-pyS)]' undergo irreversible oxidations at +1.42 V and +l.46 V 
vs. SCE, respectively, during cyclic voltammetry experiments at a Pt disk 
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Figure 2.5. Cyclic Voltammogram of 1 mM Ph3PAu(p-thiocresolate) using Pt working and auxiliary 
electrodes and Ag/AgCl reference in 0.1 M Bu4NBF4/CH2C12 at 50 mV/s. 
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working electrode recorded at 200 mVs-' in 0.1 M BudWFdCH2C12 solution.6c 
Bulk Electrolysis Experiments. Bulk electrolysis of Auranofin at +1.2 V vs. Ag/AgCl in 
0.1 M B Q N B F ~ / C H ~ C ~ ~  showed that the first oxidation is 0.5 electron process (data 
based on 9 runs; 0.44, 0.65, 0.25, 0.6, 0.54, 0.54, 0.49, 0.38, and 0.61). The data supports 
the irreversible oxidation at +1.1 V is due to a fast chemical reaction, which is the 
oxidation of thiolate to the corresponding disulfide and rapid rearrangement of the gold 
product to a cluster. Bulk electrolysis results on Auranofin at +1.6 V showed the process 
is consistently >2 electrons. Completion of electrolysis experiments after the first 
oxidation was checked by CV experiments. The first oxidation wave disappears 
completely in the cyclic voltammogram of electrolysis product solution, while the last 
oxidation remains almost the same as for the initial Auranofin cyclic voltammogram. 
Figure 2.6 is an example of bulk electrolysis curve obtained during the experiment. 
Discussion 
This work reports oxidative cyclic voltammetry studies on Auranofin in a non- 
aqueous solvent (CH2C12). There are two oxidation processes that occur at +1.1 V and 
+1.6 V. Both appear to be irreversible at all scan rates investigated (50-2,000 mV/s). 
Table 2.1 shows the results of CV studies on Auranofin and related phosphine gold 
thiolate complexes." All of the complexes show two irreversible oxidation processes that 
are separated by 400-800 mV. The first oxidation process for the PPh3 and dppe 
complexes have been assigned as a sulfur based oxidation.6a,b 
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Table 2.1. Cyclic Voltammetry Data for Auranofin and Related Complexes. 
C o mp 1 ex Oxidation Reduction Solvent Ref. Elec. Ref 
Aurano fin +1.1 (irr)a CH2C12 Ag/AgCl b 
+1.6 CH2C12 Ag/AgCl b 
-0.5 (rev)‘ SCE 4 
Ph3PAu@-tc) +0.82 (irr) CH2C12 Ag/AgC1 b 
+l.50 (irr) CH2C12 Ag/AgCl b 
Au2(p-dppe)@-tc)2 +0.72 CH2C12 SCE 6a 
+1.54 SCE 6a 
Au2(P-dPPe)@dt) +0.77 CH2Cl2 SCE 6a 
+1.2 CH2C12 SCE 6a 
Me3PAu@-tc) +0.93 (irr) CH3CN Ag/AgCl 6b 
+1.55 (in) CH3CN Ag/AgCl 6b 
- 
a. CV experiment at 1 mM Auranofin and 50 mVs-’ using 0.1 M Bu4NBF4 solution. b. This work. 
b. Reversible at pH > 9; assigned to the Au”’ couple. d. Pt wire working electrode and 0.1 M TBAH solution; 
scan rate of 50 mVs-’. 
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Recent results from our laboratory on binuclear as well as on mononuclear 
phosphine gold thiolate complexes indicate that after an initial one-electron sulfur-based 
oxidation, the gold complex rapidly undergoes rearrangement to form a gold cluster and 
disulfide.' ' This suggests the possibility that one-electron oxidation of Auranofin may 
provide a pathway to higher molecular weight gold complexes as well as a mechanism to 
increase disulfide concentration. Characterization of the one electron oxidation products 
will be discussed in chapter 3 
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CHAPTER 3 
The Formation of a Gold(I) Cluster and Disulfide 
From Oxidation of the Antiarthritic Gold Drug: Auranofin 
Introduction 
Gold compounds have been successfully used in the treatment of rheumatoid 
arthritis (RA) for over half a century.’ The antitumor activity of gold compounds in 
several tumor models such as P388 leukemia was also investigated.2 Recently a few 
gold compounds showed high potency in the treatment of Auranofin (‘Ridura’ 
from Smith Kline and French Laboratories) is one of the orally active groups of the 
slow-acting anti-arthritic gold drugs, and is used mainly to delay progression of the 
arthritis and prevent or reduce subsequent damage to the  joint^.^ 
Despite its extensive clinical investigation, the mechanism by which Auranofin, 
2,3,4,6-tetra-O-acetyl- 1 -thio- p-D-glucopyranosato-S)(triethylphosphine) go MI)’ 
inhibits rheumatoid inflammation and alters disease pathophysiology is poorly 
understood.’y2 This is mainly due to a lack of understanding of the etiology of the 
arthritis disease.’ Previous studies on the interaction of gold drugs with albumin, a thiol 
containing protein, identified cysteine-34 as the preferred binding 
site of g~ ld ( I ) .~  Free triisopropylphosphine oxide was obtained from triisopropylphosphi 
ne (2,3,4,6-tetra-O-acetyl- 1 -thio-P-D-glucopyranosato-S)gold(I), an Auranofin 
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analogue, in the reaction with serum albumin via a protein-bound phosphonium 
intermediate.6 
H OAc 
A 
Figure 3.1. Structure of Auranofin showing numbering scheme for ring protons. 
Auranofin, (Et3P)Au(TATG), TATG = Tetraacetylthioglucose, is monomeric, 
lipid soluble, and nonconductive.' The X-ray structure shows that gold(I) is equidistant 
between thiolate (Au-S = 2.29 A) and phosphine (2.26 A) ligands and the S-Au-P 
linkage is nearly linear (173.6 0).7 The Et3P unit plays a role in stabilizing the gold- 
thiolate moiety.' The 1 9 7 A ~  Mossbauer spectroscopy has been used successfully to 
determine oxidation state, type of ligand, and degree of coordination of anti-arthritic 
gold drugs.' The IS and QS values of Auranofin (3.55 and 8.64 mm s-l) are closer to the 
characteristic values for bis(triethy1phosphine) gold (3.06 and 8.93 mm s-') than those 
for the polymeric gold thiolate drugs (1.40 and 6.2 m m ~ - ' ) . ~  
Studying the redox behavior of gold@) thiolate drugs emerged as an effective 
5,9,10 approach in understanding their pharmaceutical effects in rheumatoid arthritis. 
Oxidizing conditions in vivo are believed to play a role in the therapeutic effect of the 
anti-rheumatoid drugs. In plasma the thioglucose moiety undergoes exchange with 5,9,10 
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other thiolates and the triethylphosphine ligand releases to form the very stable Et3PO.' 
Sadler et. a1 reported on the formation of Et3PO from Auranofin in the presence of 
albumin.' Colloidal gold and gold(I), in the presence of oxygen and penicillamine, 
undergo a redox reaction of importance in crysotherapy models.' ' Chemical oxidation of 
Auranofin by hypochlorite, a strong oxidant released by phagocytic cells, has been 
studied by Shaw et. a1.l' Sulfonate and the very stable Et3PO formed first followed by 
oxidation of gold(1) to gold(III)." Biooxidation of metals other than gold(1) is known 
such as Hg(0) oxidation to Hg(II) in vivo.I2 
A recent review of the electrochemistry of gold and silver complexes shows that 
studies of the redox behavior of gold compounds related to medicinal effects are still 
1a~king.l~ The electrochemical reduction of Auranofm in C2H50H/H20 reported at -0.5 
V vs. SCE, involves one electron reduction, i.e., Au".'~ The oxidation of Auranofin in 
0.1 M Bu&BF4/CH2C12 solution was reported recently. There are two irreversible 
processes at 1.1 and 1.6 V vs. Ag/AgCl (Chapter 2)." Hemple et. a1 studied the effect of 
aqueous HC1 on Auranofm, (Et3P)Au(TATG), TATG = Tetraacetylthiglucose, to mimic 
its behavior in stomach acid.I6 The ionic [(Et3PAu)2(TATG)]Cl was proposed as one of 
the products; however, trials to isolate the ionic structure resulted only in 
(Et3P)Au(TATG) and Et3PA~cl . l~  The formation of the ionic complex, 
[(Et3PAu)z(TATG)]Cl, involves two reversible steps; the first step involves formation 
of Et3PAuCl with the stability constant, K1 = 4.6 x M-' and the second step involves 
formation of the ionic digold complex with the stability constant, K2 = 2.0 x lo3 M-' in 
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water at 37' C while K1 = 7.8 x 
methanol/water. ' 
M-' and K2 = 1.3 x lo2 M-' in 50 % 
A thorough examination of Chemical Abstracts showed many trials to detect 
10,17,18,19 disulfide as a possible product from the redox reactions of gold(1) thiolate drugs. 
Formation of disulfide along with gold(0) from Solganol, (aurothioglucose) in aqueous 
medium was proposed by Shaw Regliniski et. a1 studied the disulfide produced 
from Myochrysine (aurothiomalate) as a source of oxidative stress in arthritic patients." 
Chemical and electrochemical results from our lab indicated formation of a 
gold(1) cluster and disulfide upon oxidation of phosphine gold(I) thiolates in non- 
aqueous medium.' The irreversible electrochemical oxidation processes of Auranofin 
imply a possible chemical change upon oxidation, i.e., an EC mechani~rn.'~ We decided 
to investigate the possible redox activity at the thiolate center using the well-known one- 
electron oxidizing agent, [CplFe]PF6, which has an oxidation potential comparable to 
the thiolate center in Auranofin.20 The results of the oxidative study on the thiolate 
center in Auranofin, which are presented in this chapter, may help to understand the 
possible sources of toxic and therapeutic effects. 
Experimental Section 
Materials. All solvents are reagent grade and used without purification. Auranofin was 
purchased form Pfanstiehl, IL. HAuC14 is a gift from Johnson Matthy. Et3PAuCl was a 
gift from Dr. David T. Hill, Temple University. AgN03, CF$03Ag, AgPF6, and AgBF4 
were purchased from Aldrich. Oxidized glutathione for disulfide exchange experiments 
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was purchased from Sigma. Solvents for NMR studies, CDC13, D20, and DMSO were 
purchased form Aldrich. [Cp2Fe]PF6 for chemical oxidation was purchased from 
Aldrich and was finely grounded before use. 
31P NMR Measurements. The 3'P{'H}NMR resonances were recorded at 81 MHz 
using a Gemini 300 spectrometer. The 31P NMR chemical shifts were referenced to an 
external sample of 85% H3P04. 
'H NMR Measurements. The 'H NMR resonances were recorded at 81 MHz using a 
Gemini 300 spectrometer. Chemical shifts were measured relative to the solvent 
resonance at room temperature. About 10 mg of the desired complex was dissolved in 
CDC13 and spectra were recorded directly. In the chemical oxidation studies a downfield 
shift for the triethylphosphine ligand was noticed with some overlapping with the 
resonances for the tetraacetyl groups on the thioglucose ligand. Thus this upfield 
(aliphatic) region is not very informative. Data will be reported for the downfield region 
only, which corresponds to H 1 -H6 of the thioglucose ligand. 
Electrochemical Experiments. All electrochemical measurements were undertaken at 
room temperature using an EG & G Princeton Applied Research 273 
potentiostat/galvanostat under computer control. Measurements were carried using the 
same procedure as described in chapter 2 and Figure 2.1. 
ESI FT-ICR Mass Spectrometry. Mass spectroscopy studies have been carried out by 
Dr. Touradj Souloki, Department of Chemistry, University of Maine. The ESI FT-ICR 
mass spectra were acquired with an IonSpec FT-ICR mass spectrometer equipped with a 
7 T superconducting magnet (IonSpec Corp., Irvin, CA) and IonnSpec99 software. A 
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stock solution of Auranofin or its cluster was prepared by dissolving 1 mg of the sample 
in 50:50 methanol: water solution (1 mg/ml, -0.5% acetic acid). 
Oxidation of Auranofin by [CpzFe]PF6 (one electron oxidation): To 500 mg (0.73 
mmol) of Auranofin dissolved in 100 ml CH2C12 under nitrogen was added 122 mg 
(0.36 mmol) of [Cp2Fe]PF6 (1:OS). Stirring continued for 24 hr until the blue color of 
ferrocenium disappeared and a yellow color of ferrocene formed. The solvent was 
evaporated in vacuo and the residue was washed with ether (3X) to remove CpzFe. The 
remaining off-white solid was recrystallized by dissolving in a small amount of CH2C12 
(3 ml), followed by addition of ether or hexane. 
Independent Synthesis of the Digold p-thiolato, [(R3PAu)z(TATG)]X (R = Et, Me; 
X = PFC, NO;, CF$OY, BFi). 1 mmol of AgX was dissolved in 10 ml CH3CN or 
C~HSOH and was added slowly to 1 mmol of Et3PAuCl or Me3PAuCl dissolved in 10 
ml CH2C12 at 0' C. Stirring of the mixture at 0' C for 30 min continued in the dark and 
AgCl was then filtered on celite. The filtrate was reduced to 3 ml in vacuo and ether was 
added to form a white precipitate of Et3PAuX which was filtered and washed with ether. 
To 1 mmol of (Et3P)Au(TATG) or (Me3P)Au(TATG) dissolved in 10 ml CH2C12 was 
added 1 mmol of Et3PAuX or Me3PAuX, respectively, dissolved in 10 ml CH2Cl2 and 
the mixture was stirred for 30 min at 0' C. The mixture was reduced to 5 ml in vucuo 
and ether was added to give an off-white precipitate. The sample was recrystallized by 
diffusion of ether into methylene chloride and dried over P205 in vucuo for 24 hrs. 
Elemental analysis calculated for [(E~~PAu)~(TATG)]NO~, C 29.57, H 4.64, Found, C 
29.14, H 4.60. 'H NMR (300 MHz; CDC13) 1.2 (18H, dt, PCH~CHJ), 1.85-2.1 (24, m, 4 
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OAc + 6 PCH2CH3), 4.0 (2H, m, H5), 4.25-4.30 (2H, dd, H6), 5.0-5.15 (2H, m, H2-H4), 
5.50 (lH, d, Hl); 31P {'H}"IR (300 MHz,  CDC13) 36.5 ppm. Elemental analysis 
calculated for [(Me3PAu)*(TATG)]N03.ether: C 26.17; H 4.16. Found, C 26.13; H 4.01. 
'H NMR (300 MHz; CDC13), 1.2 (18H, d, PCHj), 2.0-2.1 (12, 4s, 4 OAc), 3.9 (2H, m, 
H5), 4.20-4.25 (2H, dd, H6), 5.0-5.2 (3H, m, H2-H4), 5.35 (lH, d, Hl); 31P {'H}NMR 
(300 MHz, CDC13) -0.17 ppm. 
Synthesis of Bis(tetraacetylthiog1ucose). 0.5 ml of 12 (0.93 M in acetonitrile) was 
added to 1.00 ml of HSATg (0.41 M in acetonitrile). After stirring for two minutes, the 
deep brown solution was titrated with 0.2 ml of double distilled water to a light yellow 
color, stirred for 10 min and then poured into 80 ml of cold aqueous KI solution (1.0 
M). The solution was filtered and the precipitate was washed with water and dried.21 
Trials to Grow X-ray Quality Crystals. The procedures involved in growing X-ray 
quality crystals of digold p-thiolato cluster obtained by oxidation of Auranofin were 
meticulous and time consuming. Patience and persistence were the keys to success!. A 
variety of different solvent combinations, such as ether-methylene chloride, hexanes- 
methylene chloride, ether-chloroform, and cyclohexane-ethyl acetate (was used to 
obtain crystals of Auranofin) was used.' In all-solvent mixtures the crystals were either 
very fine needles or no crystals formed even after two months. Another approach 
involving slow evaporation of methylene chloride, chloroform, or water yielded oily 
residues. 
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The other approach involved changing the counter anion; PF;, NO3-, BF4-, 
CF3S03-, and Sn(Ph)2(NO);’- were all tried. Using P F i  and B F i  appeared to give oils or 
decomposition. Using CF3S03- yielded crystals that were yellowish-white and changed 
to orange-brown over time. The counter anion Sn(Ph)2(NO)32- failed to replace the 
original nitrate counter ion as evidenced by the absence of aromatic resonances in the ‘H 
NMR. The best counter anion was N03- in terms giving stable crystals, although they 
were small. The nitrate was promising also in terms of trials conducted previously by 
Dr. David Hill, who obtained acceptable crystals but the X-ray studies showed disorder 
in the final structure.22 
The magic bullet was changing the triethylphosphine to trimethylphosphine 
ligand in Auranofin. The crystals were dissolved in 3 ml and 20 ml of ether was added 
slowly without disturbing the solution. The crystals were grown by forming a colloidal 
state at room temperature first. The procedure involves sealing the test tube with a cork 
and inserting a needle to evaporate some of the solvent over a period of two days. The 
needle was then removed and the mixture was left for two days. The procedure was 
repeated for two months until a colloidal state formed and the mixture was left without 
disturbing. Finally X-ray quality crystals were obtained from the colloid as plates and 
needles. 
For X-ray examination and data collection, a suitable crystal, approximate 
dimensions 0.36 x 0.08 x 0.07 mm, was mounted on the tip of a glass fiber. X-ray data 
was carried out by Dr. J. Krause Bauer, Department of Chemistry, University of 
Cincinnati. Intensity data were collected at 150K on a Siemens SMART 1K CCD 
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diffiactometer (platform goniostat with x fixed at 54.69', sealed-tube generator, 
graphite-monochromated Mo k a  radiation, h = 0.71073 A). The structure was solved 
by a combination of the Patterson method using SHELXTL v5.1 and the difference 
Fourier technique and refined by full-matrix least squares on F2 for the reflections 
diffracting out to 0.75 A. Non-hydrogen atoms were refined with anisotropic 
displacement parameters. Weights were assigned as w-* = u2 (F:) + (ap)2 + bp where a 
= 0.0487, b = 33.7775 and p = 0.33333F: + 0.66667F:. Hydrogen atoms were 
calculated based on geometric criteria and treated with a riding model. Hydrogen atom 
isotropic temperature factors were defined as U(C)*a = U(H) where a = 1.5 for 
methyls and 1.2 for others. [(M~~PAu)~(TATG)~]~(NO~)~ crystallizes with a badly 
disordered solvent which appears to be multiple H20 molecules or highly disordered 
Et2O. A suitable disorder model could not be resolved, thus the solvent contribution 
was subtracted from the reflection data using the program SQUEEZE. The refinement 
converged with crystallographic agreement factors of R1 = 6.44 %, wR2 = 1 1.52 % for 
61 14 reflections with I 220 (I) (R1 = 9.58 %, wR2= 13.02 % for all data) and 3 14 
variable parameters. 
Results and Discussion 
Chemical Oxidation Products. Upon addition of [Cp2Fe]PF6 to Auranofin (0.5: l), the 
characteristic blue color of [Cp2Fe]PF6 changed slowly to yellow-orange due to 
formation of ferrocene. Stirring continued for 24 hr until the blue color of [Cp2Fe]PF6 
disappeared and the solution was yellow. The solvent was evaporated in V ~ C U O  and the 
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residue was washed with ether (3X) to remove Cp2Fe and disulfide. The remaining off- 
white solid was recrystallized by dissolving in a small amount of CH2C12 (3 ml), 
followed by addition of ether or hexane. After work-up of the solution, the 'H NMR of 
the isolated product showed a larger chemical shift at H1, relative to Auranofin, 
compared to other protons in the thioglucose unit. 
H NMR Studies of Auranofin and the Oxidation Products. The resonances for the 
ring protons (Hl-H6, Figure 3.2) on the thioglucose ligand in Auranofin and related 
structures have been unambiguously assigned.23 The thiolate resonances are a second- 
order pattern due to long-range virtual coupling.23 Monitoring the resonance shift of HI 
is an efficient approach for detecting coordination to gold(1). For example, replacing H+ 
of protonated tetraacetylthioglucose by [Au(PEt3)]+, to form Auranofin (Table 3. l ) ,  
produces a coordination shift (A = G ~ ~ ~ ~ ~ f i ~  - 8Tetraacetylthioglucose at H1) of 0.60 ppm in 
CDC13.23 The downfield chemical shift of H1 is due to the electron density increase on 
the sulfur atom of the thioglucose ligand when it is coordinated to gold(1). Oxidation of 
the thiol to the corresponding disulfide is accompanied by the appearance of a doublet at 
4.65 ppm in the disulfide and the disappearence of the SH resonance at 2.3 ppm (not 
shown in Table 3.1) and the triplet at 4.54 ppm in the thiol. 'H NMR data for Auranofin, 
thioglucose, disulfide, and digold p-thiolato cluster are reported in Table 3.1. The 
products of oxidation of Auranofin with [Cp2Fe]PF6 (Equation 3.1) were identified as 
[(Et3PAu)2(TATG)]PFs, (TATG)*, and CpzFe by comparison to authentic samples. 
1 
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Table 3.1. 'H NMR data in the downfield region for Auranofin, TATG, (TATG)z, and 
[(Et3PAu),(TATG)]X, with various counter ions in CDC13. 
Compound H1 H2-H4 H5 H6 
Aurano fin 5.14(d) 4.94-5.09 3.71 4.07-4.28 
TATG 4.54(t) 4.96-5.22 3.73 4.10-4.30 
(TATG)2 4.65(d) 4.96-5.40 3.80 4.20-4.38 
[(E~~PAU)~(TATG)]PF~ 5.25(d) 5.00-5.14 3.96 4.10-4.25 
[(E~~PAu)~(TATG)INO~ 5.50(d) 5.00-5.15 4.00 4.25-4.30 
[(E~~PAu)~(TATG)]CF~SO~ 5.25(d) 4.95-5.15 3.80 4.10-4.30 
2EbPAuTATG + [Cp2Fe]PF6 --+ [(&PAu)2(TATG)]PF6 + (TATG)2 + Cp2Fe 3.1 
The digold p-thiolato cluster was prepared according to Scheme 3.1, where R = 
Me, Et. The disulfide, bis(tetraacetylthioglucose), was prepared by oxidation of 
tetraacetylthioglucose with I2 (Equation 3.2). 
2HTATG + I2 -+ (TATG)2 + 2 r  + 2 w  3.2 
~ 
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The 'H NMR spectrum of [(Et3PAu)2(TATG)]PFs is shown in Figure 3.3 and the 
H NMR of bis(tetraacetylthiog1ucose) is shown in Figure 3.4. 1 
The 'H NMR data for resonances in Auranofin, disulfide, and the digold p- 
thiolato cluster with different counter anions are reported in Table 3.1 and illustrated in 
Figures 3.2, 3.3, and 3.4. Generally, a downfield shift for the thiolate protons was 
noticed in the digold p-thiolato cluster spectrum. Comparing this spectrum (Figure 3.3) 
to Auranofin (Figure 3.2), the remote hydrogens (H2-H6) from the thiolate center shift 
downfield without a change in the splitting pattern. The appreciable shift at H1 (A6 = 
0.21-0.38 ppm) in the digold p-thiolato cluster indicates the change in coordination of 
the thiolate center. 
The spectrum of the crude oxidation product mixture contains an additional 
doublet at 4.65 ppm (Hl), assigned as H1 in the disulfide (Figure 3.4). The spectrum of 
the crude mixture (Figure 3.5) is a combination of the disulfide and the digold p-thiolato 
cluster. Both of the multiplets at 3.85 (H5) and 4.2 (H6) are formed in the crude product 
and the disulfide. Assignment of the peaks due to disulfide or cluster was confirmed by 
mixing the disulfide and digold p-thiolato cluster in a 1:l ratio and comparing the 
spectrum of this mixture product after chemical oxidation. The presence of a combined 
mixture fiom the cluster and the protonated thioglucose due to possible hydrolysis can 
be excluded due to the absence of the triplet (Hl) at 6 = 4.54 ppm and the doublet (SH) 
at 6 = 2.3 ppm. 
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23 I H  Solvent dependence of the cluster is also apparent, similar to Auranofin. 
NMR of the [(Et3PAu)2(TATG)]N03 in D20 showed an upfield shift of H1 to 5.6 ppm 
in addition to a small shift in other resonances. In DMSO the resonances showed a 
distinct feature not only downfield shifted but also showed a better resolving of 
overlapped resonances. 
31P {'H}NMR of [(Et3PAu)z(TATG)]X. Previous studies showed that the 31P chemical 
Due to its shift is very dependent on the environment in gold compounds. 
sensitivity to a change in coordination and geometry in groups in the trans position, 31P 
NMR has been used eficiently in monitoring the interaction of gold drugs with 
biological systems. 31P NMR has been used to provide information concerning the 
behavior of red cells in DzO/saline in the presence of Auranofin and monitoring the 
interaction of Et3PAuCl with gl~tathione.~' The 31P N M R  spectrum of AlbSAuPEt3 in 
the presence of Et3PAuC1, in aqueous buffered solution at pH 7.9, contains a resonance 
at 36 ppm (Table 3.2) assigned to the reversibly formed species AlbS(A~PEt3)2.~l 
21,23,24 
Figure 3.6 illustrates the 31P NMR spectra of Auranofin and 
[(Et3PAu),(TATG)]X, X = P F i  and NO3-, in CDC13. Both Auranofin and 
[(Et3PAu),(TATG)]NO, gave rise to sharp 31P Nh4R resonances. The Auranofin 
spectrum shows a resonance at 38 ppm; however the gold cluster spectrum contains an 
upfield resonance at 37 ppm or 36 ppm depending on the counter anion and the solvent. 
The chemical shift (66) of 1 -2 ppm was also seen in the related clusters, 
[(PPh3Au)2( SC6&CH3)]? and [dppeAu2(SCg&CH3)]22', reported previously by our 
group.26 31P NMR spectra of all clusters at room temperature showed 
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Table 3.2. 31P NMR chemical shifts of Auranofin, [(Et,PAu)z(TATG)]X, 
and related complexes. 
Complex 6,  PPm Solvent Ref. 
Aurano fin 38 CDC13 a 
[(E~~PAu)~(TATG)]PF~ 37 CDC13 a 
[(E~~PAu)~(TATG)]NO~ 36.5 CDC13 a 
[(E~~PAu)z(TATG)INO~ 36 D2O a 
AlbSAuPEt3 38.8 D20 21 
[AlbS(AuPEt3)2]+ 36 D20b 21 
[ A~(PEf3)21' 44 D20b 21 
a. Our data; relative to 85% H3P04 in D20. The chemical shifts 
quoted are reproducible to k 0.1 ppm. b. In aqueous buffered solution at 
pH = 7.9; relative to (Me0)3PO. 
The upfield chemical shift in [(Et3PAu)2(TATG)]+ compared to Auranofin is an 
indication of the greater trans influence imposed by the p-thiolate groups, i.e., the 
greater the trans influence of the p-tetracetyl thioglucose units the weaker the trans Au-P 
bond and the more upfield the 31P chemical It is noticeable that no resonance 
observed due to free Au(PEt3); (44 ppm) or any other phosphine species is observed at 
room temperature. Ab initio study of structures and energetics of sulfur-bridged copper 
clusters [ C U ~ ~ S ~ ( P R ~ ) ~ ]  (n = 1-4, 6; m = 0, 2, 4, 6, 8; R= H, CH3) predicted that the 
tertiary phosphine ligands are the reason for the stability of this class of clusters.27 
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Titration of Et3PAuN03 with Auranofin in CDC13 was followed by 
3'P{'H}NMR (Figure 3.7). The results showed that when either Et3PAuN03 or 
Auranofin is present in excess only a sharp single peak is observed due to rapid ligand 
exchange among the Et3PAu' species present. When the ratio of AuranofmEt3PAuN03 
<1 the observed peak is broad. At the equivalence point, ([Et3PAuN03] = [Auranofin]), 
the characteristic peak for the cluster is obtained at the same chemical shift as the pure 
sample. 
Effect of Counter Ions on Chemical Shifts. 'H NMR. It is noteworthy that the H1 
resonance shifts upon changing the counter anion, which supports to a limited extent, 
the possibility of counter anion interaction with the digold p-thiolato cluster. In the case 
of X = NO; (Figure 3.8), H1 shifts to 5.5 ppm in comparison to 5.25 ppm when X = 
PF;, CF3S03-, or BFi. Generally the peaks shifted and broadened on going from 
Auranofin to the cluster, especially when X = NO). The region of 5.0 to 5.5 ppm, which 
contains Hl-H4 splits into three groups in the cluster. For example when X = P F i  or 
CF3S03-, H4 is centered at 5.02 ppm (Figures 3.3 and 3.9). In the isolated product, X = 
PFi,  NO3-, or CF3S0<, the first and second groups did not show further splitting; 
however, the third group appears as a doublet in the range of 5.25-5.50 ppm as shown in 
Table 3.1 and Figures 3.3, 3.8, and 3.9. 
The largest shift was noticed in H1 in case X = NO3-. The simple explanation for 
this noticeable shift, compared to other counter anions, is due to the interaction of NO< 
with H1 through hydrogen bond. 
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Figure 3.7. 31P NMR spectra of Auranofin, Et3PAuN03, 
and their mixtures in CDC13 solutions. The mole ratios 
of Auranofin:Et3PAuN03 are (A) 1 :0, (B) 0.66:0.34, 
(C) 0.5:0.5, @) 0.39:0.61, (E) 0.20:0.80, and (F) 0:l. 
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b) 31P NMR. Both Auranofin and the digold p-thiolato cluster with PF; counter anion 
gave sharp 31P NMR resonances at 38 and 37 ppm, respectively (Figure 3.6). A broad 
peak at 36.5 pprn was noticed in [(Et3PAu)2(TATG)JNO3-. In X = CF3S03-, 31P Nh4R 
showed a sharp peak at 37 ppm as in X = PF;. The higher shift and broadness in 31P 
NMR, X= NO3-, supports to a limited extent, the possibility of counter anion interaction 
with the digold p-thiolato cluster, which was noticed also in 'H NMR studies. 
Electrochemical Oxidation Studies. As previously discussed, Auranofin irreversibly 
oxidizes at potentials of 1.1 and 1.6 V vs. Ag/AgCl in 0.1 M BLkJ"JBF4/CHZC12 solutions 
(Chapter 2 and Figure 2.3). The CV wave-shapes of phosphine gold thiolate complexes 
are sensitive to the type of electrode and solvent due to adsorption effects at the 
e l e c t r~de . ' ~ , ' ~  The electrochemical response of Auranofin at 1.1 V vs. Ag/AgCl is 
sensitive to the nature of the supporting electrolyte. I s  
The electrochemical oxidative behavior of [(E~~PAu)~(TATG)]NO~ was 
investigated by using cyclic voltammetry (CV) in 0.1 M B Q N B F ~ / C H ~ C ~ ~  solutions 
using Pt working and auxiliary electrodes and Ag/AgCl reference. Cyclic 
voltammograms of [(Et3PAu)2(TATG)]NO, as a function of scan rate and concentration 
are shown in Figures 3.10 and 3.11. 
It is of interest to compare the oxidation potentials of Auranofin with that of the 
cluster. The isolated cluster showed only the second irreversible peak with a small shift 
to 1.65 V vs. Ag/AgCl. However, at similar concentration and scan rate, the current 
decreased from Auranofin to the cluster. The peak at 1.65 V showed dependence on 
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concentration and scan rate (Figure 3.10 and 3.11). Cyclic voltammetry of the crude 
product following the complete oxidation of Auranofin using [Cp2Fe]PF6 showed a 
reversible peak at 0.35 V, assigned for ferrocene, in addition to a peak at 1.65 V assigned 
for the cluster. 
Mass Spectroscopy Studies. 
Mass spectroscopy studies have been carried out by Professor Touradj Solouki, 
Department of Chemistry, University of Maine. Mass spectroscopy studies on 
Auranofin and its digold p-thiolato cluster (Figure 3.12 and 3.13) were carried out in 
5050 methanol: water, with 0.5% acetic acid by using ESI -1.7 keV, soft ionization, 
and positive ion Mo. The digold p-thiolato cluster, [(Et,PAu)2(TATG)]N03, showed a 
peak at m/e 993 as the parent peak in addition to another peak at m/e 994 assigned to the 
cluster + H' species (Figure 3.12). The ESI studies showed that the cluster is stable and 
no peaks due to decomposition products have been noticed. Specifically a peak at m/e 
679, which would correspond to Auranofin was not observed. 
Mass spectroscopy studies on Auranofin were carried out by using ESI -1.7 
keV, soft ionization, and positive ion Mo in 5050 methanol: water with 0.5% acetic 
acid. The spectrum showed peaks at m/e 679, 1553, and 1671 (Figure 3.13). 
Unexpectedly, the Auranofin peak at m/e 679 is not the major peak in the spectrum 
rather the peak at m/e 993 for the digold p-thiolato cluster is the major peak. The peaks 
at m/e 1553 and 1671 are assigned to [(E~~P)~(Au)J(TATG)~]+ and 
[(Et3PAu)3(TATG)zlLf, respectively. A simple explanation for these unexpected results 
~ 
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in the ESI studies of Auranofin is probably due to the acetic acid used which may have 
protonated the thiolate, allowing for formation of the digold p-thiolato cluster according 
to Equation 3.3.16 
2 Et3PAu(TATG) + H' __+ [(Et3PAu)2(TATG)lf + HTATG 3.3 
Disulfide Exchange Studies. Previous studies in our group on the disulfide exchange 
reaction between gold(1) thiolates and disulfides showed dinuclear gold(T) thiolates 
reacted with disulfides faster than mononuclear gold(1) thiolates.' 
The tetranuclear gold(I) cluster, [(PPh3Au)4(SC&CH3)2] [PF6], formed after 
chemical oxidation of PPh3Au(SC&CH3) was allowed to react with (sc6&c1)2 and 
the unsymmetrical disulfide, ClC6&SSC6&CH3, appears to form first followed by the 
symmetrical disulfide, (SC&CH3)2. Interestingly, the disulfide exchange reaction 
between the cluster and disulfide was found to be faster than the neutral gold@) thiolate 
complexes.26 
Auranofin cluster was allowed to react with glutathione disulfide, in D20 and 
the reaction was monitored for 7 days. Figure 3.14 and 3.15 show the 'H NMR of 
glutathione and digold p-thiolao, [(E~~PAu)~(TATG)]NO~ in D20, respectively. The 
spectra of the reaction mixture are complex. Therefore I chose to compare 
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the shift in H1 in [(Et3PAu)2(TATG)]NO3 at 5.6 pprn and H5 in glutathione disulfide at 
3.3 ppm. The reason for this choice is that these hydrogens are both close to the sulfur 
atoms, i.e. the disulfide exchange centers. The doublet of doublet at 3.3 ppm in 
glutathione disulfide showed a slight upfield shift after 16 hrs and a new multiple 
appeared at 3.4 pprn (Figure 3.16). After about 7 days the peak at 3.3 ppm had 
decreased and the peak at 3.4 ppm had increased. There was no further change after 7 
days. The peak at 5.6 ppm in [(Et3PAu)2(TATG)]N03 broadened and showed a 
negligible shift after 7 days. That the reaction was very slow and further studies are 
needed to clarify the nature of the reaction. 
X-ray Studies of [(Et3PAu)*(TATG)]N03 and Related Structures. The mononuclear 
gold thiolate complex PPh3Au-p-tc, similar to Auranofin, forms a tetranuclear gold 
cluster and disulfide upon oxidation by [cp~Fe]PF6.'~ X-ray data shows equi-distant 
gold atoms with a bridging thiolate bisecting the gold atoms in each unit. The four gold 
atoms form a square with Au ... Au distances of 3.15 A and 3.17 Fackler et al. 
reported the X-ray structure of [ ( P ~ ~ P A u ) ~ S C H ~ P ~ ] ~ ( N O ~ ) ~  as a dimeric structure with a 
strong gold-gold interactions of 3.07 and 3.12 A.28 
Hill et al. obtained preliminary data on the solid state structure of 
[ (E~~PAU)~(TATG)]~(NO~)~ in which two gold atoms coordinate to one sulfur (Figure 
3.17). In addition, the structure shows the two ionic units arranged in a square dimer 
composed of four gold atoms all approximately equidistant. The sulfur atoms are on 
opposite sides (trans) of the gold square bisecting the two phosphorous atoms above 
them. 
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P4 
Figure 3.17. Crystal structure of product of reaction of Auranofin and 
Et3PAUN03.22 
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The Au-S-Au angles are approximately 88' and are somewhat compressed. This 
compression may be due to the gold-gold interaction. The Au.. .Au distance was found 
to be 3.2 8, with Au-S and Au-P bond lengths ranging from 3.34 to 2.39 8, and 2.19 to 
2.35 A, respectively. Unfortunately, The quality of the data was not high enough to 
completely solve the structure, so it was never published.22 
Crystal Structure Analysis of [ (M~~PAu)~(TATG)]~(NO~)~ .  As discussed in the 
experimental part, multiple attempts to grow X-ray quality crystals for 
[(E~,PAU)~(TATG)]~(NO~)~ showed a very limited success. Changing the counter 
anions from P F i  to NO3-, BFi, CF3S03-, or Sn(Ph)~(N03)3- failed to produce X-ray 
quality crystals. A variety of different solvent combinations yielded very fine needles 
or no crystals. Trials to grow crystals by slow evaporation of CHCl3, CH2Cl2, or H20 
yielded oily residues. 
* H NMR and elemental analysis showed that both [(E~~PAu)~(TATG)]~(NO~)~ 
and [(M~,PAU)~(TATG)]~(NO~)~ contain 2 PR3, R = Et or Me, per TATG. Synthesis of 
both derivatives was achieved as shown in Scheme 3.1. Comparing 'H NMR of 
[(E~~PAu)~(TATG)]~(NO~)~ (Figure 3.3) with [(M~~PAu)~(TATG)]~(NO~)~ (Figure 
3.18) , the former showed H1 at 5.35 vs. 5.5 ppm for the later. 
Good quality X-ray crystals were achieved by replacing triethylphosphine by 
trimethylphosphine and crystals were grown from CH2C12-ether as described in the 
experimental part. 
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Crystals of [(M~~PAU)~(TATG)]~(NO~)~ were obtained as colorless plates and 
needles fiom CH2C12-Et20. Crystal data, data collection and processing parameters are 
reported in Table 3.3. Selected bond lengths and angles are listed in Table 3.4. 
The molecular structure of [(M~~PAU>~(TATG)]~(N~~)~, is shown in Figure 
3.19 and 3.20. The molecular and crystallographic symmetries coincide running 
through the center of the cation and anions (N1 and N2 of the nitrate ions lie on special 
positions). The gold-gold distances are Aul-Au2= 3.1062(7), Aul-AulA= 3.1713 (1 1) 
and Au2-Au2A= 3.1446( 12) A. 
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Table 3.3. Crystal data and structure refinement for [ (M~~PAu)~(TATG)]~  
(No3)2. 
Empirical formula C40H74A~4N2024P4S2 
Formula weight 1942.88 
Temperature 150(2) K 
Wavelength 0.71073 A' 
Crystal system, Space group Tetragonal 
Unit cell dimensions 
Volume, Z 
Density( calculated) 
Absorption coefficient 
F(000) 
Crystal size 
8 range for data collection 
Limiting indices 
Reflections collected 
Independent reflections 
Refinement method 
Datahestraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>20(I)] 
R indices (all data) 
Largest diff. Peak and hole 
a = 26.1758(6)& 
b = 26.1758(6)A, 
c = 9.7781(3)81 
6699.7(3) A3, 4 
1.926 Mg/m3 
8.957 mm" 
3712 
0.36 x 0.08 x 0.07 m 
2.46 to 28.31 
-34<h<32,-34<k<30,- 13<1<11 
44007 
8321 (Rint = 0.1028) 
Full-matrix least-squares on F2 
7403 I 0  I314 
1.099 
R1 = 0.0644, wr2 = 0.1 152 
R1 = 0.0958, wR2 = 0.1302 
1.205 and -1.018 eA-3 
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Table3.4. Selected bond lengths (A) and angles (0) for 
[(Me3PAu)2(TATG)]2(N03)2. 
Au( 1)-P( 1) 2.2 5 9( 4) Au( 1)-S( 1) 2.334( 3) 
A u ( 1 )-A u (2) 3.1 06( 7) Au(1)-Au(l)#l 3.171(11) 
A u (2)-P( 2) 2.270(4) Au(2)-S(l) 2.3 5 5( 3) 
Au(2)-Au(2)#1 3.144( 12) P( 1)-C( 15) 1.76(2) 
P( 1)-C( 16) 1.76(2) P(2)-C( 17) 1.78(2) 
P(2)-C( 19) 1.74(2) P(2)-C( 18) 1.78(2) 
P( 1)-Au( 1)-S( 1) 
S( l)-Au( l)-Au(2) 
S( 1)-Au( 1)- 
Au(l)#l 
P(2)-Au(2)-S( 1) 
S( l)-Au(2)-Au( 1) 
S(l)-Au(2)- 
Au(2)#1 
C(15)-P( 1)-C(16) 
C( 16)-P( 1)-C( 17) 
O( lO)-N( 1)-O( 12) 
O(12)-N( 1)-O( 11) 
176.94( 14) 
48.8 1 (8) 
84.12(8) 
175.1(2) 
48.22( 8) 
85.86( 8) 
105.3(9) 
104.6(9) 
127.2(3) 
1 16(5) 
P( l)-Au( l)-Au(2) 
P(l)-Au( 1)-Au(1) 
Au(~)-Au( l)-Au( 1) 
P(~)-Au(~)-Au( 1) 
P (~ ) -Au(~ ) -Au(~ )  
Au( l)-Au(2)-Au(2) 
C( 1)-S( l)-Au( 1) 
Au( 1)-S( l)-Au(2) 
O(l0)-N(1)-O(l1) 
O( 13)-N(2)-0( 14) 
128.17( 12) 
95.57(10) 
89.74(2) 
127.03( 13) 
95.65( 11) 
90.2 3 (2) 
103.1(4) 
82.96( 10) 
1 lO(5) 
1 1  l(2) 
0 
r 
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Conclusions 
The present study clearly demonstrates that Auranofin can be oxidized 
chemically and electrochemically at the thiolate center forming a disulfide and a 
bridging thiolate cluster [ (E~~PAu)~(TATG)]~(NO~)~.  Such redox behavior provides an 
insight into the possible biological reactions that occur upon administration of 
Auranofin. The prediction of the fate of Auranofin in vivo is complicated by a variety of 
reactions occurring at the gold center. In addition the circulating form may be different 
from that of the initial drug. 1,2,5,16 
Toxicity of anti-rheumatoid arthritis drugs is believed to be due to the formation 
of disulfides which lead to oxidative stress in the cell.'' The formation of disulfide and 
cluster by mild oxidation of Auranofin is directly related to the oxidative stress effect. 
One-electron oxidation of Auranofin results in homolytic cleavage of the Au-S 
bond and formation of Et3PAu' and thiyl radical, SR, which rapidly dimerizes to 
produce disulfide (see Scheme 3.2). Previous studies in our lab on the electronic 
structure of gold@) thiolate complexes have assigned the HOMO orbitals of these 
complexes as having significant sulfur character. l 9  The cation, Et3PAuf, reacts with a 
molecule of the starting mononuclear complex to form a digold complex with thiolate 
bridging two gold centers, which dimerizes via Au ... Au bonds to form the observed 
tetragold cluster. 
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LAuSR - e- ____+ LAu' + RS' 
RS' ----------, %RSSR 
LAu+ + LAuSR -b % [L~AU~(P-SR)~]*+ 
2 LAuSR - e' -b % RSSR + '/t [L4Au4(p-SR)2I2+ 
Scheme 3.2. Mechanism of Auranofm oxidation (L = Et3P, R = Tetraacetylthioglucose). 
The mechanism of Auranofin oxidation is supported by the independent 
synthesis of the tetragold cluster (see Scheme 3.1) and is consistent with the n value 
(0.5) determined by bulk electrolysis. 
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CHAPTER 4 
Electron-Transfer Studies between Ferrocene and Gold Thiolates. 
Determination of the Standard Potential of Gold@) Thiolate Oxidation 
Introduction 
The medicinal effects of gold(1) thiolate drugs have been extensively investigated 
during the last two decades.' Redox reactivity of gold(1) thiolate drugs, especially 
oxidation, has been invoked in partial explanation of both therapeutic and toxic side 
effects. Oxidation of Auranofin with hypochlorite, a strong oxidant released by 
phagocytic cells, has also been studied by Shaw and coworkers. Sulfonate and Et3PO 
formed first followed by oxidation of gold(1) and gold(III).' 
The electrochemistry of a series of neutral phosphine gold(1) thiolate complexes 
has been investigated in our lab~ratory.~ The series includes cyclic dinuclear gold(1) 
complexes formed Gom 1,2-propanedithiolate (pdt) and bis-chelating phosphines, 
Au2(LL)(pdt) (LL = dppe and dpppn), open dinuclear gold(1) complexes formed Gom 
para-thiocresolate @-tc) and bis-chelating phosphines, AuZ(LL@-tc)*(LL = dppe, dppe, 
dppp, dppb, or dpppn), and mononuclear complexes, Auranofin and Au(PPh3)b-tc). 
Oxidative cyclic voltammetry experiments were performed at Pt and glassy carbon 
electrodes in 0.1 M BQNPF~CH~CN or 0.1 M BqNBF4/CH2C12  solution^.^ 
Cyclic voltammetry studies on PPh3Au(p-tc) showed two irreversible peaks at 
+0.82 and +1 S O  V vs. Ag/AgC1.4 However, Auranofin showed two irreversible peaks at 
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higher potentials of +1.1 and +1.6 V vs. Ag/AgCI. The first irreversible peaks in 
PPh3Au(SC6&CH3) and Auranofin were assigned as thiolate oxidation to the 
corresponding di~ulfide.~ 
Our group has also studied the chemical oxidation of a series of mononuclear and 
dinuclear gold(1) thiolates using [Cp#e]PF6 in CHzC12.’ The results of the oxidation 
showed the formation of gold(1) clusters and disulfide. The chemical oxidation process is 
complete within 2-24 hours. For example, PPh3AuQ-tc) is oxidized by [Cp#e]PF6 more 
quickly than Auranofin. The simple explanation of this time variation is based on the 
accessibility of the thiolate oxidation potential to Fc/Fcf couple. 
Our goal of this study is to report the standard potential of the irreversible thiolate 
oxidation in gold(1) thiolate complexes, such as PPh3AuQ-tc) using [Cp2Fe]PF6 and 
cyclic voltammetry. Quantitative measurements of Cp2Fe and [Cp#e]PF6 will be 
measured by using W- v i s  spectroscopy. 
Experimental Section 
Reagents. Methylene chloride and acetonitrile were purchased from Aldrich. Supporting 
electrolyte, tetra-N-butylammonium teterafluoroborate (BQNBF~) was purchased from 
Aldrich and recrystallized (2X) from CH2Wether. Auranofin was purchased from 
Pfanstiehl Laboratories, Inc. PPh3Aub-tc) was prepared according to previously 
published methods. [Cp#e]PF6 and CpzFe were purchased from Aldrich; CpzFe was 
purified by sublimation. 
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Cyclic Voltammetry (CV) Experiments. CV experiments were conducted using an EG 
& G Princeton Applied Research 273 potentiostat/gavonostat under computer control. 
CV measurements were performed in CH2C12 or CH3CN with 0.15 M Bu4NBF4 as 
supporting electrolyte using the same setup as shown in Figure 2.1. Cyclic 
voltammograms were recorded in the potential range 0 to 1.9 V. 
UV-vis Measurements. W-visible spectra were obtained by using a Hewlett Packard 
8452 diode array spectrometer in I-cm quartz cuvettes. 
Chemical Equilibrium Studies. All manipulations were carried out in the dry box. 
Solutions containing the components were allowed to react in the dry box for 24, 48, and 
72 hrs and samples were taken to check the completeness of the reaction by using UV- 
vis. The quartz cuvettes for W -v i s  measurements were sealed with rubber septa. The 
reaction was found to be complete after the first 24 hrs. Chemical equilibrium constants 
and standard oxidation potentials were calculated using equations shown in the results 
section. 
Results and Discussion. 
Recently, we reported on the electrochemical and chemical oxidation of gold 
thiolates such as PPh3Au(SC&CH3) and A~ranof in .~  Electrochemical oxidation of 
Auranofin in 0.1 M BaNBF4/CH2C12 showed two irreversible peaks at +1.1 and +1.6 V 
vs. Ag/AgCl. The first irreversible oxidation potential at +l. 1 V was assigned as thiolate 
oxidation to disulfide based on bulk electrolysis studies. The chemical oxidation of 
gold(1) thiolates, using [Cp2Fe]PF6, formed a tetragold(1) cluster and di~ulfide.~ 
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Our goal is to measure the standard potential of gold(1) thiolate oxidation by using 
a reversible couple such as Fc/Fc+. The oxidation of gold(1) thiolates using [Cp2Fe]PF6 in 
acetonitrile under nitrogen produced disulfide, cluster, and ferrocene. The cluster was 
formed by dimerization of the first formed dinuclear species to form a tetranuclear 
gold(1) cluster. 
Electrochemical Studies. 
The cyclic voltammetry of a 10 mM solution of Cp2Fe in 0.15 M 
BW&BF~/CH~CN solution at a scan rate of 100 mVi '  in the potential range 0 to 0.75 V is 
shown in Figure 4.1. The reversible couple for 10 mM Fc/Fc+ is seen at El/* = 0.50 V; 
however the thiolate oxidation of a 10 mM solution of PPh3Au(SC&CH3) obtained at 
0.9 V vs. AglAgCl. A mixture of 10 mM Cp2Fe and 10 mM PPh3Au(SC6&CH3) showed 
an enhancement in current under the ferrocene peak. The enhancement in current showed 
that ferrocene is an electron-transfer ca t a ly~ t .~ '~  
UV-vis studies. Reaction of PPh3Au(SC&CH3) with [CpzFe 3' in acetonitrile was 
followed by UV-vis for several days (Equations 4.1 and 4.2). The peaks at 440 nm (E = 
98) and 630 nm (E = 395) for ferrocene and ferrocenium, respectively, were monitored 
for 3 days and the reaction was found to be complete in the first 24 hrs. Figure 4.2 shows 
the W-vis  spectra of -5.12 mM [Cp2Fe]PF6 in CH3CN and its UV-vis spectrum after 
reaction with -10 mM PPh3Au(C&CH3) after equilibration. The quantities of [Cp2Fe] 
and [CpzFe]+ at equilibrium were measured by Beer's law plots for each compound 
2 
- 
\ 
PPh3AuSC6H,CH3 (10 mM) v Ferrocene (10 mM) 
Ferrocene (10 mM) + PPh3AuSC6H,CH3 (10 mM) 
1.8 1.6 1.4 1.2 1 0.8 
E vs. Ag/AgCl 
0.6 0.4 0.2 
Figure 4.1. Cyclic voltammetry of ferrocene (1 0 mM), PPh3Au(SC6H4CH3) (10 mM), and their mixture (10 
0 
mM) in 0.15 M Bu4NE3F4/CH3CN using Pt working electrode. 
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(Figure 4.3 and 4.4). Reduction of [Cp2Fe]' to [CpzFe] referencing was 86% complete in 
the first 24 hrs. At 86% of the reaction completion, the equilibrium constant (Equations 
4.3, 4.4, and 4.5), Keq, was found to be 14.54 x M-'. Figure 4.5 shows the effect of 
completion of the first reaction (Equations 4.1 and 4.2), i.e. Fc'/Fc, on the standard 
potential of gold thiolate. In a broad sense, the standard potential decreases as the 
reaction goes to completion. From Figure 4.5, at 86% completion of the Fc'/Fc process 
the standard potential of thiolate oxidation is 0.25 V vs. Ag/AgCl; at 40% completion the 
potential is 0.37 V (Equation 4.6). 
PPh3AuSR + Fc+ = PPh3AuSR' + Cp2Fe 4.1 
PPh3AuSR+ + PPh3AuSR = [ ( P P ~ ~ A u ) ~ ( S R ) ~ ] ~ / ~  + [RSSR]lD 4.2 
4.3 
4.4 
4.5 
K1= [PPh3AuSR]+[ Cp2Fe]/[PPh3AuSR] [ Cp2Fe]+ 
K2 = [(PPh3Au)4( SR)2] '"[RS SR] 'n/[PPh3A~SR]+[PPh3A~SR] 
Keq = K1 .K2 = [(PPh~Au)~(SR)2]''2[RSSR]"2[Cp2Fe]/[Cp~Fe]+[PPh~AuSR]2 
The symbol E represents the potential and Eo (Fc/Fc+) is a constant (0.35 V), called the 
standard potential. The gas constant R is expressed in joules K'' mol-', T is the 
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temperature (in kelvin); n is the number of electrons appearing in the balanced equation 
for the half-reaction, and F is the number of coulombs per mole (965,485 coulombs).6 
= E ' I I ~ ~ ~ / F ~ + )  - RTInF log [Cp2Fe]/[Cp2Fe]+ 
E'I/Z(A~/A~+) - E ' I / ~ ~ ~ / F ~ + )  = 0.059 l/n log [PP~~AuSR]  [Cp2Fe]+/[PPh3AuSR]+[Cp2Fe] 4.6 
Where n = 1 and E'~,Z(F~/F~+) = 0.35 V 
[PPh3AuSR] = [Cp2Fe]+ 
[PPh3AuSR]+ = [Cp2Fe] 
As shown in Equation 4.2, one molecule of PPh3Au(SC&CH3) is depleted by 
reaction with another molecule of PPh3Au(SC&CH3)+ to form a gold(1) cluster and 
disulfide. Figure 4.6 shows the effect of [PPh3Au(SC6&CH3)] or [PPh3Au(SC&CH3)]+ 
depletion on the standard potential of gold(1) thiolate oxidation. As expected, as the 
species is depleted the standard potential decreases gradually. Assuming the chemical 
reaction in Equation 4.2 is not considered, the standard potential would be 0.25 V vs. 
Ag/AgCl (Figure 4.6). 
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Conclusion 
The irreversible oxidation of gold(1) thiolates was explained by an EC 
mechanism, i.e. thiolate oxidation followed by formation of disulfide. The standard 
potential of thiolate oxidation was determined using the reversible couple Fc/Fc+. The 
standard potential of the gold(1) thiolate complex, P P ~ ~ A u ( S C ~ & C H ~ ) ,  was estimated, 
based on simulation, to be 0.25 V vs. Ag/AgCl. Ferrocene, an electron-transfer catalyst, 
enhances the current of the thiolate oxidation. 
Further estimation of the potential may be found by trying other oxidants that 
have potentials more positive than [Cp2Fe]PF6 such as [Cp*2Fe]PF6. 
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CHAPTER 5 
Oxidation Chemistry of Solganol: Anti-Arthritic Gold-Sulfur Drug 
Introduction 
That gold complexes are effective as anti-rheumatoid arthritis is well 
documented.' Gold(1) thiolates, administered parenterally (by injection), have been used 
for many years in the treatment of rheumatoid arthritis. Solganol (Figure 5.1), a water 
soluble but not lipid soluble gold(1)-thioglucose drug, has been used for the treatment of 
rheumatoid arthritis for over half a century.' 
OH 
Solganol 
Figure 5.1. Structure of Solganol. 
n 
While there is no available x-ray crystal structure for Solganol; recently Bau 
reported the x-ray crystal structure of Myochrysine, gold(1)-thiomalate, as a polymeric 
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structure with two interpenetrating spirals.' The unit cell contains two independent gold 
atoms, one of which has an essentially linear S-Au-S arrangement ( I  78.9') and the other 
is distorted from linearity to 1 69.4.2 
The polymeric yellow solution of Solganol is characterized by two broad bands in 
the UV-vis spectrum; the first band occurs at 250 nm and the second at 270 nm with a tail 
beyond 400 n ~ n . ~  The 1 9 7 A ~  Mossbauer spectroscopy shows gold atoms coordinated to 
two thioglucose units (IS = 1.40, QS = 6.20 mm s-I) and extensive polymerization is 
po~sible .~ 
The chemical oxidation of Solganol in aqueous medium occurs upon addition of 
hypochlorite, a strong oxidant released by phagocytic cells5 The oxidation process 
involved thioglucose ligand followed by Au'/"' oxidation. The oxidation to Au(II1) was 
confirmed by UV-vis and Ion-Chromatography after treating the oxidation product with 
HC1. Hypochlorite oxidation of Solganol occurred slightly slower than for Myochrysine 
(gold(1)-thiomalate) near the end point5 Aqueous solutions of Solganol undergo redox 
reactions to form Au(0) and the disulfide, TgSSTg, which subsequently undergoes 
hydrolytic redox disproportionation to TgSOzH and TgSH.6 
2H20 + 4AuSTg .-b 4Auo + TgS02H + 3TgSH 5.1 
While there is great interest in the biological study of gold drugs; little is known 
about their redox behavior.' Studying the redox behavior of gold(1)-drugs is directly 
related to their toxicity and therapeutic effects in vivo. As an extension of our work on the 
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chemical and electrochemical oxidation of gold(1)-drugs we decided to investigate the 
oxidation of Solganol, in aqueous medium, using cyclic voltammetry and the chemical 
oxidizing agent such as [Cp#e]PF6. 
Experimental Section 
Reagents. Water, D20, HCl, [Cp2Fe]PF6, and sodium perchlorate (NaC104) were 
purchased from Aldrich and were used as received. Solganol was purchased from Fluka 
and was used as received. 
Cyclic Voltammetry (CV) Experiments. CV experiments were performed using an 
EG&G Princeton AppIied Research 273 potentiostatlgalvanostat under computer control. 
CV measurements were performed in 0.5 M NaC104/H20 using the same setup shown in 
Figure 2.1. Cyclic voltammograms were recorded in the potential range 0 to 1.7 V in H2O 
under nitrogen with 0.5 M NaC104 as supporting electrolyte. All potentials were referred 
to a silver-silver chloride electrode (Ag/AgCl) at room temperature. pH values were 
adjusted by Analar grade HCl. 
Bulk Electrolysis. Bulk electrolysis experiments were performed as described in chapter 
2 and Figure 2.2. The electrolytic cell was assembled after oven drying at 110' C. A 0.5 
M NaC104/H20 solution was introduced into the cell, stirred, and degassed with nitrogen 
for 10 minutes. Solganol was added (10 to 20 mg) and the solution was stirred for 10 
minutes. The total number of electron equivalencies (n) and coulombs (Q) passed were 
calculated as shown in chapter 2. 
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H NMR measurements. 'H NMR spectra, recorded in D20, by using a Gemini 300 1 
NMR spectrometer. Chemical shifts were measured relative to the HDO resonance. 
Chemical Oxidation. To 7.0 mg (1 mmol) of Solganol dissolved in 5 ml DzO was added 
3 mg (0.5 mmol) of finely grounded [Cp#e]PF6. The mixture was stirred and a sample 
was taken after 24 hr for 'H NMR. The yellowish-green color due to [Cp#e]PF6 did not 
change even after 72 hrs of mixing. 
Results and Discussion 
Cyclic voltammograms of degassed 6 mM Solganol were investigated in 0.5 M 
NaC104/H20 solutions at a Pt wire counter electrode, an Ag/AgCl reference electrode, 
and a Pt working electrode. Solganol solutions showed a well-defined irreversible 
oxidation peak at +1.2 V vs. Ag/AgCl dependent of the scan rate, concentration, and pH 
values. The oxidative response of Solganol solutions investigated in the potential range 0 
to +1.7 V is irreversible even at slow scan rates of 20-100 mV/s. 
The oxidative cyclic voltammogram of degassed 6 mM Solganol at 20, 50, and 
100 mV/s is shown in Figure 5.2. The position of the peak shifted to higher potentials 
with increasing scan rate from 20 to 100 mV/s. At higher scan rates (>lo0 mV/s) a 
reduction peak at +0.5 V (return scan) started to grow in and the peak at +1.2 V increased 
in current (see Figure 5.3). 
Multiple scan cyclic voltammograms obtained for degassed 6 mM Solganol in the 
potential range 0 to +1.5 V and at a scan rate of 100 mV/s are shown in Figure 5.4, the 
first and fifth scans are shown only in the figure. The first scan was taken after cleaning 
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the electrode while the other scans were taken continuously. The feature of the slightly 
asymmetric broad peak at +1.2 V changed to a symmetrical sharp response by the fifth 
cycle. This behavior is due to a possible filming of the redox products on the electrode. 
The newly formed peak at +0.2 V assigned to the reduction of the hydrolyzed Au(II1) 
formed after the oxidation of Au(I).' 
pH Studies. The pH dependence of the cyclic voltammograms of 6 M Solganol was 
studied by gradually decreasing the pH by the stepwise addition of HCl. Solganol showed 
similar cyclic voltammetry behavior, i.e. no additional peaks, at different pH values by 
using HC1 (Figure 5.5). Generally, the redox peaks shifted to lower potentials upon 
lowering the pH values. 
Electrochemical reduction of 6 mM HAuC14 in 0.5 M NaC104/H20 at a scan rate 
of 100 mV/s is shown in Figure 5 . 5 ~ .  The reduction peak at 0.55 V is coupled with an 
oxidation peak at 1.10 V vs. Ag/AgCl. The reduction of HAuC14 at 0.55 V is due to the 
AuCl4-/AuCl2- process and the peak at 1.10 originates from the oxidation of the generated 
AuC1; to Au(III)? 
At pH = 2, 6 mM Solganol solution showed an oxidation peak at 1.18 V vs. 
Ag/AgCl (compare Figure 5.5a vs. 5.5b). At this low pH value Solganol is expected to 
transform to AuC1; which in turn oxidizes to Au"' at 1.18 V. 
Bulk Electrolysis and Chemical Oxidation. Bulk electrolysis of Solganol at +1.3 V vs. 
AglAgC1 in 0.5 M NaC104/H20 showed that n = 2 (2.2, 2.1, and 1.8), consistent with a 
Au'"' oxidation. Bulk electrolysis of Auranofin at +1 V vs. Ag/AgCl in 0.1 M 
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BU&BF~/CH~C~~ showed that the oxidation is a 0.5 electron process, i.e. sulfur-based 
oxidation. ' ' 
Chemical oxidation using [Cp2Fe]PF6 in D20 was followed by 'H NMR. The 
characteristic peaks of the thioglucose unit did not shift and the characteristic color of 
[Cp#e]PF6 persisted in the solution. This shows the high stability of the thiolate in the 
polymeric Solganol to oxidation. Oxidation of Auranofin using [Cp#e]PF6 resulted in 
formation of disulfide and tetragold(1) cluster (chapter 3). 
Conclusion 
Previously, we reported on the oxidative cyclic voltammetry of 
Auranofin, 2,3,4,6-tetra-0-~-D-glucopyranosato-S(triethylphosphine)gold (I), in 0.1 M 
B Q N P F ~ C H ~ C ~ ~  or 0.1 M Bu&BF4/CH2C12 solutions at a Pt working electrode vs. a 
Ag/AgCl reference electrode, Table 5.1.'' Two irreversible anodic peaks at +l.l and +1.6 
V vs. Ag/AgCl were obtained and assigned as thiolate and Au(I) responses, 
respectively." 
Anderson and Sawtelle have investigated the aqueous redox processes for the 
electrogenerated gold(1) species, [AuC12]-, complexed by biologically relevant ligands 
such as cysteine and penicillamine.' They propose an aqueous reduction mechanism that 
begins with [AuC14]- as illustrated in equations 5.2-5.4. The progress of these electron 
transfer and coupled chemical reactions can be followed by cyclic voltammetry and UV- 
vis spectroelectrochemistry. Upon formation of [AuClJ, addition of cysteine or 
penicllamine leads to complexation and changes in the electrochemistry, which allows an 
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estimation of the oxidation potentials (see Table 5.1) of the Au[cysteine] and 
Au[penicillamine] complexes. Cyclic voltammetry control experiments with cysteine and 
penicillamine indicate that the observed electrochemical responses do not originate from 
these free species in solution (see Table 5.1).9 
[AuCldI- = [AuC12]+ + 2 C1- 5.2 
[AuC12]+ + 2 e- = [AuC12]- 5.3 
Au + 2C1- 5.4 - [AuC12]- + e- 
Comparing the oxidative study of Auranofin vs. Solganol, the former studied in a 
non-aqueous medium (CH2C1,) and showed two anodic peaks at 1.1 V (sulfur based 
oxidation) and 1.6 V (gold based oxidation) vs. Ag/AgCl while the latter showed only 
one anodic response at 1.2 V vs. Ag/AgCl. The second anodic peak (irreversible) in 
Auranofin at 1.6 V which was assigned as gold based-oxidation (AU~")  corresponds to 
the oxidation peak at 1.2 V in Solganol. 
Recent results fiom our laboratory indicate that mononuclear and binuclear 
phophine gold(1) thiolate complexes undergo one-electron oxidation to form tetranuclear 
gold(1) clusters and disulfide." Our study proved that Solganol behaved differently from 
other complexes, perhaps due in part to the polymeric nature of Solganol. Cyclic 
voltammetry of linear phosphine gold(1) thiolate complexes showed an irreversible 
sulfur-based oxidation process above +0.5 V (vs SCE); however, magnesium complex 
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with bridging thiolates, Mg(Py)3(p-SPh)3-Mg(pSPh)3Mg(Py)3, shows only an irreversible 
oxidation at +0.975 mV (vs SCE).'* 
To summarize, the irreversible peak at +1.2 V vs. Ag/AgC1 was assigned as Aum' 
based on the following facts: 
1. Bulk electrolysis at +1.3 V showed n = 2. 
2. Chemical oxidation of Solganol showed no change in the 'H NMR or the color 
of FcPF6, which indicates no thiolate oxidation. 
3 .  At pH = 2 (HCl), the oxidation peak for a Solganol solution is similar to the 
reduced form of HAuC14, i.e. AuClY. 
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CHAPTER 6 
Synthesis, Characterization, and Photophysical Studies of Dinuclear Gold (I) Halide 
and Thiolate Complexes of Bis(dipheny1phosphine)benzene. X-ray Crystal 
Structure of (AuC1)zdppbz 
Introduction 
Phosphine gold (I) thiolates have a long history of medicinal activity as anti- 
rheumaoid arthritis drugs. Auranofin, 2,3,4,6-tetra-O-acetyl- 1 -P-D-glucopyranosato- 
S)(triethylphosphine) gold(I) is an orally effective antiarthritic agent in experimental 
animals and men. A number of dinuclear phosphine gold(1) thiolates have been evaluated 
for antitumor activity.’,’ 
The antitumor activity of phosphine ligands has been reported after isoIating 
bis(diphenylphosphine)ethane, dppe, as a by-product fiom the synthesis of 
Ph2P(CH2)2Cl.’ Complexation of the phosphine ligands as dppe with gold(1) protects the 
ligand fiom air oxidation and increase its cytotoxicity which is evident in the 
(AuC1)zdppe with more cytotoxicty than dppe alone.’ Bisphosphines e.g. R2P(CH2),,PR2 
(n = 1-4, R = Ph or Et) and Ph’PCH=CHPPh2 have been shown to posses a broad 
spectrum of antitumor effects in p3 88 leukemia models2 Linear digold(1) bisphosphine 
molecules are the subjects of many clinical studies in order to establish their promised 
antitumor activity.’ Our group has been investigating dinuclear gold(I) complexes such as 
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Au~(P-SC~H&H~)~(LL) and Au~(SCH~CH~CH~S)(LL) where LL is a flexible, 
bisphosphine ligand varying from 1,l -bis(diphenylphosphino)methane to 1,5- 
bi~(dipheny1phosphino)pentane.~ These complexes exhibit S -b Au charge transfer 
transitions in the UV-visible (330-360 nm) that appear to be perturbed by gold(1)-gold(1) 
 interaction^.^^ Recently our group investigated the dinuclear, gold(1) complexes 
employing cis- and trans-dppee ligands, Au2Xz(cis-dppee) and AuzX2(trans-dppee) (X = 
C1, Br, I, p-SC6H&H3).4 These two series offer the opportunity to examine and compare 
electronic structure and reactivity of conformations in which the two gold atoms are 
constrained to be within bonding distance vs. where intramolecular approach of the two 
gold atoms is precluded. 
\ /Ph 
Ph 
' I  
p\ "\/ Au\X 
I I  h v  
Ph 
\ /Ph 
H\C/ AU\)( p, 
I t  - I I  
A B 
X = CI, Br, I, P S  C G H ~ C H ~  
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In this study the backbone is the phenyl ring in bis(dipheny1phosphine)benzene is 
more rigid than the ethylene group in bis(dipheny1phosphine)ethylene. Hence the cis-trans 
isomerization is precluded. Our goal is the synthesis, characterization, and investigation 
of the photophysical behavior of a new class of halo and thiolato gold (I) complexes of 
the formula (AuX)zdppbz, X = C1, Br, I, p-SC6KCH3. The x-ray of (AuC1)2dppbz as an 
example of the linear geometry of the dinuclear gold(1) complexes will be discussed. 
Ph 
\ /  Ph 
X = CI, Br, I, p-tc 
Experimental Section 
Reagents. Solvents were purchased from Aldrich and used as received without further 
purification. HAuC14.3H20 was purchased from Aithaca or was obtained as a loan from 
Alfa Aesar/Johnson Matthey.. The ligand dppbz, HAuBr4.3H20, Et4NBr, EGNI, and p-  
thiocresol were purchased from Aldrich. 
Measurements. Microanalyses were performed by Dessert Analytics, Az. Melting points 
were determined by using a Thomas Hoover melting point apparatus and reported without 
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correction. 'H NMR spectra, recorded in CDC13 or CD2C12, by using a Gemini 300 NMR 
spectrometer. Chemical shifts were measured relative to the solvent re~onance.~'P NMR 
resonances were recorded in CDC13 and referenced to an external sample of 85% H3P04. 
Luminescence experiments were made by using a Perkin-Elmer LS-50 Luminescence 
Spectrometer. A 40-50 p time delay between excitation pulse and emission detection 
was used to eliminate light scattering and to observe phosphorescence. Slit widths for 
excitation and emission monochromators were typically set at 10 nm. UV-visible spectra 
were obtained using a Hewlett Packard 8452 diode array spectrometer in 1 cm quartz 
cuvettes. 
Synthesis of [p-1,2-Bis(diphenylphosphino)benzene] bis[Chlorogold(I)] (1). In a round 
bottomed flask, thiodiethanol (0.45 ml, 2.22 mmol) in MeOH (3 ml) was added over 15 
min to a solution of HAuC14.3H20 (0.40 g, 1.1 1 mmol) in H20 ( 5  ml)/MeOH (8 ml) kept 
at 0 'C. After stirring for an additional 15 min, dppbz (0.25 g, 0.56 mmol) in a mixture of 
CHC13 (15 ml)/MeOH (10 ml) was added to the colorless gold solution yielding an 
immediate white precipitate. The mixture was warmed to room temperature (1 h) and 
MeOH (30 ml) was added to enhance the formation of precipitate. The white precipitate 
was filtered after stirring for additional 1 h and washed with MeOH and air dried to give 
0.38 g. Recrystallization of the white powder from CH2C12Et20 gave 0.25 g. Crystals for 
x-ray analysis were grown by a slow diffusion in methylene dichlorideEt20. 
Synthesis of [~-1,2-Bis(diphenylphosphino)benzene]bis[Bromogold (I)] (2). Method 
A. To 0.25 g of 1 in a round-bottomed flask, dissolved in 15 ml CH2C12, was added 
slowly 0.28 g of BWNBr, dissolved in 5 ml CH2C12, and the solution mixture was stirred 
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for 15 min. A cloudy white precipitate formed and stirring continued for 30 min. The 
solvent was reduced in vucuo to 5 ml. Excess methanol (20-30 ml) was added to facilitate 
the precipitation process. The white precipitate was filtered, recrystallized from 
CH2C12Et20, and air-dried to yield 0.26 g. Method B. In a round bottomed flask, 
thiodiethanol (0.50 ml, 5.0 mmol) in MeOH (3 ml) was added over 15 rnin to a solution 
of HAuBr4.2H20 (0.50 g, 0.84 m o l )  in H20 ( 5  ml)/MeOH (8 ml) kept at 0 'C. After 
stirring for an additional 15 min, dppbz (0.166 g, 0.37 mmol) in CHC13 (15 ml)/MeOH 
(1 0 ml) was added to the colorless gold solution yielding an immediate white precipitate. 
The mixture was warmed to the room temperature (lh) and MeOH (30 ml) was added to 
complete the precipitation process. The white precipitate was filtered after stirring for an 
additional lh, washed with MeOH, and air dried to give 0.25 g. Recrystallization of the 
white powder from CHzClzIether gave 0.20 g. 
Synthesis of [~-1,2-Bis(diphenylphosphino)benzene]bis[Iodogold (I)] (3). The same 
procedure was used as for 2, method A. Using BmNI as the source of iodide. The sample 
was recrystallized from CH2C12Et20 to form an off-white solid. 
Synthesis of [pL-1,2-Bis(diphenylphosphino)benzene] bis[p-thiocresolatogold (I)] (4). 
0.05 g (0.05 m o l )  of 1 was dissolved in 7 ml of CH2C12. 0.02 g (0.10 mmol) p -  
thiocresol was dissolved in 5 ml ethanol. 25 ml of 0.1 M NaOH was added slowly and the 
solution was stirred for 30 min. The thiolate solution was slowly added to the methylene 
dichloride solution of 1 and a yellow color formed immediately. Stirring was continued 
for 30 min and a yellow precipitate formed gradually. The volume was reduced to 5 ml in 
V ~ C U O  and more precipitate formed. The yellow precipitate was filtered and washed with 
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hexanes and ethanol. In order to get rid from the tetrahedral structure which formed I did 
the solvent extraction by water of (Au-p-tc)2dppbz solution in methylene dichloride. The 
product was recrystallized from CH2C12hexanes to yield 0.021 g.' Table 6.1 shows the 
characterization data for (AuX)zdppbz, X = C1, Br, I, andp-CH&&S. Figures 6.1, 6.2, 
and 6.3 show 'H NMR of dppbz ligand and its complexes. 
Abbreviations: The following abbreviations are used: p-tc = p-thiocresol; pdt = 1,3- 
propanedithiol; dppe = 1,2-bis(diphenylphosphine)ethane; dppp = 1,2- 
bis(dipheny1phosphine)propane; dppb = 1,2-bis(diphenyIphosphine)butane; dpppn = 1,2- 
bis( dipheny1phosphine)pentane. 

Figure 6.1. ‘H NMR spectrum in CDCl3 of bis(dipheny1phosphino)benzene. 
P P 
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Crystal Structure Analysis of [pL-l,2Bis(diphenylphosphino)benzene] 
bis[Chlorogold(I)](l). Crystals of (AuC1)2dppbz were obtained as colorless needles from 
CH2C12-Et20. Crystal data, data collection and processing parameters are reported in 
Table 6.2. Selected bond lengths and angles are listed in Table 6.3. Atomic coordinates [x 
1 04] and equivalent isotropic displacement parameters [A2 x lo3] for (AuC1)zdppbz are 
given in Table 6.4. For x-ray examination and data collection, a suitable crystal, 
approximate dimensions 0.45 x 0.12 x 0.08 mm, was mounted on the tip of a glass fiber. 
X-ray data was carried out by Dr. J. Krause Bauer, Department of Chemistry, University 
of Cincinnati. Intensity data were collected at 293K on a Siemens SMART 1K CCD 
diffractometer (platform goniostat with x fixed at 54.69', sealed-tube generator, graphite- 
monochromated Mo k a  radiation, h = 0.71073 A). The structure was solved by a 
combination of the Patterson method using SHELXTL v5.1 and the difference Fourier 
technique and refined by full-matrix least squares on F2 for the reflections diffracting out 
to 0.75 A. Non-hydrogen atoms were refined with anisotropic displacement parameters. 
Weights were assigned as w-' = o2 (F t )  + (ap)2 + bp where a = 0.0299, b = 0.000 and p = 
0.33333Ft + 0.66667F;. Hydrogen atoms were calculated based on geometric criteria 
and treated with a riding model. Hydrogen atom isotropic temperature factors were 
defined as U(C)*a = U(H) where a = 1.5 for methyls and 1.2 for aromatics. (AuC1)zdppbz 
crystallizes with a badly disordered solvent which appears to be EtzO. A suitable disorder 
model could not be resolved, thus the solvent contribution was subtracted from the 
reflection data using the program SQUEEZE. The refinement converged with 
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crystallographic agreement factors of R1 = 4.29 %, wR = 6.60 % for 5769 reflections 
with I 2 2 0  (I) (R1 = 8.86 %, wR2 7.64 % for all data) and 325 variable parameters. 
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Table 6.2. Crystal data and structure refinement for (AuC1)zdppbz (1) 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system, Space group 
Unit cell dimensions 
Volume, Z 
Density(calcu1a ted) 
Absorption coefficient 
F(000) 
Crystal size 
8 range for data collection 
Limiting indices 
Reflections collected 
Independent reflections 
Max. and min. transmission 
Refinement method 
Data/restraints / parameters 
Goodness-of-fit on F2 
Final R indices [1>20(1)] 
R indices (all data) 
Largest diff. Peak and hole 
C30H24AU2C12P2 
911.27 
293(2) K 
0.71073 A' 
Orthorombic, Pbca 
a = 16.955(3)& 
b = 18.160(2)A, 
c = 22.225( 1)A 
6843.7(2) A3, 8 
1.769 Mg/m3 
8.830 mm-' 
3408 
0.45 x 0.12 x 0.08 mm 
2.40 to 28.30 ' 
- 18<h<22,-23<k<24,-29<1<24 
45724 
8478 (Rint = 0.0605) 
0.5385 and 0.1093 
Full-matrix least-squares on F2 
8478 I 0  I325 
1.048 
R1 = 0.0429, wr2 = 0.0660 
R1 = 0.0886, wR2 = 0.0764 
0.573 and -0.576 eA-3 
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Table 6.3. Selected bond lengths (A) and angles (O) for (AuC1)2dppbz (1) 
Au( 1)-P( 1) 
Au( l)-Au(2) 
Au(2)-C1(2) 
P(1)-C(l) 
P(2)-C( 19) 
P(2)-C(25) 
P( l)-Au( l)-C1( 1) 
C1( l)-Au( l)-Au(2) 
P(~)-Au(~)-Au(  1) 
C(7)-P( 1)-C( 1) 
C( 1)-P( 1)-C( 13) 
C(  1)-P( 1)-Au( 1) 
C(19)-P(2)-C(14) 
C( 14)-P(2)-c(25) 
C( 14)-P(2)-Au(2) 
C( 14)-C( 13)-P( 1) 
2.24 l(2) 
2.996( 1) 
2.2 93 (2) 
1.8 17(6) 
1.821(6) 
1.828(6) 
173.07(6) 
102.99( 5) 
95.7 l(4) 
104.1(3) 
106.0(3) 
113.6(2) 
1 04. 8(3) 
103.7(3) 
120.2(2) 
123.4(4) 
Au( l)-C1( 1) 
Au(2)-P(2) 
P(1 )-C(7) 
P( 1)-C( 13) 
P(2)-C( 14) 
C( 1 3)-C ( 14) 
P( l)-Au( l)-Au(2) 
P(2)-A~(2)-C1(2) 
C ~ ( ~ ) - A U ( ~ ) - A U (  1) 
C(7)-P( 1)-c(13) 
C(7)-P(l)-Au( 1) 
C( 13)-P(l)-Au(l) 
C(  19)-P(2)-c(25) 
C( 19)-P(2)-A~(2) 
C(25)-P(2)-Au(2) 
C(13)-C(14)-P(2) 
2.292(2) 
2.23 6(2) 
1.807(6) 
1.837(6) 
1.824(6) 
1.4 1 5 (8) 
79.6 3 (4) 
173.2(6) 
91.06(5) 
107.1(3) 
116.8(2) 
108.6(2) 
106.4(3) 
1 10.6(2) 
1 10.2(2) 
127.3(4) 
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Table 6.4. Atomic coordinates [x 1 04] and equivalent isotropic displacement 
parameters [A2 x 1 03] for (AuC1)2dppbz (1). 
X Y z U(eq> 
1358(1) 81 85( 1) 4859(1) 4 w  
2894( 1) 
996( 1) 
3465( 1) 
1589(1) 
2474( 1) 
1029(3) 
304(4) 
160(5) 
874(5) 
1297(4) 
2596(3) 
2947(4) 
3 722 (4) 
4154(4) 
3837(4) 
3060(4) 
1280(3) 
1609(3) 
1266(4) 
645(4) 
340(4) 
652(4) 
3 2 5 2( 4) 
4 0 0 7 (4) 
4635(4) 
4508(4) 
3 122(4) 
2224(3) 
2502(4) 
2272(5) 
1781(5) 
- 127(4) 
3 7 5 7( 4) 
8904( 1) 
7635(1) 
7780( 1) 
8815(1) 
10059( 1) 
848 l(3) 
8 14 l(3) 
7869(4) 
7920(4) 
8259(5) 
8536(4) 
8836(3) 
9461(4) 
9472(5) 
8835(6) 
8 198(5) 
8 190(4) 
10240(3) 
10934(3) 
1 1 189(3) 
10729(4) 
10030(3) 
10625(3) 
1054 l(4) 
1094 l(4) 
11412(4) 
1 1505(4) 
11 124(3) 
10478(3) 
1 1 160(4) 
11460(4) 
11079(5) 
9774(3) 
4549( 1) 
3973(1) 
4370(1) 
5708( 1) 
4686( 1) 
6350(2) 
6259(3) 
672 l(3) 
7298(3) 
7405 (3) 
6925(3) 
5974(3) 
6204(3) 
6377(3) 
6329(3) 
61 15(3) 
5 93 2( 3) 
5 5 95 (2) 
5 150(3) 
5069(3) 
5415(3) 
5846(3) 
5012(2) 
4790(3) 
503 l(3) 
5488(3) 
5720(3) 
5471(3) 
3963(3) 
3256(3) 
2884( 3) 
5 93 5( 3) 
3797(3) 
15 13(5) 10399(6) 3 04 1 (4) 
C(30) i734(4) 1 00 8 3 (4) 3 578( 3) 
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Results and Discussion 
The reaction of [AuCl (thiodiethanol)], generated in situ by reduction of HAuC14 
with thiodiethanol, with dppbz (2: 1) leads to a linear two-coordination complex, 
(AuC1)zdppbz (1). Reacting 1 with Et4NBr or Et4NI leads to the formation of 
(AuX);?dppbz, X = Br (2), or I (3), respectively. The thiolato derivative, 4 is obtained by 
reacting 1 with deprotonated p-thiocresol. The thiolato substituent is prepared in situ by 
deprotonation of p-thiocresol with an ethanol solution of NaOH. Isolated products were 
assigned on the basis of NMR spectroscopy and analytical data (Table 6.1). 
The 'H NMR of dppbz in CDC13 shows a complex multiplet at 7.0-7.4 pprn 
(Figure 6.1). Coordination to gold derivatives shifts the peaks slightly downfield to 7.17- 
7.6 pprn with a noticeable splitting in the peaks (Figure 6.2-6.4). A singlet resonance is 
observed in all complexes in the 31P{ 'H} NMR study, which indicates the presence of 
two equivalent phosphorous atoms at room temperature. The resonance of the free ligand 
is recorded at -13.0 ppm and a downfield shift is observed upon coordination to gold(1). 
The chemical shift of 30.8 ppm for 4 is characteristic of phosphine gold t h i ~ l a t e s . ~ ~  
Molecular Structure of (AuC1)zdppbz (1). The molecular structure of (AuC1)2dppbz (1) 
is shown in Figure 6.4; bond lengths and bond angles are reported in Table 6.3. The Au- 
Au distance of 3.0(1)A is comparable to those observed for Aw(tppb)(C=CPh)4, tppb = 
tetraphenylphosphinobenzene 
c4 
Figure 6.4. Thermal probability ellipsoids of (AuC1)zdppbz. 
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3.1 541(4)A,' A u ~ ( ~ - S ~ C ~ B , O H , O ) ( P P ~ ~ ) ~ ,  3.0746(9) Au~(~-L-S~C~BIOHIO)(~-L-~PP~Y), 
3.0195(5) A,8 and Au2(pS2C2BloHlo)(pL-dppph), 2.9771( 10) A.7 The P-Au-Cl moieties 
are linear (-1 73') with a dihedral angle of 105.9'. 
(AuC1)2dppbz crystallizes in S-shaped layers with what appears to be badly distorted 
Et20 solvent molecules. The solvent resides in the channels created by the S-shaped 
nature of the layers. Since the identity of the solvent is not exactly known, the 
crystallographic refinement was completed with the solvent contribution subtracted from 
the data. 
The bond lengths of Au-Cl and Au-P, bond angle of P-Au-Cl, and Au.. .Au distance in 
(AuC1)2dppbz (l), a benzene-bridged complex, are of similar values to cis-(AuC1)2dppee, 
an ethylene-bridged c~rnp lex .~  In cis-(AuC1)2dppee, the Au-P and Au-C1 lengths are 
2.239(5) and 2.299(5) A, respectively, which are similar to those of 2.236(2) and 
2.293(2) in 1. The P-Au-C1 angle in 1 of 173.21' is comparable to 173.2' in cis- 
(AuC1)zdppee. The gold-gold interaction did not change greatly by replacing ethylene by 
phenyl; in cis-(AuC1)2dppee the Au.. .Au distance is 3.05 A, which is slightly greater than 
that in 1 3.0 A. 
UV-vis and Photophysical Studies. The W - v i s  spectra of (AuX)zdppbz, X= Cl, Br, I, 
p-tc in methylene chloride at room temperature all show a broad UV absorption band 
(Ima = 280 nm) that tails into the near visible. The UV-vis spectra for 1-4 in Figure 6.5 
show a red shift in the onset of the manifold of low energy transitions going from X = C1 
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to X = SR, which correlates to the softness of X. This trend indicates a significant 
contribution of the ligand, X in the lowest energy transitions. 
Luminescence studies on (AuX)zdppbz in degassed methylene chloride at room 
and low temperatures resulted in peaks indistinguishable from the solvent. Similar results 
were obtained for (AuX)2dppee under the same  condition^.^ 
n 
X W 
C-L 
W 
X 
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1. INTRODUCTION 
Gold and silver belong to the group known as coinage metals. They occupy positions near 
the bottom of the electrochemical series and so they are difficult to oxidize. Silver'oxidizes 
to Ag+ at +0.7996 V vs NHE while Auo + Au' oxidation takes place at +1.692 V and 
Au' -+ Au"' occurs at +1.498 V (Table 1). In contrast, metals near the top of the electro- 
chemical series, such as Na, are very active, i.e. Na oxidizes to Na+ at -2.71 V vs NHE'. 
The reactivity of Cu, Ag and Au decreases down the group2. Although gold and silver are 
often grouped together, their chemical and physical properties differ significantly, partly 
as a result of increased relativistic effects for gold3. The effects of solvent interaction 
The chemistry of organic derivatives of gold and silver 
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TABLE 1 .  Standard reduction potentials of gold and silver compounds' 
Reaction I?, V YS NHEa 
+ e- = 
+ 2e-  = 
+ e- = 
+ e- = 
+ e- = 
+ e- = 
+ e- = 
+ 3e-  = 
+ e- = 
+ 3e-  = 
+ 2 e-  = 
+ 3 e-  = 
+ e- = 
+ e- = 
+ 1- 
+ co3z- 
+ Br- 
+ c1- 
+ NOz- 
+ F- 
+ 4Br-  
+ 2Br-  
+ 4 c1- 
-0.15224 
-0.017 
t0.07 133 
t0.22233 
t0.564 
t0.779 
t0.7996 
t0.854 
t0.959 
+ 1.002 
1- I .40i 
+ 1.498 
t 1.692 
+ 1.980 
"A1 25°C and I am. 
and ligand stabilization on redox properties are also quite pronounced. The most common 
oxidation state of silver is + I  while for gold the +1 and +3 states are most common. In 
aqueous solution, Ag", Agm and Au' are either unstable or form insoluble compounds. 
However, in nonaqueous solvents, Au' can be stabilized by the appropriate ligand set. 
Linear Au' compounds containing a combination of trialkyl or triaryl phosphine ligands 
with an anionic ligand, such as thiolate or halide, are especially prevalent. 
There is no doubt that the chemistry of gold and silver has expanded dramatically since 
1980. However, electrochemical studies are still fairly limited compared with those of 
other transition metals of biological importance. To our knowledge, no extensive reviews 
have appeared on the electrochemistry of gold and silver complexes. Several reviews that 
are more limited in scope have appeared in the literature and these are referenced in the 
appropriate sections. 
This chapter is organized by ligand type. This organization recognizes the importance 
that ligand-metal interactions play in the redox chemistry of gold and silver compounds. 
The general approach has been to offer an interpretation of trends in redox potentials as a 
function of each ligand type. An extensive tabulation of physical and spectroscopic prop- 
erties has not been included. The chapter is built around several core sections concerning 
gold and silver interactions with carbon (phosphorus ylides and organometallics), biologi- 
cally active molecules (drugs and phosphine gold thiolates) and complexes with promising 
commercial applications (dithiolenes and dithiocarbamates). Other sections such as L2Au 
and L,Ag, phosphine gold halides, and imides and anilides are provided to give coverage 
to ligand types that are related to the core sections. Although comprehensive literature 
citation of electrochemical studies was not the major goal, we hope that reasonably good 
coverage of the core sections was achieved. finally, we have also included a brief survey 
of a few other iigands and structural types where electrochemistry of gold and silver have 
been reported. 
The electrochemical investigations of gold and silver have employed a range of electro- 
chemical techniques, working electrodes, solvents and reference electrodes. In compiling 
the tables that appear in this chapter, a decision was made to report all potentials as 
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TABLE 2. Conversion of reference electrodes and couples". 
SCEb AdAgCF Fc/Fcfd NHE Ag/Ag+' 
~ 
+0.045 V -0.307 V +0.241 V -0.559 V SCEb - 
AglAgCl' -0.045 V - -0.352 V +0.197 V -0.604 V 
$0.549 V -0.252 V - FC@C+~ +0.307 V $0.352 V 
NHE -0.241 V -0.197 V -0.549 V - -0.800 v 
Ag/Ag+' +0.559 V $0.604 V +0.252 V $0.800 V - 
"Read across table and add voltage factor 10 conver7 from one reference electrode or couple to 
another. All data taken from Reference 4. 
bHg/Hg2Clz. KCI (sat'd). 
=KCl (sat'd). 
dReference 4. p. 701, FdFc+ couple in 0.2 M LiClO&leCN = +0.307 V vs SCE. 
'Reference 4. p. 699. 
_- 
published using the reference system employed, and not to also report the potentials in 
a common reference scale. An obvious disadvantage of this omission is that it makes 
direct comparison between studies employing different reference systems somewhat cum- 
bersome. However, we believe the decision is sound because a significant proportion of 
the redox processes reported in this chapter involve irreversible electrochemical processes 
measured in nonaqueous solvents. These redox processes are particularly sensitive to a 
host of factors such as electrode, solvent, electrolyte and cell configuration, which in turn 
affect capacitance, adsorption and cell resistance (iR drop). 
Despite the caveat expressed above, it is still often useful to convert from one reference 
system to another when discussing studies involving closely related compounds. Table 2 
presents the conversion factors employed in discussions in the chapter. A survey of the 
electrochemical literature reveals that differences in conversion factors exist. Thus, Table 2 
is provided only for the purpose of approximating potentials in different reference systems. 
The reader is referred to a number of excellent reference which discuss the complications 
involved in rigorously converting reference systems5. 
In compiling the redox couples for tables that appear in this chapter, we have routinely 
rounded peak potentials to the nearest 10 mV. Redox potential values that appear to occur 
outside the normal useful working range of a solvent at a particular electrode4 were not, 
in general, included in the tables. For ligands that have common or easily recognized 
abbreviations, these are also provided in the tables and may also be used in the text and 
equations. For many of the-entries in the tables, notations have been made about reversible 
(rev), quasi-reversible (qr) or irreversible (ir) processes. 
11. DITHIOLENES AND DISELENOLENES 
In 1,2-dithiolene complexes (or the selenium analogs), there is extensive delocalization 
of the electrons through the rr system of the ligand as well as with metal dn orbitals of 
the corresponding symmetry6. This extensive delocalization makes it possible for dithi- 
olene complexes to exist with a range of electron populations. It also makes assignment 
of the metal oxidation states ambiguous. The 1,2-dithiolenes are expected to have more 
metal-ligand Ir-bonding than 1,l -dithiolenes (e.g. dithiocarbmates), which is evidenced 
by the short M-S bond lengths and facile reversible redox reactions in the former. In con- 
trast, 1,1 -dithiolene complexes, with strained four-membered chelate rings and deviation 
from ideal coordination geometries, are expected to show less reversible redox behav- 
ior and have weaker M-S bonds than 1,2-dithiolenes6. Monomeric bis( 1,2-dithiolene) 
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complexes may undergo one, two or three redox processes according to equation I ,  where 
the two dithiolene ligands are represented simply by S 4 .  
(1)  [M-S4I2- f=;f [M-S4]- F====+ [M-S4Io __1 [M-S4]+ 
The expansion in dithiolene chemistry is due to a wide variety of applications of 
this type of compound in fungicides, pesticides, fingerprint developers, specific ana- 
lytical reagents and highly electrical conductors. There are a number of examples of 
1 ,2-dithiolene and diselenolene gold complexes, but to our knowledge there are no exam- 
ples of silver for which electrochemical data are available. 
Electrochemical potentials obtained from cyclic voltamhetry studies of gold 1,2- 
dithiolene and diselenolene complexes are listed in Table 37-21. These studies reveal 
TABLE 3. Cyclic voltammetry data (V) of 1,2dithiolenes and 1,2-diselenolenes 
Compound Alternative Redox couples Ref. Solvent Ref. 
formula couple 
1 /O 011- 1-12- 2-/3- 
[Au(mnt)21" + I S 1  (rev) -0% (rev) 
-0.96 (rev)" 
-0.42 (rev)" 
-O.6la 
[Au(tfdhl" +1.32 (rev) -0.97 (rev)" 
+1.20 (rev)" b 
[Au(tds)Zl" +1.04 (ir) -1.10 
[ A u ( C ~ S ~  h I" +0.72 (41) -0.52 
[Au(C3 Se5 )Z 1" +0.34 (ir) -0.70 (rev) 
[Au(dddth]" +0.82 (qr) +0.41 (rev) -1.32 (rev) 
[Au(oxdtdt);?]" f0.41 (rev) 
[A~(CsH4Sshl" +0.10 
[Au(diodh]" +0.64 (ir) C 
[Mdpdt)zl" +1.28 (ir) +0.63 (i) 
[ A ~ W t h l "  +0.53 (qr) -1.57 (rev) 
+0.37 (rev) 
[Au(tdO21" f0.46 (qr) -1.61 (rev) 
-1.95 (rev) 
[A~(Bu-r-bdt)~]" +0.59 (u) -1.59 (rev) 
[Au(xdt)21n +0.22 (rev) 
+0.25 (rev) 
+O.M (rev) 
+0.26 (rev) 
+0.15 (ir) 
fo.43 (ir) 
fo.29 (rev) 
[Au(Meqbdt)Z]" +0.13 (rev) 
[Au(tcdt)z]" - 1.67" 
[Au(Naphdt)Z I" f0.51 (rev) 
-1.33 (ir) Ag/AgCl CH2C12 7 
Ag/AgClO4 DMF 8 
S C E  MeCN 9 
SCE MeCN 10 
SCE CH2C12 I 1  
SCE MeCN 9 
SCE MeCN 12 
SCE DMF 13 
SCE DMF 13 
SCE CH2c12 14 
SCE CHzClz 15 
SCE DMF 16 
SCE MeCN 17 
SCE MeCN 18 
S C E  MeCN 19 
FcfFc+ DMF 20 
SCE MeCN 19 
Ag/AgCI04 DMF 8 
SCE MeCN 19 
F&c+ DMF 20 
FdFc+ DMF 20 
FdFc+ DMF 20 
FdFc+ DMF 20 
FdFc+ DMF 20 
Fc/Fc+ DMF 20 
Fc/Fc+ DMF 20 
FdFc+ DMF 20 
Ag/AgCiO4 DMF 21 
Fc/Fc+ DMF 20 
"Polarography at dme. 
bNo wave found in the range 0 to -1.5 V. 
=Not observed. 
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a rich redox chemistry, consistent with the behavior of many other metal dithiolene 
complexes. There are several prominent features of the data; the redox couples are 
highly ligand dependent and many of the redox processes are reversible. Transition 
metal complexes with the maleonitnledithiolate Ligand (mnt, I)  have been intensely 
studied since the mid-1960s when reports began to appear describing the ability of 
mnt to form highly colored transition metal complexes in interesting oxidation states. 
Cyclic voltammetry studies of square planar, [Au(mnt)2]- complexes have measured 
the potentials for the O/ l - ,  1-/2- and 2-/3- couples. The first two redox couples are 
reversible in CH2C1z7, DMF8 and MeCN9*" (see equations 2 and 3)?. A seemingly 
wide range of redox potentials has been reported for the 1-/2- couple. However, 
inspection of Table 3 reveals that the reference electrode/solvent systems employed are 
largely responsible for this difference. For example, the 1-/2- couple at -0.96 V vs 
Ag/AgC104 would be approximately -0.4 V vs SCE, which compares favorably with 
other values reported for this couple. While the 2-/3- couple of the IC~(mnt)2]~-  
analog is electrochemically reversible, [Au(mnt)2]- shows an irreversible electrochemical 
process in CHzClz at 200 mV s-l (equation 4)7. This was further investigated by infrared 
spectroelectrochemistry which indicates that a chemically reversible process occurs at 
longer timescales. These differences were attributable to kinetics of the reactions and the 
electronic structure of the complexes. 
[Au(mnt)zl+- e- [Au(mnt>21- El12 = f1.51 V (2) 
[Au(mnt)z]- + e- +====+ [Au(mnt)2I2- = -0.54 V (3 1 
[Au(mnt)2I2- + e- --+ [Au(mnt)2I3- E, = -1.33 V (4) 
(la) E = S , X = C N  (2a) E = S  (3) 
( lb)  E = s, x = c F 3  
(1c) E = Se, X = CF3 
(2b) E = Se 
(4) 
The O/ l -  couple in [Au(tfd)2]- (tfd = bis(trifluoromethyl)ethylenedithiolate, 1 b) 
occurs at a slightly lower potential (+1.32 V vs SCE in CHzC12) than the mnt 
counterpart9.". This is in accord with observations that in other transition metal 1,2- 
dithiolene complexes the ease of oxidation is dependent on X with X = Ph > CF3 > CN9. 
Replacing sulfur with the less electronegative atom, selenium, results in a lower oxidation 
potential for [Au(tds)z]- (tds = bis(trifluoromethyI)ethylenediselenolate, lc) relative to 
[Au(tfd)z]- 12. More electronegative substituents make a complex easier to reduce, as 
expected. Thus, the 1-/2- couple for [Au(mnt)2]- occurs approximately 500 mV more 
positive than the same couple for [Au(tds)2]-. 
Similar electronic effects are observed for the cyclic ligands, 2a and 2b. The sulfur 
complex, [Au(C3S5)2]-, is oxidized quasi-reversibly at +0.72 V vs SCE (Figure la)  while 
the selenium complex, [Au(C3Sej)? J- ,  undergoes an irreversible oxidation at +0.34 V 
(Figure lb)13. Assignment of the 0/1- couple as a ligand-based oxidation was made on 
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I I I I I I 1 I I I 
- 0.8 - 0.4 0 0.4 0.8 
E,V YS SCE _ _  
FTGURE 1. Cyclic voltammograms for 4.7 x M compound in 0.1 M [BQNJCIO~IDMF at room 
temperamre and Scan rate of 100 mV s-I: (a) 2a; (b) 2b. Reproduced by permission of the Royal 
Society of Chemistry from Reference 13 
the basis of ESR data, and is consistent with the electrochemical potentials observed. The 
1-/2- couple for the selenium complex is reversible (Figure lb) and occurs at a lower 
potential than for the sulfur counterpart. The reason for the differences in reversibility for 
the sulfur and selenium derivatives is not apparent. 
An interesting feature concerning the redox properties of the complex, [Au(dddt)2]- 
(dddt = 5,6-dihydro- 1,4-dithiine-2,3-dithhiolate, 3), is that the one-electron oxidized prod- 
uct, [Au(dddt)-Jo, can be i~olated '~.  An X-ray anaIysis of the neutral complex reveals 
a square planar gold structure stacked in 'dimeric' units as a result of intermolecular 
S - - - S contacts. Extended Huckel calculations predict that the odd electron resides pri- 
marily in a x* orbital of the ligand and suggests that oxidation of the monoanion is ligand 
based. Oxidation of the neutral complex to the monocation was also reported to occur at 
+0.82 V vs SCE14. 
Incorporation of two of the sulfurs in an eight-membered ring has no apparent effect 
on the O/l- couple, i.e. [Au(oxdt-dt)z]- (oxdt-dt = ortho-xylenedithiodithiolate, 4) oxi- 
dizes at the same potential as [Au(dddt)z]-, +0.41 V vs SCE. The one-electron oxidized 
product, [A~(oxdt-dt)2]~, was also isolated and characterized by elemental analy~is '~.  
Gold complexes of dithiolene ligands containing many sulfur atoms are expected to 
be oxidized at lower potentials. This is demonstrated by [Au(Cg&S8)2]- (c8&& = 
2-(4,5-ethylenedithio)- 1,3-dithiole-2-ylidene- 1,3-dithiole-4,5-dithiolate, S) ,  which oxidizes 
very readily to the neutral complex at +0.10 V vs SCEl6. The partially oxidized complex, 
[Au(C8&S8)2]'++. could also be obtained, which is of interest for molecular conductivity. 
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The 0/1- couple for [Au(dpdt)$ (dpdt = 6,7-dihydr0-6-methylene-SH- 1P-dithiepine- 
2,3-dithiolate, 6) occurs at +1.28 V vs SCE, which suggests that the electronic properties 
of dithiolene 6 are intermediate between mnt (la) and tfd (lb)I7. However, the 1-12- cou- 
ple is reported at +0.63 V vs SCE, which is significantly more positive than the 1-/2- 
couples for the other gold dithiolene complexes listed in Table 3. In addition, reduc- 
tion of the monoanion, [Au(dpdt)z]-, is irreversible, in contrast to the other complexes, 
suggesting that in this case the product dianion is unstable. 
A dithiolene ligand incorporating an oxygen atom in the ring backbone has recently 
been prepared and the corresponding nickel, copper and gold complexes were studied". 
The gold complex, [A~(djod)~  1- (diod = 1,4-dithia-6-oxa-2,3-dithiolate, 7), which was 
difficult to prepare, shows only a single irreversible oxidation at +0.64 V vs SCE. Reduc- 
tion to the dianion was not observed up to -1.5 V vs SCE. Apparently, this dithiolene 
ligand is less able to delocalize negative charge. 
A large number of derivatives of [Au(bdt)z]- (bdt = benzene dithiolate, 8a) with dif- 
ferent substituents on the aromatic part of the ligand have been prepared (8-11). The 
monoanionic gold complexes are typically green and contain square planar AuU1. Oxida- 
tion to the neutral complexes occurs at low, positive potentials and is dependent on the 
electronic properties of the aromatic s u b s t i t ~ e n t s ' ~ - ~ ~ .  The stability of the monoanion rel- 
ative to the dianion is greater for [Au(8)2]" than for [Au(mnt)21n. An SCF-HF calculation 
using LANLlDZ core pseudopotentials was carried out on [Au(bdt)~]-*'. The calcula- 
tion predicts that the HOMO is primarily a ligand-based TI orbital while the LUMO is a 
mixed ligand/metal (cu 50% Au dxy) orbital (see Figures 2a and 3). The HOMO should 
therefore be destabilized by electron-releasing substituents while the LUMO may be less 
sensitive to substituent electronic effects. The electrochemical data are consistent with this 
orbital description. Within series 9, the complex which is easiest to oxidize is [Au(9c)2]- 
with two methoxy groups, while the complex which is hardest to oxidize is [Au(9f)2]-. 
Note that the CV data for this series of complexes are referenced against the Fc/Fc+ 
couple and the sweep rate necessary to achieve chemical reversibility varied*'. Oxidation 
of [Au(9e)2]- and [Au(9f)2]- was irreversible even at u = loo0 Vs-I, suggesting that 
the neutral species was chemically unstable. 
X 
(8a) R = H 
(8b) R=Me 
(8c) R=t-Bu 
(9a) X = Me 
(9c) X = OCH3 
(9e) XX = - OCH2CH20- 
(9b) X = SCH3 
(9d) XX =-SCH2CH2S- 
(90 xx = -SC(S)S- 
(9g) XX = - SC(0)S- 
x 
(10a) X = Me 
(lob) X = C1 
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Y 
t 
(b) 
- L(n*) - UT*) 
- M(Pr) blu. 5.52 eV LUMO+I 
o*(xy) hg 3.56 eV - M(Pz) b,, 2.46eV LUMO+ I 
a*(q) hg - 0 53 eV LUMO I nl (xz) bZs- 3.18 eV SOMO 
n2 (2) bl,-7 10 eV SOMO-I 
- n3 (2) b3,-8 53 eV SOMO-2 
HOMO n, (xz) bZg - 4.14 eV 
HOMO - 1 ~ ~ ( 2 )  b,,-4.98eV 
~ 0 ~ 0 - 2  - n3(Z) bg-5.52eV 
- L(n) - L ( 4  
(1) (la)  
FIGURE 2. (a) Coordinate system of [Au(Sa)Z 1- used in the ab initio calculation; (b) electronic struc- 
ture in the valence region of I = [ A U ( S ~ ) ~ ) -  (left) and Ia = [ A U ( S ~ ) ~  J (right). Reprinted with permission 
from Reference 20. Copyright (1995) American Chemical Society 
0.69 A u ( ~ ~ )  ;0.21 Au(dzx) 
: 0.34S(P2) 
i 0.27 S(p,) + 0.30 S(pJ + O.ISS(s: not shown) 
* .  I .  8 .
: i ,-O.21C(P2) : . .  : -0.16C(Px) . . .  
-0.11 Au(Pz) 
: 0.27S(Pz) 
0.22 Au(dp) 
. ,  ;0.29S(P2) . .  . .  v .  
0 1  I ,
. 0.24C(Pz) 
. .  . .  
1 .  
0.15 C(P,) 
HOMO-2 (b$ HOMO- 1 (blu) 
FIGURE 3. Valence molecular orbital basis function coefficients according to the ab initio calculations 
on [Au(Sa)z]-. Reprinted with permission from Reference 20. Copyright (1995) American Chemical 
Society 
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The 1-/2- couple has been reported for only a few members of the  [Au(bdt)z]- 
series. However, the available data suggest that substituent electronic properties also 
affect the reduction potential of the monoanion. The complex, [Au(tcdt);?]- (tcdt = 
3,4,5,6-tetrachlorobenzene-] ,ZdithioIate, lob), with four electron-withdrawing chlorine 
atoms, is easier to reduce (-1.67 V vs Ag/Ag+)*' than [Au(tdt)z]- (tdt = toluene-3,4- 
dithiolate, 8b) with one electron-releasing methyl group (-1.95 V vs Ag/Ag+)'. 
An SCF-HFcalculation on the neutral complex, [Au(bdt)z], reveals a similar ordering of 
the frontier orbitals compared to [Au(bdt)2 1- but with significantly different energies (see 
Figure 2b)20. Thus the calculation predicts that the odd electron in [Au(bdt)2] resides in 
a ligand-based orbital, consistent with experimental results from other laboratories which 
suggest that the 011- couple in An" dithiolenes is a ligand-based oxidation (vide supra). 
Ill. DITHIOCARBAMATES 
Electrochemical data for gold dithiocarbamate (dtc) complexes are listed in Table 4. 
Van der Linden and coworkers studied a series of square planar Ad'' dithiocarbamates, 
[Au(l2)# and mixed 1,2-dithiolene and dithiocarbamate complexes, Au(mnt)(dtc) and 
Au(tdt)(dtc)'o*22. Note that the potentials in these studies were all obtained using a rotating 
TABLE 4. 
Compound Alternative Formula Redox couples Ref. Couple SolvenP Reference 
110 oil- 
Electrochemical data (V) of 1.1-dithiolenes and mixed 1.1- and 1.2dithiolenes 
-0.29 SCE 
-0.22' SCE 
-0.26a SCE 
-0.28' SCE 
-0.29 SCE 
-0.19" SCE 
-0.46' SCE 
-0.41 (rev)'' SCE 
-0.45 (IXV)" SCE 
-0.46 (rev)' SCE 
-0.87' SCE 
-0.80 (rev)' SCE 
-0.11' SCE 
-0.82' SCE 
-0.84' SCE 
-0.19 SCE 
-0.75' SCE 
-0.76b SCE 
-l.loc FdFc+ 
10 
22 
22 
22 
22 
22 
10 
22 
22 
22 
10 
23 
23 
23 
23 
23 
23 
23 
24 
"Rotating disk. 
'Polargraphy . 
cCyclic voltammetry. 
d~~ = propytene carbonate. 
cTol = toluene 
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Pt disk electrode'0*22. In contrast to the gold 1,2-dithiolene complexes, only one redox 
couple has been reported for the complexes containing dithiocarbamates. The monoca- 
tions reduce at less negative potentials than the neutral, mixed complexes. The 1/0 couple 
for [Au(l2)2]+ is irreversible and is fairly insensitive to the substituents bonded to nitro- 
gen. Similarly, in the mixed 1,l- and 1,2-dithiolene complexes, the 0/1- couple is more 
sensitive to the nature of the 1,2-dithiolene ligand rather than to the substituents on the 
1,l-dithiolene ligand. 
(12a) R = H  
(12b) R=Me 
(12~)  R=Et 
(12d) R=Pr 
(12e) R=Bu 
(120 R=Ph 
(12g) R=Bn 
Reduction of a series of Aum dithiocarbamates, [Au(SzCNR2)3], R = Et (12c), Pr 
(12d), Bu (12e) and Bn (12g), was investigated by polarography, chronoamperometry and 
cyclic voltammetry at a mercury electrode23. All the complexes show one main reduction 
wave in the polarogram in a fairly narrow potential range, -0.76 V to -0.82 V vs SCE. 
Constant potential coulometry gave n values of 2.27-2.93 for the series. The noninte- 
gral values for n are indicative of a chemical reaction coupled to the electron transfer 
process. Cyclic voltammograms of the series were more complex than the polarograms. 
For example, the cyclic voltammogram for [Au(l2c)3] is shown in Figure 4. The major 
reduction peak at ca -1.4 V vs Ag/Ag+ (-0.8 vs SCE) is assigned as the 0/1- couple. 
1 
-2.0 
E (V) vs Ag/AgCIOd i"\i t 
FIGURE 4. Cyclic voltammogram for 4.0 x M [Au(lk)3] in 0.2 M NaC104/propylene carbonate 
at 25 "C and scan rate of 50 mVs-'.  Reproduced by permission of The Australian Journal of Chemistry 
from Reference 23 
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There are also two smaller reduction waves at more positive potentials. Similar cyclic 
voltammograms displaying three cathodic reduction peaks and two anodic oxidation peaks 
were obtained for the other complexes in this series. The main reduction peak for each 
gold complex is similar to the peak obtained from the polarographic study (see Table 4, 
values labeled c). The nonintegral n values and the complex CVs were attributed to dis- 
sociation of the dithiocarbamate ligand upon reduction of Aunr(dtc)j to [A~'(dtc)3]~-, 
followed by reaction of free dtc with the mercury electrode (see Scheme 1). 
I A ~ ~ ' ( d t c ) 3 ] ~  + 2e-  [Au'(dtc)3J2- (unstable) 
[Au'(dtc)3J2-  Au'(dtc) + 2(dtc)- 
(dtc)- + Hgo ---+ Hg'(dtc) + e- 
2 Hg'(dtc) Hg"(dtc)z + Hgo . 
SCHEME 1 
The final entry of Table 4 represents the only example we found of a silver dithiocarba- 
mate complex for which electrochemical data have been reported24. Addition of AgBF4 
to cobalt tris dithiocarbamate complexes has been reported by Bond and coworkers. In 
the absence of silver, a fully reversible redox couple occurs which is assigned to the 
[CO(S~CNR~)~]+/C~(S~CNR~)~ couple. When R = Pr (12d), this redox couple occurs 
at +0.355 V (vs Fc/Fc+). Upon addition of AgBF4 to the toluene/CH2C12 solution of 
Co(l2d)3 several new redox couples appear. The electrochemical data are consistent with 
the existence and stability of the complex cation, [Ag{Co(l2d)3)2]+, in solution. Reduc- 
tion of the complex cation occurs at cu - 1.1 V and this is assigned to a process involving 
reduction of the silver ion. Oxidation occurs at +0.83 V which is assigned as involving 
one of the cobalt dtc ligands. The solid state structure of [Ag(Co(l%d)3}2]BF4 reveals 
a central Agf ion in a highly distorted tetrahedral geometry coordinated by four sulfurs 
from the dtc ligands, bridging between Ag and Co. There is no direct Ag-Co bond. The 
solution interactions of a number of cobalt, rhodium and indium tris dtc complexes with 
Ag+ were also in~es t iga ted~~.  
IV. L ~ A u  AND LnAg COMPLEXES 
The series of gold(1) bis(dipheny1phosphine) compounds, [Au(l3a-d)2]+, shown in 
Table 5, was studied extensively by McArdle and B ~ s s a r d ~ ~ .  Cyclic voltammetry at 
a gold electrode shows diffusion controlled, reversible or quasi-reversible behavior 
consistent with a two-electron process (Au'/'" redox couple) occurring at potentials 
ca +0.6 V f 0.2 V YS SCE. Bulk electrolysis studies on [Au(13a)zJPF6 indicate that 
2 electrons (1.81 and 1.83) are removed during oxidation at +0.7 V, while the peak- 
to-peak splitting in the CV study was 37 mV, indicative of near-idealized two-electron 
behavior (0.59Un). The other complexes showed similar CV peak-to-peak separations. 
The bulk electrolysis experiment for [Au(13b)2]PF6 was complicated by decomposition 
of the oxidized product and the generation of another redox active compound. This 
prevented the authors from completing the electrolysis and resulted in an estimate for 
the n value of >1.7 before the secondary process became significant- The oxidation 
products of [Au(13c)z]PF6 and [Au(13d)z]PF6 were too unstable for the authors to attempt 
bulk electrolysis experiments. McArdle and Bossard were also able to gain significant 
insight into the electrochemical process by performing UV-vis-spectroelectrochemistry 
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TABLE 5. 
n = 1,2) 
Compound Alternative Formula Oxidations Reductions Ref. couple Solvent Reference 
[ A 4 1 3 a h  I+ [Au(dppb)z]+ +0.46 (rev) SCE MeCN 25 
[Au(13b)zlf [Au(dppen)zl+ +0.57 (qr) SCE MeCN 25 
[Au( lk)z  I' jAu(dppeh1' $0.46 (qr) SCE MeCN 25 
/Au( lWzJi  IAu(dppp)z I' +0.75 (qr) SCE MeCN 25 
Au[P(C6H5)31zt +0.78 (ir) SCE MeCN 26 
Au[P(OCz H h I z '  +1.10 SCE MeCN 26 
A g ( W f  +1.17 (qr) Ag/AgCl Acetone 27 
Au(15a)z3+ -0.45 (ir) Ag/AgCIO4 MeCN 28 
Au(15b)z3+ -0.17 (ir) Ag/AgC104 MeCN 28 
Ag( 15a)z3+ -0.03 (ir) Ag/AgC104 MeCN 28 
Ag(l5b)z 3+ f0.26 (ir) Ag/AgCI04 MeCN 28 
Cyclic voltammetry data (V) of LzAu and L,Ag complexes (L = phosphine or mine ,  
on [A~(13a)z]PF6~'. During oxidation at +1.26 V they found clean conversion of one 
species to another as evidenced by a series of isosbestic points. They proposed that during 
oxidation, tetrahedral gold(1) is converted to square-planar gold(II1). The differences in the 
electrochemical behavior of the series were proposed to be a consequence of the lability of 
the gold-phosphorus bond and the overall rigidity of the four-coordinate gold compounds. 
(15a) E = P  
(15b) E = A s  
Anderson and coworkers investigated the effect of added phosphine to solutions of 
Au(PR3)CIz6, which results in additional phosphine ligands attaching to a central gold(1) 
atom as shown in equation 5. 
( 5 )  Au(PR3)Cl+ (n  - l)PR3 F==+ Au(PR3),+ + CI- 
PR3 = PPh3 or P(OC;!Hs)3, n = 2-4 
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Conductivity data show that adding PPh3 to the nonelectrolyte solution of Au(PPh3)CI in  
MeCN produces a weakly conducting solution at 1-2 equivalents of PPh3, and a strongly 
conducting solution at >4 equivalents of PPh3, indicative of the presence of a 1 : 1 
electrolyte. By keeping the amount of added phosphine low, Anderson and coworkers 
ensured that &he multiple equilibria implied in equation 5 involved predominately n = 1 
and 2, thereby allowing them the opportunity to investigate the electrochemical oxida- 
tion of [Au(PPh3)2]+ and [Au(P(OC2Ng)3)2 ]+ (see Table 5). Interestingly, the cationic 
complex, [Au(PPh3)2]+, is easier to oxidize than Au(PPh3)CI (+ 1.54 V vs SCE)26 sug- 
gesting that the CI- ligand stabilizes and 'protects' the gold from oxidation. Substituting 
the triphenylphosphine ligand by the electron-withdrawing triethylphosphite shifts the 
Au'/"' couple to higher potentials, as expected. 
The silver diiminodiphosphine complex, Ag(14)+, was investigated electrochemically 
by using a Pt working electrode in 0.1 M tetraethylammonium perchlorate/acetone 
solution2'. The quasi-reversible redox couple, Ag(14)C/Ag(14)2+, occurs at + 1.17 V 
(vs Ag/AgCl). Comparison of the oxidation potentials of the four-coordinate gold(1) bis- 
phosphine complexes, [Au(l3a-d)2]+, shown in Table 5,  indicates that the silver complex 
is on average 0.5 V harder to oxidize, which is in line with expectations from comparisons 
of the Ad/" and Agr/" redox couples discussed in the introduction. Rauchfuss and 
coworkers also reported that the fully reversible Cu'/" redox couple found for the copper 
analog, Cu(14)+, occurs at +0.77 V (vs Ag/AgC02'. 
Reduction of the gold and silver complexes of 15a,b was investigated by cyclic 
voltammetry at a Pt electrode28. These data afford an interesting comparison of the elec- 
trochemical behavior of Au vs Ag and P vs As. The Au"' complexes are harder to reduce 
than the corresponding Ag'" complexes, which reflects the relative chemical stability of 
Au" and Ag"'. The Agnr complex, [Ag(lSb)2](C104)3, decomposes readily in the pres- 
ence of water, chloride and many organic solvents23. A qualitative comparison of the 
reduction potential of [Au(l5a)2l3+ (-0.45 V vs Ag/Ag+ or cu +0.15 V vs SCE) with 
the reversible redox couple for [Au(13a)2]+ (+0.46 V vs SCE) is also in line with the 
difference in electronic properties of methyl vs phenyl groups on P. 
V. PHOSPHINE GOLD HALIDES 
The electrochemical properties of phosphine gold halide compounds have been the subject 
of a number of investigations. Anderson and coworkers26 reported that Au(PPh3)CI and 
Au(PEt3)CI undergo oxidations at + 1.54 V and + 1.51 V, respectively (vs SCE), in MeCN 
solutions at 100 mVs-* (see Table 6). The oxidation process for Au(PEt3)CI involves a 
broad irreversible oxidation wave, is diffusion controlled (i.e. iP/v1i2 is constant) and 
the value of Epa shifts positively with an increase in scan rate. On the basis of cyclic 
voltammetry, bulk electrolysis and UV-vis spectroelectrochemistry studies, the authors 
conclude that an overall two-electron oxidation of Au' --+ Au"' occurs, followed by a 
fast chemical reaction. The n value for bulk electrolysis of Au(PEt3)CI was 2.0 f 0.5. 
Cyclic voltammetry studies for Au(PEt3)CI show no reduction process out to -2.0 V, 
except when the oxidation wave at + 1 .S 1 V is first scanned, whereby a reduction wave at 
+0.20 V is observed. The observation is made that the presence of a reduction wave at ca 
0.2 V implies formation of a gold(II1) ionic species, similar to the reduction wave which 
appears for K [ A u C ~ ] * ~ .  In addition, reduction of [AuCbJ- in the presence of phosphine, 
PR3, regenerates Au(PR3)Cl. Spectroelectrochemical data show that upon oxidation of 
Au(PEt3)CI at + I  .45 V (vs Pt pseudoreference) a band at 3 10 nm appears. This band is 
assigned to AuCL-. The electrochemistry of Au(PPh3)CI was found to be very similar. 
166 
Ahmed A. Mohamed, Alice E. Bruce and Mitchell R. M. Bruce 
TABLE 6. 
Compound o x .  Red. Ref. couple Solvent Reference 
Electrochemical data (V) of phosphine gold halide complexes 
Au(PPh3 )Cl 
Au(PPh3)CI 
Au(PPh3)CI 
Au(PPh3)CI 
Au(PPh3)Br 
Au(PPh3)Br 
Au(PEt3)Br 
Au(PPh3)I 
Au(PEt3)CI 
Au[P(OCzH5)3ICI 
Au[P(OC& 13 lc1 
Au(l6)CI 
Au( 16)B r 
Au(PPh3)Cb 
Au(PPh3)Bu 
Au(16)Cb 
Au(lQBr3 
Au(l7)CI 
Au(1RCI 
+ 1.58 
+ 1.54 
+1.13 
+1.52 
+1.31 
+1.14 
+ 1.38 
+ 1.05 
+1.51 
+ 1.86 
+ 1.76 
+ 1.07 
+1.03 
+ 1.75 
+1.12 
- 1.76 
+0.03a 
-1.71 
-1.76 
- 1.54 
+0.2v 
-0.49 
-0.3 1 
-0.49 
-0.37 
Ag/AgCI 
SCE 
FcJFc+ 
SCE 
Ag/AgCI 
FcJFc+ 
AdAgCI 
AdAgCI 
SCE 
SCE 
SCE 
Fc/Fc+ 
FdFc+ 
FclFc+ 
Fc/Fc+ 
Fc/Fc+ 
Fc/Fc+ 
SCE 
SCE 
MeCN 
MeCN 
CHzClz 
MeCN 
MeCN 
CHzCl2 
MeCN 
MeCN 
MeCN 
MeCN 
MeCN 
CH2CIz 
CH2C12 
CHzCl2 
CH2C12 
CHzClz 
CH2C12 
MeCN 
MeCN 
29 
26 
30 
31 
29 
30 
29 
29 
26 
26 
26 
30 
30 
30 
30 
30  
30 
31 
31 
uReduction wave appearing after oxidation. 
Two other studies have appeared which also assign the oxidation of Au(PPh3)Cl as 
involving a two-electron Au' -+ Aum irreversible proce~s~' .~ ' .  In contrast, Rakhimov 
and coworkers have recently suggested that the oxidation of Au(PPh3)Cl is a one-electron 
process involving p h ~ s p h i n e ~ ~ .  Their analysis is based, in part, on similar oxidation cur- 
rents observed in cyclic voltammetry experiments of Au(PPh3)CI solutions containing 
equal concentrations of ferrocene, a well-known one-electron redox couple31 ~ 
Substituting alkyl phosphines for aromatic phosphines or phosphites has only a minor 
effect on the oxidation potentials in two separate ~ t u d i e s ~ ~ , ~ ~ .  Substitution of less elec- 
tronegative halides for chloride might be expected to make the oxidation of gold(1)-halide 
moieties easier. This was indeed observed in cyclic voltammetry studies in 0.05 M 
[EbN]BF4/MeCN solution at a Pt working electrode where Au(PPh3)Br and Au(PPh3)I 
are 27 mV and 53 mV, respectively, easier to oxidize than A u ( P P ~ ~ ) C ~ ~ ~ .  However,
Nelson and coworkers found little change when Br- is substituted for C1- in cyclic 
voltammetry experiments run in 0.1 M [ B Q N ] C ~ O ~ / C H ~ C I ~  solution at a Pt working 
electrode: oxidation of Au(PPh3)Br occurs at +1.14 V and for Au(PPh3)CI at f1.13 V 
vs Fc/Fc+ (see Table 6)30. The oxidation potentials of gold(1) I-phenyldibenzophosphole 
(16) halide compounds are also insensitive to halide substitution. Oxidation of Au( 16)Cl 
occurs at +1.07 V vs Fc/Fc+ and for Au(l6)Br at +1.03 V30. In fact, all four compounds 
investigated by Nelson and coworkers are reported to oxidize within a narrow range 
1.09 V f 0.06 V (vs  Fc/Fc+)~O. Substitution of more electronegative halides for bromide 
might be expected to result in making reduction of gold(II1) easier. Nelson and coworkers 
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observe this for AuLX3 compounds (L = PPh3, 16; X = C1, Br) where substitution of 
Br- for CI- decreases the average Au(UI) reduction potential by 150 mV3'. 
Ligand 17 is believed to act as a monodentate Iigand for Au', coordinated through the 
phosphine only, on the basis of I3C NMR data which show that the aromatic carbon 
atoms bonded to nitrogen remain practically unchanged, in contrast to the carbon atoms 
bonded to phosphorus which are shielded after complexation. The oxidation of Au(l7)CI 
and Au(l7)zCI complexes was studied by Castan and coworkers3'. The major anodic 
process of Au(l7)Cl is an irreversible wave occumng at +1.75 V (see Table 6) which is 
assigned as Au' to Au"'. A shoulder at +0.95 V occurs which is assigned to oxidation 
of the free ligand (+0.87 V vs SCE). In the cyclic voltammogram of Au(l7)2CI, there is 
also a shoulder at ca 0.95 V and a major oxidation wave at +1.12 V, which is assigned 
as a Au' + Au" oxidation. The authors suggest that increasing the coordination number 
around gold from two in Au(l7)CI to three in Au(l7)zCI is responsible for decreasing the 
oxidation potential. This observation is further supported by comparison with the redox 
couple for the four-coordinate Au' complex, [Au(l3a)*]+, found in Table 5. This simple 
relationship is illustrated in Figure 5. 
2.0 
0.0 I I I I 
2 3 
Coordination Number 
4 
FIGURE 5. Oxidation potentials vs coordination number: W Au(l7)CI, +1.75 V; 0 A ~ ( 1 7 ) ~ C l ,  
+ I .  12 V; A [Au(13a)z If. +0.46 V. All potentials vs SCE 
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VI. PHOSPHJNE GOLD THIOLATES AND MIXED DONOR LIGANDS 
The electrochemistry of a series of neutral phosphine gold(1) thiolate complexes has 
been i n v e ~ t i g a t e d ~ ~ , ~ ~ .  The series includes cyclic dinuclear goId(1) complexes formed 
from 1,2-propanedithiolate (pdt, 18) and bis-chelating phosphines, Au2(13c,g)(18), open 
dinuclear gold(1) complexes formed from para-thiocresolate (p-tc, 19) and bis-chelating 
phosphines, Auz(13c-g)(19)2, and a mononuclear complex, Au(PPh3)( 19). Oxidative 
cyclic voltammetry experiments were performed at Pt and glassy carbon electrodes 
in 0.1 M [Bu4N]PF6/MeCN and CH2C12 solutions. Adsorption effects occurred in all 
electroddsolvent combinations investigated and were minimized by wiping the electrode 
between each CV experiment. Scan rates between 50 and 500 rnVs-' were employed 
and several replications at each scan rate were obtained. Table 7 shows the results 
of the oxidative cyclic voltammetry experiments at a Pt working electrode in 0.1 M 
[ B u N ] P F ~ / C H ~ C I ~  solu t ion. 
The position and wave shape of the oxidation processes were somewhat dependent on 
the electrodekolvent combination. The effect of changing the solvent from CH2C12 to 
TABLE 7. Cyclic voltammetry data(V) of phosphine gold thiolate and mixed donor ligand complexes' 
Compound Alternative formula Oxidations Reductions Solvent Reference 
Au2(1k)(18) Au~(dppe)(pdt) +0.77' (ir) f1.20 (ir) CHzClz 32 
Auz(13g)(18) Auz(dpppn)(pdt) +0.63 (ir) + 1.23 (ir) CH2CI2 32 
Au(PPh3)(19) Au(PPh3)(p-tc) +0.82 (ir) +IS2 (ir) CH2C12 32 
Auz(l&)(19)2 Auz(dppm)(p-tc)z +0.58' (ir) +1.52c (ir) MeCN 33 
AU2(1k)(19)2 Auz(dppe)(p-tc)~ $0.72 (ir) +IS4  (ir) CH2C12 32 
Auz(13d)(19)2 Au2(dppp)(p-tc)z +0.77 (ir) +1.54 (ir) CH2C12 32 
AU2(13f)(19)2 Auz(dppb)(p-tc)2 +0.83 (ir) +1.59 (ir) CHzCl2 32 
Au2(13g)(19)2 Au2(dpppn)(ptc)z +0.78 (ir) + I  .56 (ir) CH2C12 32 
[Auz(1W(20)lf + 1.42 (ir) CH2CI2 34 
[Au~(JW(~O)I' + I  .46 (ir) CH2C12 34 
35 
36 
36 
36 
37 
37 
IM21)zl' -0.86 (rev) MeCN 
22a +0.26 (rev) +0.59 (rev) - 1.22 (ir) MeCN 
22b t0.32 (rev) +0.68 (rev) -1.18 (ir) MeCN 
-1.0 (ir) MeCN 22c +0.65 (rev) 
t0.08 (rev) MeCN 23a + 1.2 (ir) 
-0.10 (rev) MeCN 23b + I  .2 (ir) 
uAII studies employed a €3 working electrode except as noted. Reference was SCE in all studies, except Reference 35 
which was Fc/Fc+. 
bAdsorption wave appears at t0 .47  V. 
'Glassy carbon working electrode. 
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MeCN in cyclic voltammetry experiments of Au2(13c)(18) at glassy carbon is illustrated 
in Figure 6. The broadness of the irreversible oxidation wave shown in Figure 6b was 
noted in the study3'. The difference between the potential maximum and half currents 
( E p ,  - Epa/2) was found to be 150 mV. A similar observation about broadness in the 
oxidation wave of phosphine gold halide complexes was made by Anderson and coworkers 
during investigation of the oxidation of Au(PEt3)ClZ6. The first oxidation process of 
all complexes shown in Table 7 occurs at +0.7 V f 0.1 V (vs SCE), with the possible 
exception of Au2(13c)(18) for which the presence of an adsorption wave at t0.47 makes 
the exact potential of the first oxidation process somewhat difficult to determine. The first 
oxidation process is followed by a second one which occurs between +1.2 V and +1.6 V 
(see Table 7). With the exception noted for Au2(13c)(18), substituting aromatic thiolate, 
19, for alkyl thiolate, 18, shifts both the first and second oxidation processes to lower 
potentials. Figure 7 shows the 0.0 V to +2.0 V cyclic voltammograms for Au2(13c)(18) 
and Au2(13g)(18) in CH2C12 or MeCN solutions. Lengthening the bis-chelating phosphine 
from 13c to 13g has only a small effect on the overall cyclic voltammogram waveshape 
(compare Figure 7a and 7c). It has been noted that for a particular solventlelectrode 
combination the first oxidation wave broadens as the length of the bis-chelating phosphine 
becomes very short (i.e. 13e, not shown) and may indicate weak coupling of the two 
gold(1) redox centers33. 
Comparison of the oxidation processes of Au(PPh3)X (see Figure 8, X = halide) shows 
an inverse linear relationship between the oxidation potentials and the electronegativity 
of the X ligand. Since the electronegativity of sulfur is similar to iodine, oxidation of 
phosphine gold thiolate complexes may be expected to occur near f l . O  V. However, as 
shown in Table 7, the first oxidation occurs at ca 200-400 mV lower potential. In addi- 
tion, constant potential electrolysis studies at +1.0 V result in formation of the disulfide, 
P - C H ~ C ~ H & S % & C H ~ - ~  and n values of 1 and 0.5 for the dinuclear and mononuclear 
gold(1) complexes, respectively. The lowest transition state energy of phosphine goId(1) 
thiolate complexes has been assigned as a sulfur-to-metal charge transfes'. This assign- 
ment and the formation of disulfide are consistent with sulfur-based oxidation, in contrast 
to Au(PPh3)X where gold-based oxidation was suggested by several  author^^^,^',^'. This 
0 
- 2 
P A  
- 4  
- 6  1 1 1 1 1 1 1 1 1  
800 400 0 
E ( m V v s  SCE) 
0 
- 2  
- 4  
-6 i / I I I l l I l 1 l 1  
800 400 0 
E(mV v5 SCE) 
FIGURE 6. Cyclic voltammograms at a glassy carbon electrode at room temperature and scan 
rate of 50 rnVs-': (a) 4.7 x lo-' M Au2(13c)(lS) in 0.1 M [Bu4N]PF6/MeCN; (b) 4.8 x lop4 M 
Au2(lk)(l8) in 0. I M [ B Q N ] P F ~ / C H ~ C ~ ~ .  Reproduced by permission of Freund Publishing House 
from Reference 32 
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FIGURE 7. Cyclic voltammograms at a glassy carbon electrode at room temperature: (a) 4.8 x lo4 M 
Au2(13c)(18) in 0.1 M [BU&]PF~/CH~CI~ at scan rate 200 mvs- ' .  (b) 4.7 x M Au2(1k)(18) 
in 0.1 M [Bu4N]PF&leCN at scan rate 50 mVs-'. (c) 4.8 x loa M Au2(13g)(lS) in 0.1 M 
[BuN]PF~/CH~CI~ at scan rate 100 mVs-l. Reproduced by permission of Freund Publishing House 
from Reference 32 
difference may be significant for the biological activity of phosphine gold thiolate com- 
plexes such as Auranofin, since the redox chemistry of gold(1) centers interacting with 
tho1 groups of proteins and enzymes may be critical to the mechanism of action of a drug. 
The electrochemistry of gold(1) complexes with pyridine-2-thiolate, 20, was inves- 
tigated by Laguna and coworkers34. The gold(1) cationic complexes [ A u ~ (  13e)(20)1+ 
and [Au2(13c)(20)]+ undergo irreversible oxidations at +1.42 V and +1.46 V, respec- 
tively, during cyclic voltammetry experiments at a Pt disk working electrode recorded at 
200 mVs-' in 0.1 M [ B U ~ N ] P F ~ / C H ~ C ~ ~  solution. No reduction waves were observed 
out to -1.8 V. The reference electrode was SCE, which was standardized against either 
the Fe(r&Hs)2]+-[Fe(q-C-jHs)2] or the [Fe(r7-CsMes)2lf-[Fe(rl-CsMes)2I couple as 
an internal standard (Eo = 0.47 and -0.09 V, respectively). 
The electrochemistry of a square-planar gold(II1) complex with 2-(diphenylphosphino) 
benzenethiolate (21) was reported by Dilworth and coworkers35. Cyclic voltammetry 
experiments on [Au(21)2]BPh indicate a reversible redox couple at -0.862 V (vs the 
Fc/Fc+ reference couple) in 0.2 M [ B u ~ N I B F ~ N ~ C N  solution. Peat-to-peak separation 
of the redox waves was 84.2 mV and convolution methods were used to establish that 
the redox couple was reversible and involved the same number of electrons as the 
femocenelferrocenium couple under identical conditions. The reductive scan was assigned 
9. The electrochemistry of gold and silver complexes 
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FIGURE 8. Electronegativity of halides vs oxidation potentials of phosphine gold0 halides: (a) 
Au(PPh3)CI, +1.54 VZ6; (b) Au(PPh3)Br. + I 2 7  VZ9; (c) Au(PPh3)I. +1.01 VZ9. The oxidation 
potentials of Au(PPh3)Br and Au(PPh3)I were converted to the SCE scale using Table 2 
as Au"' -+ Au". The reversibility of the redox couple under slow scan rate conditions 
(50 mVs-I) indicates that the gold(I1) complex is stable over the time scale of the 
electrochemical experiment. In contrast, the neutral Pt(I1) and Pd(1I) analogs, Pt(21)2 
and Pd(21)2, are electrochemically inactive over the accessible range of DMF (-2.4 V 
to +1.2 V relative to ferrocene). 
The synthesis, characterization and electrochemical investigation of an interesting series 
of gold(I1) complexes with o-aminobenzenethiolate ligands has been reported by Gosh, 
Manoharan and  coworker^'^. The ligands are noteworthy, because they have both hard and 
soft donor atoms which may contribute to stabilizing gold(I1) complexes. The dinuclear 
gold(I1) complex, 22a, is prepared by the reaction of NaAuC4 with o-aminobenzenethiol. 
The isomer, 22b, forms after refluxing 22a for 2 hours in dry, degassed methanol, while 
the mononuclear complex, 22c, is formed upon dissolution, refluxing and workup of 22a 
in DMF. ESR measurements in DMF solution on 22a and 22b show a seven-line pattern 
(1 : 2 : 3 : 4 : 3 : 2 : 1) assigned as two interacting gold(I1) nuclei (Au, I = $, 100%). The 
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mononuclear complex, 22c, shows a four-line pattern. Close agreement between the ESR 
experimental results and simulation was found. Cyclic voltammetry experiments at a Pt 
working electrode in 0.1 M [Et4N]C104/MeCN solution at 50 mVs-' show two sets of 
reversible redox couples for 22a and 22b and one for 22c (see Table 7). The small shifts 
in the pairs of redox couples for 22a and 22b support the idea that these complexes are 
isomers with gold(I1) atoms in slightly different electronic environments. The complexes 
22a-c all display a broad irreversible reduction wave at ca -1.0 V, presumably due 
to reduction of Au" to Au'. The o-aminobenzenethiol ligand does not show any redox 
behavior in this region. 
QNH* I 
Ghosh, Manoharan and coworkers have also reported on a pair of isomers formulated 
as shown below, 23a and 23b37. Four-line patterns were observed in  the ESR of each of 
these complexes which appear to originate from one interacting gold nucleus. The authors 
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suggest that the complexes have Au(I1)-stabilized radical structures containing oxidized 
ligands where the unpaired electron is highly delocalized onto the ligand. Cyclic voltam- 
metry experiments demonstrate that the redox behavior of these complexes is somewhat 
complicated, in contrast to the relatively well-behaved features found in 22a and 22b. 
On oxidative scans, both complexes show irreversible oxidation processes occurring at 
about +1.2 V. On reductive scans, a reversible couple occurs near t O . 1  V, but there is 
also a broad reduction wave at ca +0.35 V that appears coupled to two successive oxida- 
tive processes occumng near +0.4 V and +0.6 V. The origin of these redox features is 
not discussed. 
l+ 
l+ 
VII. PHOSPHORUS YLIDES 
Dinuclear gold(1) and gold(I1) phosphorus ylide complexes have been the subject of sev- 
eral separate electrochemical investigations by Fackler and coworkers39 and Laguna and 
c ~ w o r k e r s ~ ~ , ~ ~ .  The neutral, cyclic bis-ylide, gold(1) complex, 24, undergoes two quasi- 
reversible, stepwise oxidations at +O.f 1 and +0.24 V (vs Ag/AgCi) (see Table 8)39. The 
stepwise oxidations presumably involve one electron each, to form a gold(I1)-gold(II) 
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complex. Precipitation of a yellow compound complicated efforts of further electro- 
chemical analysis. The cyclic gold(I1)-gold(I1) halogen adducts, 25a-c, all show one 
irreversible reduction wave and the potentials are dependent on the nature of the halogen 
l i g a n d ~ ~ ~ .  The reductions are followed by a chemical reaction that generates 24, which 
can be clearly detected electrochemically. Bulk electrolysis of the Au(I1) halogen adducts 
yields an n value of 2 electrons per molecule. For 25c two quasi-reversible oxidation 
waves are seen, whereas for 25a and 25b only ill-defined, irreversible oxidation processes 
are observed. The electrochemistry of 25d and 25e is complicated by an equilibrium 
that involves 24 which results i n  deteriorating electrochemical signals39. Therefore, the 
potentials listed in Table 8 for 25d and 25e were obtained under conditions of excess 
alkyl halide. 
X 
PPh2 
/ 
Y 
(25a) X = Y = C 1  
(25b) X = Y = B r  
(25c) X = Y = I  
(25d) X = Me, Y = Br 
(25e) X = Me, Y = I 
Cyclic voltammetry experiments on cyclic, dinuclear goldo) ylide dithiocarbamate com- 
plexes, 26a-c, show irreversible oxidation processes between +0.30 V and +0.4 V (see 
Table 8)40. Electrochemical analysis was complicated by formation of a coating on the F’t 
electrode surface. These complexes oxidize at potentials which are intermediate between 
TABLE 8. Cyclic voltammetry data (V) of phosphorus ylide complexes 
Compound 0 x 1  0 x 2  Red 1 Red2 Refxouple Solvent Reference 
24 
25a 
25b 
25c 
25d 
25e 
26a 
26b 
26c 
27 
28a 
28b 
$0.24 +0.11 
+IS 
+ 1.22 
+1.12 +0.88 
+0.38 
+0.42 
+0.30 (ir) 
+0.37 (ir) 
+0.42 (ir) 
t0.53 (ir) 
a 
(I 
Ag/AgCI 
-0.92 (ir) Ag/AgCI 
-0.69 (ir) Ag/AgCI 
-0.58 (ir) Ag/AgCI 
-0.75 -1.18 Ag/AgCl 
-0.68 -1.14 Ag/AgCI 
SCE 
SCE 
SCE 
SCE 
-0.44 (ir) SCE 
-0.43 (ir) SCE 
THF 
THF 
THF 
THF 
THF 
THF 
CHzCl2 
CHzClz 
CHzClz 
CHzCl2 
CHzClz 
CHzCl2 
39 
39 
39 
39 
39 
39 
40 
40 
40 
34 
34 
34 
‘Oxidation wave observed at +0.55 (ir) after reduction 
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R 
\ Ph2PL*U- rAu-StN/ s R 
(26a) R = M e  
(26b) R=Et  
(26c) R=Bn 
those of [Au~{,u - S*CN(CH2Ph)2)2] (irreversible wave at f1.15 V)40 and 24. Increas- 
ing the electron-donating ability of the substituent groups on the dithiocarbamate ligands 
from Bz to Me leads to a decrease in  the oxidation potential. 
Dinuclear gold(1) and gold(I1) complexes of pyridine-2-thiolate, 27, 28a and 28b, were 
studied by cyclic voltammetry at a Pt working electrode in CH2C1234s The dinuclear 
gold(1) complex, 27, has an irreversible, extended oxidation process at +0.53 V vs SCE. 
No reduction wave was observed out to -1.8 V. The cyclic voltammograms for the 
dinuclear gold(I1) complexes show irreversible reduction waves at -0.44 V (28a) and 
-0.43 V (28b). After reduction, the return oxidation scan shows an irreversible oxidation 
process at +0.55 V, indicative of the presence of 27. 
X 
I 
(28a) X=C1 
(28b) X = B r  
VIII. ORGANOMETALLICS 
The electrochemistry of a fairly large number of organometallic gold compounds has been 
studied (Table 9). With few exceptions, these complexes also contain a triphenylphosphine 
(or a derivative) ligand. Many of the compounds exhibit ‘typical’ linear, two-coordinate 
gold, with the organometallic ligand coordinated to gold through a Au-C single bond. 
Gold-gold bonding is also possible, and there are several examples of three-coordinate 
gold organometallic compounds that have been investigated. 
The prototypical gold(1) organometallic compounds are Au(PPh3)R (R = Me, Ph). They 
are oxidized at +1.6 V (vs Ag/AgCI) and reduced at ca - 1.6 V (see Table 9)29. Compar- 
ing these potentials with those for Au(PPh3)X (X = CI, Br and I, Table 6) suggests that 
the alkyl and aryl groups in Au(PPh3)Me and Au(PPh3)Ph, respectively, are electronically 
similar to the chloride anion. The effects of different substituent groups on the oxidation 
potentials of a series of Au(PPh3)R compounds can be explained on the basis of sim- 
ple electronegativity arguments. Placing an electron-donating rnethoxy group in the para 
position of the aryl group makes oxidation of Au(PPh3)(4-MeOC&) ca 300 rnV easier 
than for Au(PPh3)R (R = Me, Ph), while a para fluoride makes Au(PPh3)(4-FC6Hq) ca 
400 mV harder to oxidize. Cyanide has a similar effect (R = CN, CH2CN etc.), as do 
the other electron-withdrawing groups, CH(COR)2 (R = Me, Ph or t-Bu). Note that the 
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TABLE 9. Cyclic voltammetry data (V)  of organometallic complexes 
Compound 
Au(PPh3)Me 
Au(PPh3)Ph 
Au(pPh3)(4-h'leOC&) 
A u ( P P ~ ~ ) ( ~ - F C ~ & )  
Au(PPh3 )CN 
Au(PPh3)CHzCN 
Au(PPh3)CH(COOEt)CN 
Au(PPh3)CMe(CN)z 
Au(PPh3)CH(COMe)z 
Au(PPh3)CH(COMe)(COPh) 
Au(PPh3)CH(COPh)z 
Au(PP~~)CH(COBU-~)~  
A u ( P P ~ F c ~ ) ( ~ - F G ~ & ) ~  
Au(PFc~)(~-FC&)~ 
29a 
29b 
29c 
29d 
29e 
2% 
29g 
29h 
2% 
3Oa 
30b 
31a 
31b 
32 
33 
34 
35 
Oxidatlons 
f1 .59  
+1.61, +1.97 
+1.28, +1.71 
+2.00 
+2.25 
+2.24 
+2.17 
+2.30 
+2.00 
+2.05 
+ 1.96 
+ 1.86 
+0.61, +0.80, +2.w 
+0.57, +0.72, $0.86, +2.13 
+0.76 (ir), + 1.01 (qr) 
+0.74 (ir). + 1.03 (qr), +2.05 
+0.78 (ir). +1.05 (qr), +1.66, 
+1.73, +1.88 
+0.74 (ir), +1.05 (qr), +1.27, + 1.39, + 1.54, + 1.70 
+0.66 (ir). +1.08 (qr), +1.97 
+0-95 (ir), + I .  I I (qr) 
+0.93 (ir), +1.11 (qr) 
+0.98 (rev) 
+ 1.03 (rev) 
t0 .24  
t0 .81  
+0.68, +1.62 
+0.88, +1.81 
+0.72, +2.21 
+0.48, +1.36, +1.97 
+1.52, +1.94 
+0.79, +1.08, +1.41, t-2.04, 
+0.84 
36 
Reductions Conditions 
- 1.63 a 
- 1  73 a 
b a 
b a 
-0.78~ C 
-0.98b C 
-0.796 C 
-1.00,-1.91 c 
-1.64 a 
-1.60 a 
- 1.56 a 
-1.60,-1.78 a 
b a 
b a 
e 
e 
e 
Reference 
29 
29 
29 
41 
29 
29 
29 
29 
29 
29 
29 
29 
41 
41 
42 
42 
42 
e 
e 
e 
e 
f 
f 
b a 
- 1.669 a 
- 1.62 a 
-1.77 a 
-2.21 a 
- 1.84 a 
b h 
- 1.36 h 
-0.62.-0.84 i 
42 
42 
42 
42 
43 
43 
44 
44 
44 
44 
44 
29 
29 
29 
45 
working electrode. 0.05 M [EtqN]BF.&leCN, Ag/AgCI reference couple. 
bNo reduction observed at a Pt working electrode. 
'=Dropping mercury electrode. 
d~~ =ferrocenyl. 
eGlassy carbon working electrode, Ag/AgCI reference couple in CHzC12. potentials reported v5 SCE. 
~ S C E  reference in C H ~ C I ~ .  
gReduction of the nitro group. 
hAg/AgCI reference couple in hleCNICHzCI2 (I :  10). 
'SCE reference in MeCN. 
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electron-releasing t-butyl groups in Au(PPhs)CH(COBu-t)2 have only a modest effect on 
the oxidation potential. 
Replacing triphenylphosphine with ferrocenyl-derivatized phosphines adds additional 
redox centers with very rich organometallic chemistry of their own46. The cyclic voltam- 
mogram of Au(PP~Fc; ! ) (~-FC~H~)  shows an oxidation process at ca +2 V, simdar to that 
of A u ( P P ~ ~ ) ( ~ - F C ~ H ~ ) ,  and two additional redox processes at +0.61 V and +0.80 v that 
appear to be associated with coupled, iron-based redox processes. 
A number of dinuclear gold(1) complexes containing the 1, 1'-bis(dipheny1phosphino)fer- 
rocene (dppf) ligand, 29a-i, have been analyzed e l e c t r ~ c h e m i c a l l y ~ ~ ~ ~ ~ .  On the basis of 
the above discussion, two oxidation processes are expected, one that is ferrocenyl-based 
and the other associated with the organogold fragment. Indeed, this is what is reported 
for 29a. However, the situation is obviously more complicated for the other dinuclear 
gold(1) complexes (29b-i), where up to six anodic processes are reported in the range 
of 0-2 V (see Table 9). In the dppf chemistry of other transition metals, the dppf ligand 
is often found chelated to a single This suggests that in solution the two Au'R 
redox centers might easily encounter each other to produce redox coupling, resulting in 
splitting of peaks, or perhaps initiating a facile chemical reaction, following the electron 
transfer process. 
There are several other factors that make it difficult to assign the redox processes in 
29b-i. The oxidation potential of the dppf ligand is somewhat solvent-dependentG. The 
dppf redox couple is generally reversible; however, in the presence of water, the dppf 
ligand undergoes a fast chemical reaction following oxidation47. In cyclic voltammetry 
experiments run under similar conditions but employing different electrodes, the oxidation 
potentials reported for dppf are +0.68 V43 (vs SCE at Pt in 0.1 M [NBu~]PF~/CHZC~Z 
at 100 mVs-') and +0.97 V42 (vs SCE at glassy carbon in 0.1 M [ N B U ~ ] P F ~ / C H ~ C ~ ~  
at 100 mV s-I), which suggests that the nature of the electrode also significantly affects 
the oxidation potential. 
RAu-P-q& Ph2 
(29a) R = M e  (29d) R = C14H9,9-anthryl (29g) R = CSCBu- f  
(29b) R=Ph  (29e) R = c16H9. 1 -pyrenyl (29h) R = c6F5 
(29c) R = C I O H ~ ,  1-naphthyl (290 R = C e C P h  (29i) R = CH2PPh2Me 
In compounds 29a-g, the quasi-reversible oxidations at cu +1.0-1.1 V occur almost 
identically where dppf oxidizes at a glassy carbon electrode, which suggests that the 
redox process at this potential is iron (dppf) based. The anodic waves occurring at lower 
potentials in the range between +0.66 V and +0.95 V have been assigned as one-electron 
oxidations of gold in 29a-g4'. Comparing the first oxidation potential of Au(PPh3)Ph 
(+1.61 V) vs Au(PPh3)(4-FC&) (+2.00 V), it is expected that the pentafluorinated 
phenyl substituent in 29h would push gold-based oxidation to much higher potentials, 
possibly switching the lowest energy oxidation process to a dppf-based oxidation. In 
cyclic voltammetry experiments on 29h, the first oxidation process (+0.98 V at a Pt 
electrode) is reversible with peak-to-peak splitting of 60 mV, suggesting that this is indeed 
what has occurred. Until more data are available, e.g. bulk electrolyses as a function of 
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potential, it is prudent to reserve judgment about the assignment of these redox processes. 
Nevertheless, what is evident is the rich electrochemistry of these complexes. 
(30a) X = H (31a) X = H  
(31b) X = COOMe (30b) X = NO2 
The electrochemistry has been reported for a variety of other structural types, notably 
compounds where one AuPPh3 is directly attached to a Cp ligand in ferrocene (30a,b)44, 
two AuPPh3 units are bonded to the same carbon of a Cp ring stabilized by intramolecular 
gold-gold interactions (31a,b)44, two AuPPh3 units are coordinated to a sulfur substituent 
on a Cp ring (32) and a series of compounds where AuPPh3 is sequentially added to 
cyclopentadiene (33-35)29. The reduction potentials for 30-35 occur in a fairly narrow 
range (see Table 9). However, the oxidation processes vary tremendously (e.g. compare 
33 vs 34) suggesting significantly different electrochemical properties that would be quite 
interesting to investigate further. 
Ph Ph + 
B F4- 
Finally, the electrochemistry of the organometallic gold(II1) carborane complex, 36, 
has been reported45. The cyclic voltammogram of 36 in MeCN solution shows two redox 
processes. The first is a reversible redox couple (-0.62 V vs SCE) that has been assigned 
as a one-electron reduction to a stable gold(I1) complex. The second reduction process 
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involves a quasi-reversible redox couple, presumably to the gold(1) carborane. Strong 
evidence that the intermediate redox compound is a gold(I1) complex was found by 
investigating the electrochemistry of an isolated gold(II) compound made by reduction of 
36 with sodium amalgam. The dianionic gold(I1) compound displays an initial cathodic 
process (-0.92 V vs SCE) similar to that found in the second reduction process of 36 
(-0.84 V vs SCE). In addition, a reversible redox process is observed at -0.62 V vs SCE 
for oxidation of the gold(1I) compound. 
I Au 
- I  
IX. DRUGS 
Although the antibacterial effects of silver and the biological activity of gold have long 
been known, few electrochemical studies have appeared on the redox properties of gold 
and silver complexes of biological importance. Gold complexes such as [Au(lk)2 J f  have 
been shown to be potent cardiovascular toxins2’ while complexes such as Auranofin, 37, 
have been used successfully to treat rheumatoid arthritis. While the mechanism of action 
of anti-inflammatory gold drugs is not clear, the interaction of gold(1) centers with the 
thiol groups of proteins and enzymes is believed to play a role. 
AcOH~C 
S-AuPEt, AcO 
OAc 
P6rez and coworkers investigated the reduction of 37 at a dropping mercury electrode48. 
Figure 9 shows the electrochemical behavior of 37 i n  deoxygenated alkaline 0.06 M 
K3P04 ethanovwater (1 : I )  solution using dc polarography (a) and differential pulse 
polarography (b) techniques. The polarographic techniques were used to establish that the 
electrochemical processes are diffusion controlled and reversible in alkaline media. Bulk 
electrolysis at -0.8 V leads to an n value of 0.9 electrons per molecule and suggests 
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FIGURE 9. Electrochemical behavior of Auranofin, 37, in deoxygenated alkaline 0.06 M K3PO4 
ethanovwater ( I  : 1) solution: (a) direct current polarography; (b) differential pulse polarography. 
Reproduced by permission of the American Pharmaceutical Association from Reference 48 
-0.20 1% 
8 . 
I I 
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PH 
FIGURE 10. The pH dependence on Ell2 of Auranofin, 37. Reproduced by permission of the American 
Pharmaceutical Association from Reference 48 
that the reduction involves the Au"' redox couple. Interestingly, the reduction poten- 
tial is strongly sensitive to the pH values below 8.5 as shown in Figure 10. Above a 
pH of 9, there is no proton-dependent pathway and the redox couple appears at -0.5 V 
vs SCE (see Table 10). Below a pH of ca 8.5, a proton-dependent reduction pathway 
is indicated. Protonation of triethylphosphine (equation 6, pKa = 8.69) is believed to be 
responsible for the shift in potential as a function of pH. A linear relationship between the 
limiting current and Auranofin concentration was also noted in the concentration range 
3.63 x M. Effects of adsorption processes at the electrode surface to 5.1 x 
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TABLE 10. Electrochemical data (V) of gold drugs 
Compound Alternative Oxidations Reduction Conditions Solvent pH Reference 
formula 
37 Auranofin -0.5 LI EtOWH20 > 9 48 
Au(41 ) A u[ L-cys teine] +1.19 b H 2 0  1.67 49 
Au(42) Au[D-penicillamine] + 1.14, + 1.35 b H 2 0  1.67 49  
~~ ~-~~ ~ ~~ 
Polarography, SCE reference, dropping mercury workmg elecucde 
b ~ y c ~ i c  voltammetry, SCE reference, PI working electrode 
appear at concentrations above 3 x M. 
p(c2H5)3 + H+ 6 [p(c2HS)3Hl+ (6) 
The reducing properties of antiarthritic drugs such as Auranofin, 37, sodium auroth- 
iomalate (myocrisin), 38, sodium aurothiopropanol sulfonate (allocrysin), 39, and auroth- 
ioglucose (solganol), 40, were investigated by Huck and coworkers5'. The standard redox 
potentials of drugs which instantly react with the oxidant, 5,5'-dithiobis-(2-nitrobenzoic 
acid), were determined by titration with potassium hexacyanoferrate(m) in a 0.1 M phos- 
phate buffer (pH 7.0, 25"C), at a dropping mercury electrode using a SCE reference. 
Unfortunately, none of the gold-containing compounds reacted very quickly with the oxi- 
dant and the standard potentials could not be measured directly even after long incubation 
periods in phosphate buffer at 37 'C". 
COONa AuS-CH~ 
n 
(38) (39) 
HOHzC 
HO-s-*u HO 
OH n 
Anderson and Sawtelle have investigated the aqueous redox processes for the elec- 
trogenerated gold(1) species, [AuC12]-, complexed by biologically relevant ligands such 
as cysteine, 41, and penicillamine, 4249. They propose an aqueous reduction mechanism 
that begins with [AuCb]- as iIIustrated in equations 7-9. The progress of these electron 
transfer and coupled chemical reactions can be followed by cyclic voltammetry and UV- 
vis spectroelectrochemistry. Upon formation of [AuC12]-, addition of 41 or 42 leads to 
complexation and changes in the electrochemistry which allows an estimation of the oxida- 
tion potentials (see Table 10) of the Au[cysteine] and Au[penicillamine] complexes. Cyclic 
voltammetry control experiments with cysteine, cystine and penicillamine indicate that the 
observed electrochemical responses do not originate from these free species in solution. 
[AuCLI- F==+ [AuCI~]' + 2 CI- (7 1 
[AuC12]+ + 2 e- 6 [AuC12]- (8) 
[AuC12 1- + e- Au + 2 C1- (9) 
The mechanisms of a wide range of bactericidal agents, including silver sulfadiazine, 
43, which has an extended polymeric structureS1, were examined by Ames, Ryan and 
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Kovacic using cyclic voltammetry measurement at either Pt or dropping mercury working 
electrodes52. Unfortunately, because of the low solubility of 43 in 0.1 M KH2P04/0.1 M 
NaOH solution (pH 7.0), no reduction wave was observed. 
. 
X. IMIDES AND ANlLlDES 
Two series of linear silver salts of imides and anilides, formulated as [Ag(L)2]NEh 
(amide = 44a-h) and [Ag(L)z]Ag (L = 44a-e), have been studied using linear 
voltammetry, cyclic voltammetry and coulometry at F't and vitreous electrodes in 
a ~ e t o n i t r i l e ~ ~ , ~ ~ .  The linear voltammograms obtained for [Ag(L)2 ]Ag show two cathodic 
waves and one anodic wave (see Table 11). The first cathodic wave at cu -0.2 V vs 
Ag/Ag+ for [Ag(44a)2]Ag corresponds to reduction of the loosely bound silver ion 
(equation 10) and the second wave at cu -1.3 V vs Ag/Ag+ corresponds to reduction 
of the tightly bound silver ion (equation 11). As expected, there is only one reduction 
wave at -1.35 V for [Ag(44a)2]NEh which corresponds to reduction of the tightly bound 
silver ion. 
ca -0.2 V 
[Ag(44a)2]Ag + e- [Ag(44a)21- + Ago (10) 
The second cathodic process in [Ag(44e)2]Ag is broad and occurs at a very low potential 
(-0.5 V vs Ag/Ag+) compared to the other silver salts in this series. This anomalous 
behavior was attributed to the lower stability of the silver complex and the presence of 
several isomeric forms of the acyclic imide Iigand. 
Both the silver salts and the mixed silver/tetraethylammonium salts show anodic waves 
that are similar in potential and amplitude, demonstrating similar oxidation processes 
in both salts. Coulometric measurements and n values show that the oxidation process 
is irreversible and involves one electron. This process was assigned as a ligand-based 
oxidation. In general, the complexes with cyclic imide ligands (Ma-d) oxidize at cu 
+IS V vs Ag/Ag+. The oxidation potentials of the silver complexes with acyclic lig- 
ands (44e-h) are more sensitive to changes in ligand composition. The presence of two 
electron-withdrawing carbonyl groups in 44e gives rise to a higher oxidation potential than 
those with only one carbonyl group (44f-h). Placing an electron donating methoxy group 
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TABLE 1 I .  
Compound Alternative formula Oxidationsb Reductionsb Reference 
Electrochemical data (V) of imides and anilidesa 
[Ag(succinimide-)2]NEb 
[Ag(succinimide-)2 ]Ag 
[ Ag(Me4 succinimide-)z]NEh 
[Ag(Me4succinimide-)z ]Ag 
[Ag(phthalimide-)z ]NEb 
[Ag(phrhalimide-)2 ]Ag 
[Ag(benzoylimide-)2 ]NE& 
[Ag(benzoylimide-)2]Ag 
Au(PPh3)NHCOMe 
Au(PPh3 )NHCOCH2 CI 
Au(PPh3)NHCOPh 
Au(PPh3)NHGb NOz-o 
Au(PP~~)NHC~I%N@-P 
+ I  .48‘ 
+ 1 .48‘ 
0.Od 
+ 1 .56‘ 
+ i s w  
.O.Od 
+1 .52‘ 
+ 1.52‘ 
0.od 
+ 1-47‘ 
+ 1 .45‘ 
0.od 
+1.01‘ 
+ 1.04‘ 
0.0d 
-0.1’ 
+0.4lC 
+0.27‘ 
t0.65‘ 
+1.89 
+ 1.9@ 
+2.27’ 
+ 1 .54’ 
+ 1.44d 
- 1 .35‘ 
-0.18‘ -1.3w 
-0.25’ -1.sod 
-0.16‘ -1.52‘ 
-0.26’ -1.7od 
-0.17‘ -1.3oC 
-0.22’ - 1 .46’ 
-0.18‘ -1.38‘ 
. .  
-0.48’ -1.66d 
-0.2oc -0.Y 
-0.3od -0.54‘ 
-0.27‘ -1.38‘ 
-0.3od -1.74d 
- 1 .77’ 
-1.80d 
- 1 .92’ 
- 1.65’ 
-1.37’ -1.76’ 
-1.43’ -1.65’ 
-1.43’ -1.84‘ 
-1.51’ -1.75’ 
-1.87’ 
53.54 
53 
53 
54 
53 
53 
54 
53 
53 
54 
53 
53 
54 
53 
53 
53 
53 
54 
54 
29 
29 
29 
29 
29 
29 
29 
29 
29 
“Electrochemical studies reported at Pt working electrode and Ag/Ag+ reference couple in MeCN. 
bValues reported in Reference 29 as E I ~  and References 53 and 54 as Epc. 
‘Linear rotating disc voltammetry at UJ = 600 rpm. 
’cyclic voltammetry. 
in the para position of the phenyl ring (44g) makes the silver complex, [Ag(44a)2]NEk, 
easier to oxidize (+0.27 V vs Ag/Ag+) than the parent complex, [Ag(44f)2JAg ($0.41 V 
vs Ag/Ag+). The silver complex, [Ag(44h)2]NEk, with an electron-withdrawing cyanide 
substituent, is harder to oxidize (f0.41 V vs Ag/Ag+). 
Finally, in the cyclic voltammetry studies of the silver salts, there are two cathodic 
waves, with similar potential values as observed in the linear voltammetry studies. How- 
ever, on the return sweep in the CV, there was an anodic peak at 0 V vs Ag/Ag+ which 
was attributed to oxidation of electrodeposited silveS3. 
A series of triphenylphosphine gold amide complexes (45-48) was studied by 
Rakhimov and coworkers29. The anodic process was in general assigned to a one-electron 
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oxidation of the amide or anilide ligands, followed by a series of chemical reactions that 
resulted in deposition of Auo on the platinum electrode. The aniline derivatives can be 
doubly and triply ‘aurated’ (46-48) by addition of two or three (AuPPh3)+ groups. 
Auration does nor have a predictable effect on the oxidation potential (see Table 11). 
However, changing the substituent on the phenyl ring appears to have a significant effect 
on the oxidation potential. For example, [(AuPPh3)3NC6&Me-p]+ with an electron- 
donating methyl in the para position of the ring oxidizes at +0.95 V vs Ag/AgCl, while 
the para-nitro derivative is harder to oxidize by 560 mV. 
Au(PPh3) 
/ / 
\ \ 
(PPh3)Au- N 
H 
(PPh3)Au- N 
R R 
1 Au(PPh3) / \ (PPh3)Au- N-Au(PPh3) R 
(48a) R = C6H4N02-p 
(48b) R = C6H4Me-p 
The first cathodic process for the amide gold complexes is proposed to be a one- 
electron reduction. As the number of (AuPPh3)+ groups increases, the reduction process 
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becomes less reversiblez9. The para-nitroaniline complexes also show a second cathodic 
process with n values of 2.8-4. A scheme was proposed that included initial one-electron 
reduction of the p-nitroaniline ligand followed by formation of metallic gold and 
regeneration of a molecule that is electrochemically active in the same potential range29. 
XI. OTHER LIGANDS AND STRUCTURAL TYPES 
This section includes selected examples of electrochemistry of gold and silver com- 
plexes with other ligands and structural types that were not included in previous sections. 
We have also included a list of references divided into the following areas that can be 
consulted for additional information: sulfur- and nitrogen-containing macro cycle^^^-^^, 
p ~ r p h y r i n s ~ ' - ~ ~  and clusters97- ' 1 6 .  
A. Macrocycles 
Macrocycles are well known to bind to a variety of metals in several oxidation states and 
the macrocycle cavity size can be vaned to electronically tune redox couples. A number of 
electrochemical investigations have been conducted on gold and silver macro cycle^^^-^^. 
Electrochemical data for complexes with the sulfur-coordinated macrocycles, [9]aneS3 
(49) and [18]aneS9 (SO) are listed in Table 1257,62. Silver(1) and gold(1) coordinate to 
two molecules of 49 but only one molecule of 50. In [Ag(49h]+, the silver atom is six 
coordinate. In contrast, the X-ray structure of [Au(SO)]+ shows a distorted tetrahedral 
TABLE 12. Cyclic voltammetry data (V) of other ligands and structural types 
Compound Oxidations Reductions Conditions Reference 
Macrocycles -Suljiur 
[A~(49)21+ +O. 12, +0.46 
rAg(49)21+ +0.75 
IAu(SO)l+ +0.36, +0.56 
[Ag(50)1+ +1.00 
Macrocycles - Nitrogen 
[Au(S1)J3+ 
[Au(52)I3+ 
[Ag(51)l2' t0 .86  
Porphyrins 
Ag(53) + O X ,  + 1.64 
[Au(53)1+ +1.68 
CIusters 
IAg,3(113 - Fe(co),)sl3- 
[Pd(A~PPh3)81~+ 
[Pt(AuPPhj)s 12+ 
[Au(AuPPh3)8 J3+ 
-0.57 
-0.42 
-0.16, -0.62, -0.98 
- 1.28, - 1.42, - I .89 
- 1 . 1  
-0.59 
-0.37(rev),-0.65(rev) 
- I  .8O(rev),- 1.98(rev) 
- 1.57(rev),- 1.72(rev) 
-1.03(rev),-l.l ](rev) 
a 
a 
a 
a 
b 
b 
b 
C 
C 
b 
d 
d 
d 
62 
57 
62,66 
57 
70 
70 
68 
80 
80 
1 07 
I10 
1 1 1  
1 1 1  
~ ~~ 
aMeCN, ws Fc/Fc+ couple 
bMeCN, vs SCE 
'CH2CI2. referenced to Ag/AgCl but reponed YS SCE 
dCH2C12, ws Fc/Fc+ 
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geometry with Au' coordinated to four of the sulfurs in the ring62. Figure 11 shows a 
cyclic voltammetry experiment on [Au(50)]+ in MeCN solution66. Two redox couples 
occur at  +0.36 V and +0.56 V (vs Fc/Fc+) which were assigned as two successive 
one-electron oxidations: Au' + Au" followed by Au" + Au". The corresponding Ag' 
macrocycle complexes, [Ag(49)2]+ and [Ag(SO)]+, show one oxidation process at higher 
potentials that have been assigned as the Ag'/" couples. The influence of the macrocycle 
ring size can be illustrated by comparing the oxidation potentials for the complexes with 
49 and 50. The gold and silver complexes with 50 are harder to oxidize reflecting the 
increased stability of Au' and Ag' coordinated to the larger macrocycle. 
Examples of the electrochemistry of nitrogen-containing gold and silver macrocycles are 
listed in Table 12. Kimura and coworkers have investigated a series of complexes based 
on cyclams such as [14]aneN4 (51)70. Cyclic voltammetry experiments of [Au(51)l3+ in 
0.1 M [Bu4N]PF6/MeCN solution at a glassy carbon working electrode shows three irre- 
versible reduction waves. The reductions which occur at -0.16 V, -0.62 V and -0.98 V 
vs SCE were assigned as successive one-electron processes. The Aum complex with the 
triphenylphosphine-pendant cyclam, 52, shows dramatic shifts in the reduction potentials, 
indicating that this gold complex is greatly stabilized toward reduction (see Table ~2 )~ ' .  
Po and coworkers investigated the Ag" complex, [Ag(51)l2+ 68- Cyclic voltammetry 
experiments at a Pt electrode in 0.1 M [Et4N]C104/MeCN solution show a quasi-reversible 
redox couple at +0.86 V w SCE assigned to the Ag"/" couple. 
I I 
+ 0.05 + 1.05 V vs FC/FC* 
FIGURE 11. Cyclic voltammetry experiment on [Au(SO)]+ in  MeCN. Reproduced by permission of 
Kluwer Academic Publishers from Reference 66 
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. Porphyrins 
There is great interest in studying the electrochemistry of gold and silver porphyrins 
in aqueous and nonaqueous  solution^^^-^^. The redox reactions for rnetalloporphyrins 
include changes in the oxidation state of the porphyrin nucleus and, in some cases, 
changes in the oxidation state of the metal. The porphyrin ring tends to stabilize the 
higher oxidation states of silver and gold. 
The electrochemical data for many gold and silver porphyrins can be exemplified by 
considering their complexes with the tetraaphenylporphyrin ring, 53 (see Table 12). The 
metal-based oxidation (Ag"/m couple) of Ag(53) at +0.55 V vs SCE occurs between the 
porphyrin ring oxidation (+1.64 V) and reduction (-1.1 V) processes. In contrast, in the 
Auru analog, [Au(53)]+, gold is inert and only ring-based redox processes are observed. 
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C .  Clusters 
The tendency of clusters to undergo facile rearrangements or decomposition upon elec- 
tron transfer, as well as the presence of a large number of redox centers, can make the 
assignment of the redox behavior of clusters a ~ h a l l e n g e ~ ~ - ~ ~ ~ .  An interesting example 
is provided by [Ag,3(pyFe(C0)4}gl3-, a cluster composed of a core of 12 silver atoms 
arranged in a cuboctahedron structure, with an additional silver atom at the center bridg- 
ing to the other 12 silver atoms (54)Io7. Eight p~-Fe(C0)4 units cap each triangular face 
of the cuboctahedron (not shown in 54). Cyclic voltammetry experiments of [Ag13(p3- 
Fe(C0)4)gl3- at low concentrations (0.1 mM/MeCN) display two reversible cathodic 
processes (see Table 12). Controlled potential bulk electrolysis at -0.5 V yields an n value 
equal to one electron per cluster molecule. However, at higher concentrations (2.1 mM), 
the first redox process remains reversible, but the second becomes irreversible, suggesting 
a second order following reaction. Figure 12 shows the cyclic voltammogram recorded at 
the higher concentration using a Pt working electrode and a scan rate of 200 mVs-'. The 
large wave that appears in the cathodic scan at cu -0.2 V vs SCE appears to be a silver 
surface wave, i.e. the result of oxidation of silver metal deposited at the electrode in the 
reduction scan. The wave is similar in shape and potential to that seen in the analysis of 
silver during a stripping voltammetry experiment"'. 
- 1.0 - 1 SO0 
V 
FIGURE 12. Cyclic voltammogram for 2.1 x M [EbN][Agl3(p3-Fe(C0)4)8] at a platinum elec- 
trode in 0.2 M [EbN]C104/MeCN at scan rate 200 mVs-'. Reproduced by permission of Plenum Press 
from Reference 107 
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I I I I 
+1.0 +0.5 0.0 - 0.5 -1 0 -1.5 
Potential (V vs SSCE) 
FIGURE 13. Cyclic voltammogram for [Pt(AuPPh,)8I2+ in 0.1 M [BQN]PF~/CH~CI~  at scan rate 
200 rnVs-'. Reprinted with permission from Reference 11 1. Copyright (1989) American Chemical 
Society 
The electrochemistry of [Pd(AuPPh3)*l2+ was investigated by cyclic voltammetry and 
differential pulse polarography in CH2C12 and MeCN solutions"'. This cluster undergoes 
two stepwise, reversible one-electron transfers, thus showing an EE reduction mechanism 
(see equations 12 and 13, and Figure 13). It is interesting to note the large shift to more 
positive potentials as the central metal atom in [M(AuPPh3)sJn+ changes from PdU to 
Pt" to Au" (see Table 12)11091'1- 
[Pd(AuPPh3)8I2+ + e- --1 [Pd(AuPPh3)8]+ El12 = -1.80 V vs Fc/Fc+ (12) 
[Pd(AuPPh3)8]+ + e- __1 Pd(AuPPh3)8 E1/2 = -1.98 V vs Fc/Fc+ (13) 
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